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ABSTRACT
Purpose: To examine potential effect modification by race-ethnicity of the relationship
between physical activity (PA) and diabetes-related mortality risk using a sample of U.S. adults
from the Third National Health and Nutrition Examination Survey (NHANES III). Methods:
The sample (n=10,717) included adults (≥20 years) who attended the Mobile Examination
Center (MEC). An age-standardized PA score (PAS) was calculated from the self-reported
frequency and intensity of 12 leisure-time aerobic activities. The PA scores were then grouped
into three categories: inactive (PAS = 0), insufficiently active (PAS >0 - <10), and active (PAS
≥10). A PAS of 10 was chosen as a proxy cutoff for 5 bouts/wk of moderate-intensity activity,
the 2007 American Heart Association/American College of Sports Medicine aerobic PA
guideline. Diabetes-related mortality was defined as either death from diabetes mellitus as the
primary cause or if diabetes was flagged on the death certificate as a contributing cause. Raceethnic groups included: non-Hispanic white (NHW), non-Hispanic black (NHB), and Mexican
American (MA). SAS 9.4 survey procedures were used for all statistical analyses. Results: There
was no interaction between PA and race-ethnicity (p=0.83). Compared to inactive NHW, there
was a significantly lower risk for diabetes-related mortality for insufficiently active (Hazard
Ratio [HR] 0.51, 95% Confidence Interval [CI] 0.29-0.89) and active (HR 0.57, 95% CI 0.331.00) NHW adults. Statistical significance was not achieved for any level of activity for NHB
and MA. A significant p-for-trend was revealed only for MA. Conclusions: The results of this
study suggest that accumulation of any volume of PA is associated with a significantly lowered
risk for diabetes-related mortality only in NHW. A significant dose-response relationship was
only observed among MA. However, the interaction between race-ethnicity and PA did not attain
statistical significance. Thus, the presence of effect modification could not be determined from
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the current study, but further investigation is warranted. Given longer follow-up time in the
NHANES III cohort, the ability to estimate more precise risk reductions will become plausible.
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PART 1
INTRODUCTION
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Diabetes is a deleterious metabolic condition characterized by chronic hyperglycemia.
Currently, diabetes is the seventh leading cause of mortality among adults in the United States;
with the vast majority of these deaths being related specifically to type 2 diabetes (T2D) (1).
Despite being a top ten cause of death, diabetes is more likely to be a contributing cause of death
rather than the primary cause of death (2, 3). Furthermore, it is postulated that diabetes is
underreported as a cause or contributing cause of death (2). On the death certificates of those
with diabetes, approximately 35-40% have diabetes reported as a cause. Moreover, only 10-15%
of people with diabetes who died have diabetes listed as the primary cause (2). Considering its
strong link to cardiovascular disease (4, 5), cancers (6), kidney disease (7), and stroke (8); it is
evident that diabetes plays a substantial role in mortality related to cardiovascular and metabolic
causes.
Among race-ethnic groups, substantial disparities exist in the current, as well as the
projected, prevalence of diabetes. American Indian/Alaskan Natives have the highest estimated
prevalence of T2D (15.9%), with the next highest prevalence rates being found among NonHispanic Blacks (NHB, 13.2%), Hispanics (12.8%), and Asians (9.0%) (2). Those who are nonHispanic White (NHW) have the lowest prevalence of T2D (7.6%) (2). Honeycutt et al. (9)
reports the projected 50 year increase in prevalence of type 2 diabetes to be higher among NHBs
(118%), Hispanics (149%) and other ethnicities (170%), as compared to NHW (104%).
The current mortality rates associated with diabetes also differ across race-ethnic groups
(1). The age-adjusted death rate (per 100,000) attributable to diabetes is higher among Hispanics
(25.1) and NHBs (38.2) compared to those who are NHW (18.6) (1). Moreover, compared to
NHWs, NHBs and Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively
(1). It can be hypothesized that these disparities in diabetes-related mortality rates between race-
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ethnic groups may be influenced, in part, by differences in physical activity (PA) participation or
physiological differences through which the same levels of PA have different levels of protection
(10) .
Currently, two studies have investigated the relationship between PA and diabetesspecific mortality (11, 12). Andersen et al. (11) found that participation in sports (Hazard ratio
[HR] 0.34, 95% CI 0.21-0.55), cycling (HR 0.61, 95% CI 0.42-0.89), or gardening (HR 0.42,
95% CI 0.28-0.62) resulted in significantly lower HRs for diabetes-related mortality compared to
those reporting no participation in these activities. In those reporting walking, statistical
significance was not attained (HR 0.77. 95% CI 0.44-1.33). Williams et al. (12) examined the
relationship between MET-hrs/d of walking and diabetes-related mortality. MET-hrs/d of
walking were categorized into four levels: <1.07 MET-hrs/d (category 1), 1.07-1.8 MET-hrs/d
(category 2), >1.8-3.5 MET-hrs/d (category 3), and ≥3.6 MET-hrs/d (category 4). Only those in
category 4 (HR 0.17, 95% CI 0.04-0.73) had a significant reduction in risk for diabetes-related
mortality. In a separate analysis adjusting for reported BMI, a significant HR was found for
category 4 (HR 0.17, 95% CI 0.04-0.80). While these two studies provide insight into PA and
diabetes-related morality, there currently exists no literature examining this relationship
specifically investigating the effect modification by race-ethnicity.
The National Health and Nutrition Examination Survey (NHANES), and the available
National Data Index (NDI) linked data, provides a population based opportunity to examine the
extent in which PA protects against diabetes-related mortality across several race-ethnic groups.
Therefore, the purpose of this study was to examine the effect modification of race-ethnicity on
the association between PA and diabetes-related mortality using the NHANES III and the 19992006 NHANES, as well as the NDI. From the NHANES III and the 1999-2006 NHANES, self-
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report PA is available to examine the association between PA and diabetes-related mortality.
Also, within the 2003-2006 NHANES, objectively-measured PA, via accelerometer, is available
to further investigate this relationship. Along with the data from the NDI, the multiple measures
of PA will allow for a comprehensive examination of the relationship between PA and diabetesrelated mortality.
Definitions
The following section provides details on commonly used nomenclature within the document
1. Diabetes: a deleterious metabolic condition characterized by chronic hyperglycemia
(inclusive of type 1 diabetes and type 2 diabetes)
2. Type 2 Diabetes: Chronic hyperglycemia as a result of defects in insulin action and/or
secretion (13).
3. Race-ethnicity:
a. NHANES race-ethnic groups
-

Non-Hispanic White: Those who are white and without Hispanic origin.

-

Non-Hispanic Black: Those who are black and without Hispanic origin

-

Mexican American: Those who are of Mexican origin

-

Other: Those who are of Hispanic/Latino origin other than Mexican;
Asians, and Native Americans as well as those who are multi-racial

b. Other studies included in the document
-

Hispanic: Those of any Hispanic/Latino origin i.e. Puerto Rican, Cuban,
Central/South American, Mexican (1)

4. Diabetes-related mortality: defined as either death caused by diabetes mellitus or if
diabetes was flagged on the death certificate with multiple causes of death
4

Statement of the problem
Currently, no prospective population-based study has examined effect modification by
race-ethnicity on the relationship between PA and diabetes-related mortality. The purpose of this
study was to investigate the dose-response associations between PA and diabetes-related
mortality across race-ethnic groups using data from NHANES III, the 1999-2006 NHANES, and
the NDI. Below are the specific research questions to be addressed in this study.

Research questions
Specific to adults (20-79 years of age) participating in the NHANES III, the following research
question will be addressed:
1. Is there a dose-response relationship between self-reported PA and diabetes-related
mortality across race-ethnic groups?
Specific to adult participants (20-79 years of age) in the 1999-2004 NHANES the following
three questions will be addressed:
2. Among the 1999-2004 NHANES, is there a dose-response relationship between selfreported PA and diabetes-related mortality across race-ethnic groups?
Questions specific to adult participants (20-79 years of age) within the 2003-2006 NHANES:
3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA
and diabetes-related morality across race-ethnic groups?
3B. Is there a dose-response relationship between quartiles of accelerometer-derived total
activity counts/day (TAC/d) and diabetes-related morality across race-ethnic groups?
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Significance
This study will add to the current literature by providing insight into the race-ethnic
specific associations between PA and diabetes-related morality. This will be the first study to
determine the extent in which PA relates to diabetes-related morality across several race-ethnic
groups.
Delimitations
For research question 1, the analyses will be limited to adults 20-79 years of age that did
not die within the first three years of follow-up. For analyses using the 1999-2006 NHANES, the
analyses will be limited to adults 40-79 years of age. Within the 2003-2006 NHANES,
participants with less than four days and ≤10 hours of accelerometer wear time per day were
excluded.
Limitations
There are several limitations inherent to the design of the NHANES. The limitations are
described below.
1. The diabetes mortality variable includes death from type 1 diabetes, malnutrition-induced
diabetes and other types thus the deaths from diabetes are not limited to just T2D
(appendix 1, table 2)
2. Duration of PA was not measured in NHANES III, thus limiting the interpretability of
total volume of activity.
3. Within the 2003-2006 NHANES, the ActiGraph 7164 model was used. A limitation with
this device is limited onboard storage capacity thus devices were initialized to sample at
60-second epochs to ensure 7-days of activity could be recorded.
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4. The cutpoints used within the analyses may under or overestimate time spent across
intensities thus the true time spent in MVPA may not be accurately captured.
5. Self-reported PA found in both the NHANES III and 1999-2006 surveys are subject to
recall bias.
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PART 2
REVIEW OF THE LITERATURE

8

Introduction
Diabetes is characterized by a chronic state of hyperglycemia resulting from defects in
insulin secretion, insulin action, or both (13). It is well known that diabetes is associated with
other deleterious chronic conditions such as heart disease, stroke, obesity, and kidney disease
(13). The association between PA and diabetes risk and mortality within populations, including
multi-ethnic populations that have diabetes, has been extensively studied. A part of
understanding the epidemiological impact of diabetes relates to understanding how race-ethnicity
is associated with the disease. More specifically, it is important to understand the role of raceethnicity as an effect modifier of the relationship between PA and diabetes as well as diabetesrelated mortality. However, there currently are no studies examining the effect modification of
race-ethnicity on the relationship between PA and diabetes-related morality.
The following review of literature will discuss: 1. diabetes; 2. the burden of diabetes; 3.
physical activity behavior and race-ethnicity; 4. physical activity and diabetes risk; 5. physical
activity and mortality in those with diabetes; and 6. physical activity and diabetes-related
mortality.
Diabetes
History
The history of diabetes is both long in time as well as complex in nature. Dating back to
as early as 1500 BC, there are records of individuals suffering from polydipsia and polyuria (14)
which are common symptoms of chronic hyperglycemia. In early work of Greek physicians (1 st
and 2nd century AD), diabetes was classified by the symptoms of polydipsia and polyuria
exclusively. The name diabetes was first introduced; arising from the word “diabaino” which
9

means “the condition that the fluid runs through” (14, 15). Further evidence of the long history of
diabetes comes from the 5th century in the work of Sushruta who characterized “diabetes” by the
honey-like smell and sticky consistency of one’s urine (14). However, it wasn’t until the 1800’s
that the study of “diabetes” began to become a leading focus in the medical community.
Many discoveries in diabetes research were made in the 1800’s to early 1900’s (14, 15).
Claude Bernard hypothesized that the excess secretion of glucose by the liver caused diabetes
and he also discovered a link between glucose homeostasis and the central nervous system.
Oskar Minkowski and Joseph Von Mering discovered the pancreas’ contribution to the
development of diabetes. Paul Langerhans discovered the cells that secreted (what would later be
known as) insulin; the islets of Langerhans.
Arguably the most important discovery in diabetes history was by Frederick Banting,
John McLeod, Charles Best and James Collip, who all played roles in the discovery that the
defect in secretion or lack of insulin caused diabetes to develop. It is important to note that
Frederick Banting and James McLeod are credited with the discovery of insulin (as the Nobel
Prize was awarded to them both), however both Best and Collip served as co-investigators in the
process (14, 15). It was from this work that treatment of diabetes flourished beginning in the mid
1950’s.
It was not until 1949, in an article authored by Himsworth (16), that the notion of
different “types” of diabetes were discussed. Himsworth concluded that “abnormal
hyperglycemia” was either a result of impaired carbohydrate metabolism (i.e. insulin secretion
defects) or an inability to store carbohydrates. Further suggestion of two types was discussed by
Yalow and Berson in 1960 (17), who noted that despite still making their own insulin, some
study participants still had diabetes; suggesting that “insulin sensitivity” could be a cause of

10

diabetes and not just defects in insulin secretion. It was not until 1979 that the diabetes
classification system was introduced to include the four types: insulin-dependent/type 1, noninsulin-dependent/type 2, gestational, and environmental (18).
Type 2 diabetes
Type 2 diabetes (T2D) was formally known as non-insulin dependent diabetes mellitus
until 1997 (18). It is characterized by defects in insulin action and is primarily driven by
increasing resistance to insulin resulting in chronic hyperglycemia (13). Moreover, T2D makes
up 90-95% of all cases of diabetes (13). Until 1997, T2D was diagnosed using one of two
methods; a fasting plasma glucose (FPG) ≥140 mg/dL or a 2-hr plasma glucose ≥200 mg/dL
following a 75-g oral glucose tolerance test (OGTT) (13). Beginning in 1997, the diagnostic
criteria for T2D changed in regards to FPG; from ≥140 mg/dL to ≥126 mg/dL (13).
In 2009, the American Diabetes Association began recommending the use of
glycosylated hemoglobin (A1c) to diagnose T2D, using a cutpoint of ≥6.5% (13). The
justification for this recommendation is rooted in A1c having greater pre-analytical stability
compared to FPG, no need for fasting to measure, better reflection of chronic glycemic status
over the course of two to three months, and it is less affected by stress and illness (13).
Furthermore, the International Expert Committee on Diabetes has highlighted the vast
epidemiological evidence in support of the use of A1c to diagnose diabetes (13, 19).
Improvements in A1c as a diagnostic tool have been recently highlighted as the assays are now
standardized (13). It is important to note that both FPG and 2-hr OGTT are still validated
methods to diagnose T2D.
Several criticisms have been raised in regards to using A1c as a diagnostic tool (20-22).
Kilpatrick et al. (22) raised the point that A1c is higher in older adults compared to younger
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adults despite similar glucose tolerance. Furthermore, there may be inherent differences across
race-ethnic groups that could influence or potentially mis-represent true estimates of diabetes
prevalence specific to race-ethnicity (21-23). Guo and colleagues (21) found differences in the
relationship between A1c, FPG and 2-hr OGTT in a sample from the 2005-2010 NHANES.
Results indicated discrepancies in FPG and A1c, as at a given A1c value, non-Hispanic blacks
(NHB) had lower FPG and 2-hr OGTT values. In contrast, at given FPG or 2-hr OGTT, NHB
had higher A1c values.
In a recent study conducted by Lacy and colleagues (23), A1c, FPG, and 2-hr OGTT
values were compared in a sample of African Americans (AAs) with and without sickle cell trait
(SCT). The results of the analysis indicated that A1C was significantly lower in those with SCT
at a given FPG and 2-hr OGTT. Given that the prevalence of SCT is approximately 8-10% in
AAs (24), it is possible that diabetes estimates in AAs are underestimated in population based
studies when using A1c.
The burden of diabetes
Prevalence
It is well known that the burden of diabetes (inclusive of type 1 and T2D) has increased
since the late 1950’s quantified by increasing prevalence across years. Moreover, these
prevalence estimates have consistently been higher among minority groups compared to nonHispanic white (NHW). It is also projected that the disparities in diabetes prevalence estimates
will continue to expand in the next 30+ years; which is a major public health concern. Along
with the current and projected diabetes disparities, the diabetes-specific mortality rates differ
across race-ethnic groups.
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Diabetes has increased in a linear fashion beginning in 1958 (0.93%) to the late 1990s
(1998: 3.8%) (25). Since the late 1990’s, the prevalence of diabetes has increased drastically.
According the Centers of Disease Control and Prevention (CDC), using self-report data from the
National Health Interview Survey (NHIS), the current national diabetes prevalence rates among
adults is 9.3% (2, 25). It is important to note that the surveillance system used to track diabetes,
as well as the definition (self-report vs measured values), influence prevalence estimates. For
example, a study using the 2011-2012 NHANES (26), diabetes prevalence was 14.3% based on
self-report diabetes, and measured A1c ≥6.5%, FPG ≥126 mg/dl, or 2-hr OGTT ≥200 mg/dl.
Disparities in the prevalence of diabetes exist across race-ethnic groups. Based upon selfreported data from the 2010-2012 NHIS and 2012 Indian Health Service’s National Patient
Information Reporting System (2), the current national prevalence estimates of diagnosed
diabetes is higher among Asians (9.0%), Hispanics (12.8%), non-Hispanic blacks (NHBs)
(13.2%), and American Indians/Alaskan Natives (15.9%) compared to NHWs (7.6%). These
disparities in diabetes prevalence across race-ethnicity have been observed since the 1970’s.
Using data from NHANES I (1971-1975), II (1976-1980), III (1988-1994) and 1999-2004,
Zhang et al. (27) examined the prevalence of self-reported diabetes among NHW, NHB, and
Mexican Americans (MA) (Table 2.1). This study found that the prevalence of diabetes
increased across all race-ethnic groups over the course of the NHANES cycles.
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Table 2.1. Prevalence of self-reported diabetes across cycles of the NHANES

NHW

NHANES 1
1971-1975
2.9%

NHANES II
1976-1980
4.4%

NHANES III
1988-1994
5.9%

NHANES
1999-2004
7.8%

NHB

4.5%

9.0%

10.6%

13.8%

MA

3.4%

7.2%

12.6%

13.2%

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American; NHANES:
National Health and Nutrition Examination Survey
Source: Zhang Q, Wang Y, Huang ES. Changes in racial/ethnic disparities in the prevalence of
Type 2 diabetes by obesity level among US adults. Ethn Health. 2009;14:439-457.

The current race-ethnic specific prevalence rates of diabetes differ dependent upon the
definition used to denote diabetes. For example, Menke et al. (26) investigated the prevalence of
total diabetes (diagnosed and undiagnosed) across race-ethnic groups using data from the 20112012 NHANES. Total diabetes was defined as either: self-reported physician diagnosis,
measured A1c ≥6.5%, FPG ≥126 mg/dL, or 2-hr OGTT ≥200 mg/dL. Those classified as NHB
(21.8%) Asian (20.6%) or MA (23.8%) had significantly higher prevalence rates for total
diabetes compared to NHW (11.3%). Moreover, these rates are all significantly higher than the
aforementioned prevalence rates from the NHIS (2, 25).
The prevalence of diabetes is projected to vastly increase by the year 2050. Overall, in
the U.S., the projected prevalence will increase to between 21% and 33% by the 2050 (28). Two
studies have provided projected prevalence increases stratified by race-ethnicity (9, 29). Using
data from the 1994-2000 NHIS, Honeycutt et al. (9) projected the 2050 prevalence rates of
diabetes will be higher among NHBs (118%), Hispanics (149%) and other ethnicities (170%),
compared to NHW (104%). A similar analysis and model by Narayan et al. (29), using the 198414

2004 NHIS, found similar 2050 projected prevalence rates; NHBs (107%), Hispanics (127%)
and other ethnicities (158%), NHW (99%).
Diabetes mortality and race-ethnicity
Race-ethnic disparities in diabetes-related mortality rates have been confirmed across
multiple population-based surveys (1, 2, 30, 31). Historically, the percentage of mortality related
to diabetes has been higher among ethnic minorities compared to NHW. Using data from the
NHIS, the rates of mortality from diabetes was estimated between NHW and NHB males and
females from 1980-2009 (31). While the incidence of death from diabetes declined across all
groups, there was a distinct pattern in which mortality rates were higher in NHBs compared to
NHWs. Furthermore, the rates were much higher across the years in NHB males compare to
NHW males and females as well as NHB females (appendix 3). In a study by Beydoun et al.
(30), utilizing data from the NHANES III (1988-1994), the mortality rate attributable to diabetes
was significantly lower in NHWs compared to NHBs (NHW:8.4% vs NHB:10.8%, p<0.001), as
well as in NHWs when compared to MAs (NHW:8.4% vs MA:13.9%, p=0.002). According to
the 2014 final deaths report, the estimate of deaths attributable to diabetes (per 100,000) is higher
among Hispanics (25.1) and NHBs (38.2) compared to NHW (18.6) (1). When compared to
NHWs, NHBs and Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively
(1).
A recent analysis by Stokes et al. (32) examined the population-attributable fraction
(PAF) of mortality related to diabetes, as well as the prevalence of diabetes-related mortality.
Data from the NHIS (1997-2009) and NHANES (1999-2010) were used for this study. A total of
282,322 participants aged 30-84 were used in the sample. The PAF for mortality from diabetes
was 11.1% in NHW, 13.0% in NHB, and 13.0% in Hispanics. The prevalence of diabetes being
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reported as the underlying cause was 2.6% in NHW, 5.0% in NHB, and 7.0% in Hispanics. The
prevalence of diabetes being assigned as a contributing cause of death was 9.7% in NHW, 14.4%
in NHB, and 15.7% in Hispanics. From these results it is evident that diabetes-related mortality
affects those who are NHB and Hispanic more than those who are NHW.
Physical activity behavior and race-ethnicity
Physical activity (PA) behavior
PA is associated with a plethora of positive health outcomes and lower risk for T2D. In
order to understand the population-level impact of PA on T2D, it is imperative to know the PA
behavior of adults. Beyond this, it is important to know PA behavior across race-ethnic groups as
this may explain disparities in different health outcomes. The following section will detail the
prevalence of PA participation in the U.S.; comparing different survey methods, self-report vs.
accelerometry-derived PA, and the differences in these across race-ethnicity.
Several survey systems, such as the NHIS, BRFSS and NHANES, examine the
prevalence of meeting the 2008 Department of Health and Human Services (DHHS) aerobic
physical activity guideline (PAG) to understand the PA behaviors in U.S. adults. Quantified, the
aerobic PAG is either ≥150 min/wk of moderate-intensity PA or ≥75 min/wk of vigorousintensity PA (33). Furthermore, it is important to note that PA attributable to meeting these
guidelines can come from all domains including: LTPA, transportational PA, occupational PA
and domestic PA.
Using self-report data from the 2015 NHIS, the current national prevalence of adults
meeting the 2008, through leisure-time PA (LTPA), is approximately 49% (34). However,
depending upon the self-report survey, the current estimates of PA behavior vary in U.S. adults
(35, 36). Using data from the 2013 Behavioral Risk Factor Surveillance System (BRFSS), the
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national estimate for meeting the 2008 PAG (LTPA) was 50.2% in 2015 (37). In an analysis by
Keadle et al. (38), using self-report data from three different population surveys, (2011-2012
NHANES, 2013 NHIS, and 2013 BRFSS), the prevalence of older adults (≥65 years) meeting
the 2008 DHHS aerobic PAG (using only LTPA) differed across surveys; 35.8% for NHIS,
27.3% for NHANES, and 44.3% for BRFSS.
When examining PA participation including other domains (i.e. transportational and
household), the prevalence estimates of PA increase. It is important to note that both the NHIS
and BRFSS only assess LTPA. In a 2011 analysis using self-report data from the 2005-2006
NHANES, Tucker et al. (39) compared the prevalence of meeting the 2008 DHHS PAG by
summarizing PA participation across several domains of self-report PA (LTPA, transportation
and household). The PAG were categorized in three ways: 150 minutes of moderate to vigorous
PA (MVPAG), the second way was calculated by weighing each minute of vigorous activity as
two minutes of moderate PA (MV2PAG), or 500 MET-min/wk (METPAG). For all three
categories of PAG, three levels were denoted: none (no PA), insufficient (from 1 to <150 min or
500 MET-min/wk), and meeting the PAG (≥150 min or ≥500 MET-min/wk). The prevalence of
meeting the PAG was 59.6% (MVPAG), 62.0% (MV2PAG), and 65.7% (METPAG).
Differences in the estimation of PA behavior in population-based surveys exist when
measuring PA with objective methodologies such as accelerometers (40-42). Furthermore, within
accelerometer research, the use of different cut-points can impact the estimates of time spent in
MVPA (40, 41, 43) further impacting the prevalence of meeting the PAG. In a study using the
accelerometry data form the 2003-2006 NHANES, Boyer et al. (40) found significant differences
in the mean bouted minutes of MVPA comparing the 2020 cpm (7.0 ± 0.4 minutes) to the 760
cpm (15.2 ± 0.1 minutes) cutpoint. In an analysis by Watson et al. (43) using data from the 2003-
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2006 NHANES, investigators compared the prevalence of meeting the 2008 DHHS aerobic PAG
using 12 different accelerometer cut-points commonly used to denote MVPA and estimates
ranged from 6.3-98.3%.
As highlighted by the aforementioned studies as well as Price et al. (36), the methodology
employed to measure PA will drastically affect prevalence estimates of PA behavior due to
inherent limitations specific to the methodologies. Within the self-report data the prevalence of
meeting the aerobic PAG ranges from 49.0% (35) to 65.7% (39). For accelerometry-derived PA,
the prevalence ranges from 6.3% to 98.3% (43).
Physical activity behavior and race-ethnicity
As mentioned previously, there are distinct disparities in the prevalence of diabetes
across race-ethnic groups (2, 26, 27). Furthermore, it is equally important to note that these
disparities are projected to increase through the year 2050 (9, 28, 29). To begin to understand
how PA relates to T2D risk between different race-ethnic groups, it is important to grasp the
population-level prevalence of PA behavior in these groups. As with national estimates, there are
differences in PA behavior when examining PA by self-report vs. accelerometry methods.
However, despite these differences specific to measurement method, PA participation tends to be
lower in NHBs compared to other race-ethnic groups.
According to the estimates from the CDC using data from the 2015 NHIS, the prevalence
of meeting the 2008 DHHS aerobic PAG differs across race-ethnicity; 42.4% (NHB), 43.0%
(Hispanics), and 52.9% (NHW). Keadle et al. (38), examined the prevalence of meeting the 2008
DHS aerobic PAG among older adults (≥65 years), stratified by race-ethnicity. This populationlevel study used data from the 2011-2012 NHANES, the 2013 NHIS, and the 2013 BRFSSS.
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Across the three surveys, the prevalence of meeting the PAG (via LTPA) was significantly lower
in those who were Hispanic or NHB, compared to NHW (Table 2.2).
Table 2.2. Prevalence of meeting the 2008 DHHS aerobic PAG via self-reported LTPA in older
adults (≥65 years): stratified by race-ethnicity
NHIS

BRFSS

NHANES

NHW

37.2%

46.4%

30.1%

NHB

27.5%

33.5%

16.3%

Hispanic

29.6%

33.5%

14.6%

NHW: non-Hispanic white; NHB: non-Hispanic black;; NHANES: National Health and
Nutrition Examination Survey; NHIS: National Health Interview Survey; BRFSS: Behavioral
Risk Factor Surveillance System
Source: Keadle SK, McKinnon R, Graubard BI, Troiano RP. Prevalence and trends in physical
activity among older adults in the United States: A comparison across three national surveys.
Preventive Medicine. 2016;89:37-43.

In the aforementioned analysis by Tucker et al. (39), using self-reported data from the
2005-2006 NHANES, investigators stratified their analysis further across race-ethnicity (NHW,
NHB and MA). Results revealed that meeting the prevalence of meeting the PAG (LTPA,
transportational and household) was significantly lower in those who were MA or NHB
compared to NHW (Table 2.3).
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Table 2.3. Prevalence of meeting the 2008 DHHS aerobic PAG via self-reported PA (LTPA,
transportational PA and household PA) stratified by race-ethnicity: 2005-2006 NHANES
MVPAG

MV2PAG

METPAG

NHW

63.0%

65.0%

68.8%

NHB

47.7%

52.1%

55.1%

MA

40.7%

43.7%

48.4%

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American; NHANES:
National Health and Nutrition Examination Survey; MVPAG: 150 minutes of moderate to
vigorous PA; MV2PAG: weighing each minute of vigorous activity as two minutes of moderate
PA; METPAG: 500 MET-min/wk.
Source: Tucker JM, Welk GJ, Beyler NK. Physical activity in U.S.: adults compliance with the
Physical Activity Guidelines for Americans. Am J Prev Med. 2011;40:454-461.

In contrast to the self-report estimates, accelerometry estimates yield different results,
both in prevalence as well as race-ethnic differences. For accelerometry-derived PA using the
2003-2006 NHANES, Tucker et al. (39) showed that those who were categorized as MA had
higher prevalence rates for meeting the 2008 DHHS PAG. When examining PA categorized as
MVPAG (150 minutes of moderate to vigorous PA) the prevalence was 8.2% (NHW), 7.7%
(NHB) and 9.1% in MA. For the MV2PAG (weighing each minute of vigorous activity as two
minutes of moderate PA) the prevalence was 10.1% (NHW), 8.0% (NHB) and 9.9% in MA. For
the METPAG (500 MET-min/wk) the prevalence was 46.1% (NHW), 37.6% (NHB) and 46.8%
in MA.
Watson et al. (43) further stratified their analysis by race-ethnicity and reported the
median prevalence of meeting the 2008 DHHS PAG measured via accelerometer. Several cutpoints denoting MVPA were used based on either studies examining walking and running (WR)
or those using lifestyle activities. While not statistically different, there were differences in the
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prevalence of meeting the PAG across race-ethnicity depending upon the cut-point used (WR:
NHW: 12.0%, NHB: 9.9%, MA: 12.9%, other: 11.8%), (Lifestyle: NHW: 76.6%, NHB: 75.1%,
MA: 84.6%, other: 77.8%). Similar to the results found by Tucker et al. (39), NHB had lower
prevalence of meeting the PAG.
To summarize, there are distinct differences between race-ethnic groups when examining
PA behavior specifically when using self-report methodologies to measure PA. Consistently,
NHW have been shown to report higher prevalence of meeting the 2008 DHHS aerobic PAG
compared to other race-ethnic groups. In contrast to self-report estimates, accelerometry-derived
PA consistently showed higher estimates in MA. However, similar to self-report, NHB
consistently have lower participation in PA.
Physical activity and diabetes risk
There is a well-researched and defined inverse association between PA and T2D risk (44,
45). Two recent meta-analyses (44, 45) have provided a thorough and detailed examination of
this association across over 100 different prospective cohort studies. From these two studies
evidence of significant reductions in risk for T2D are associated with total PA (44, 45), LTPA
(44, 45), vigorous PA (44), moderate PA (44), light PA (44), walking (44), resistance training
(44), and occupational PA (OPA) (44). Furthermore, a clear, non-linear dose-response was found
in a meta-analysis by Smith et al. (45), indicating that a doubling in PA volume does not
necessarily equate to a double in risk reduction. However, it is evident that more PA is associated
with a more pronounced reduction in risk. This section will detail the results of these metaanalyses.
In 2015, Aune et al. (44) systematically reviewed and conducted a meta-analysis across
81 prospective cohort studies examining the relationship between PA and T2D risk. Domains of
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PA examined included: total PA, LTPA, vigorous PA, moderate PA, light PA, walking,
resistance training, and OPA (Table 2.4).
Table 2.4. Domains of PA and T2D risk: Results of Aune et al. (34) comparing the most vs least
active.
PA Domain
Total PA

RR for T2D
(RR, 95% CI)
0.65 (0.59-0.71)

LTPA

0.74 (0.70-0.79)

Vigorous PA

0.61 (0.51-0.74)

Moderate PA

0.68 (0.52-0.90)

Light PA

0.66 (0.47-0.79)

Walking

0.85 (0.79-0.91)

Resistance
training
Occupational
PA

0.72 (0.58-0.84)
0.85 (0.79-0.92)

PA: Physical Activity; RR: Relative Risk; CI: Confidence Interval
Source: Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of
type 2 diabetes: a systematic review and dose-response meta-analysis. European Journal of
Epidemiology. 2015;30:529-542.

In order to examine the potential dose-response relationship between PA and T2D, Aune
et al. (44) conducted additional analyses for studies reporting LTPA. For the dose-response
analyses, PA was categorized in three ways: Every 20 MET-hrs/wk, every 5 MET-hr/wk, and
every 1000 kcals/wk. For every 20 MET-hrs/wk of LTPA, there was a significant summary
reduction in the risk for T2D (RR 0.85, 95% CI 0.81-0.89). For every 5 hrs/wk of LTPA, there
was a significant summary reduction in risk for T2D (RR 0.75, 95% CI 0.67-0.85). For every
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1000 kcals/wk, a significant summary reduction in risk for T2D (RR 0.87, 95% CI 0.79-0.95)
was found.
In the same study, separate dose-response analyses were conducted for vigorous PA, light
PA, resistance training and walking. For vigorous PA, light PA, and resistance training, PA was
examined in increments of 5 hrs/wk. For walking, three PA methods were used: every 5 hrs/wk,
every 2 hrs/wk, and every 10 MET-hrs/wk. Specific to vigorous PA, for every 5 hrs/wk a
significant summary reduction is risk for T2D was found (RR 0.69, 95% CI 0.58-0.82). For light
PA, a significant summary reduction is risk for T2D was revealed per every 5 hrs/wk (RR 0.60,
95% CI 0.44-0.82). For every 10-MET hrs/wk of walking, no significant relationship was found
(RR 0.95, 95% CI 0.88-1.02). For every 2 hrs/wk of walking, a significant association was found
(RR 0.92, 95% CI 0.85-0.99). In studies examining resistance training, every 5 hrs/wk of
resistance training was associated with a significantly lower risk of T2D (RR 0.70, 95% CI 0.580.84).
In a 2016 meta-analysis, Smith et al. (45) expanded on the results from Aune et al. (44)
by conducting a more harmonized dose-response analysis examining PA and T2D. A total of 28
cohort studies were included in the meta-analysis. Significant summary effects for every 10
MET-hrs/wk accumulated of total PA (RR 0.95, 95% CI 0.93-0.98) and LTPA (RR 0.83, 95% CI
0.79-0.87). In a separate analysis, a non-linear dose-response was investigated by examining PA
in relation to the 2008 aerobic PA guidelines (11.25 MET-h/wk) and volumes equating to double
that of the 2008 PA guidelines (22.5 MET-hr/wk). Significant summary effects were found for
11.25 MET-hr/wk (RR 0.74, 95% CI 0.69-0.80) and 22.5 MET-hr/wk (RR 0.64, 95% CI 0.540.73). At volumes of 60 MET-hr/wk, a significant summary effect was found (RR 0.47, no CI
reported).
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It is evident from both of the aforementioned meta-analyses (44, 45) that a clear inverse
relationship exists between PA and T2D. More specifically, Aune et al. (44) showed that total
PA, LTPA, vigorous PA, moderate PA, light PA, walking, resistance training, and OPA are all
associated with reductions in the risk of T2D. Furthermore, there is a significant dose-response
relationship between vigorous PA, light PA, hrs/wk of walking and hrs/wk of resistance training.
No relationship was found between MET-hrs/wk of walking and T2D risk. Smith et al. (45)
further added to this relationship, specifically for total PA and LTPA, by showing a non-linear
dose-response between MET-hrs/wk and T2D risk.
Physical activity and the risk of type 2 diabetes: the effect modification by race-ethnicity
A recent meta-analysis by Boyer et al. (10) (appendix 2) examined how race-ethnicity
modifies the established association between PA and T2D. Both PubMed and Embase databases
were systematically searched up to June 2016. Studies met the following inclusion criteria:
human participants who were without T2D at the start of the studies and were adults (≥18 years)
at the time of follow-up; assessed aerobic-based PA; published or available in English; were
prospective cohort studies; assessed and reported the race-ethnicity specific relative risks (RR)
for T2D; adjusted risk estimates for age; and allowed for the determination of a most versus least
physically active group. The race-ethnic groups included were as follows: NHW, NHB, Asian,
Hispanic and American Indian. Individual study RRs (n=27) were extracted and analyzed to
assess the relationship between PA and T2D that compared the most to the least active group
across the chosen race-ethnic groups. Moreover, the effect modification of race-ethnicity was
analyzed in those meeting the current 2008 DHHS moderate-intensity PA recommendations
compared to those not meeting the recommendations.
A statistically significant summary effect was found for NHWs (RR 0.71, 95% CI 0.6024

0.85), Asians (RR 0.76, 95% CI 0.67-0.85), Hispanics (RR 0.75, 95% CI 0.64-0.89), and
American Indians (RR 0.73, 95% CI 0.60-0.88). The summary effect for NHB (RR 0.91, 95% CI
0.76-1.08) was non-significant. For analyses examining the 2008 aerobic PAG, there was a trend
towards significance for NHWs (RR 0.75. 95% CI 0.55-1.01, p=0.06) and Asians (RR 0.80, 95%
CI 0.64-1.01, p=0.06), but the estimates did not attain statistical significance. The results for
NHBs (RR 1.26, 95% CI 0.84-1.90) and Hispanics (RR 0.95, 95% CI 0.66-1.65) did not attain
statistical significance.
Several physiological mechanisms have been proposed that could explain the lack of
significance found for NHBs in this study. In short, these include: 1) genetic predisposition, 2)
compromised hepatic suppression of endogenous glucose production in response to insulin, 3)
lower insulin sensitivity in the peripheral tissues (specifically skeletal muscle) despite similar
volumes of aerobic PA, 4) a down regulation of insulin receptors driven by hyperinsulinemia and
decreased hepatic insulin clearance, 5) increases in intramuscular adipose tissue and intramyocellular lipid content deposits, and 6) skeletal muscle fiber type differences. Appendix 2
greatly expands on these mechanisms.
Summary of the effect modification of race-ethnicity on PA and T2D risk
The recent meta-analysis by Boyer et al. (10)(appendix 2) provided detailed and much
needed insight into the effect modification of race-ethnicity on the established relationship
between PA and T2D. The results indicate that those who identify as NHW, Asian, American
Indian, or Hispanic had similar risk reductions ranging from 24% to 29%. Furthermore, those
who identified as NHB had no significant reduction in risk. The results of this study can be
postulated to also be reflective of how race-ethnicity modifies the relationship between PA and
mortality; more specifically diabetes-related mortality. However, research is needed.
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Physical activity and mortality in those with diabetes
From a public health perspective, it is equally important to understand how PA, T2D and
mortality are associated, as the results from Boyer et al (appendix 2) indicate that protection from
T2D is not equally shared across other race-ethnic groups. Considering the strong association
between T2D and mortality (46-48), it is necessary to examine if an effect modification by raceethnicity exists when considering mortality. To further understand the impacts of PA and T2D,
the next section will provide a comprehensive examination of the literature investigating: a) the
relationship between PA and mortality in those with diagnosed T2D, b) the effect modification
of this relationship by race-ethnicity, and c) the relationship between PA and diabetes-related
mortality.
Physical activity, all-cause and cardiovascular (CVD) mortality in those with diabetes
For this review, a total of 13 studies (49-61) were identified that examined the
relationship between physical activity and mortality (all-cause and CVD) specifically among
those with T2D. To understand this relationship, PA has been examined using total PA (PA
across multiple domains) as well as individual domains (occupational, transportational, and
LTPA) and walking. Among these 13 studies, seven examined total PA (50, 52-54, 56, 57, 60),
seven examined LTPA (49, 51, 55-57, 59, 61), one examined occupational PA (51), one
examined transportational PA (51), one examined domestic PA (56), and five examined walking
(50, 56-59). The following section will discuss the relationship between PA and all-cause or
CVD mortality in participants with diabetes; organized by domain. A summary and metaanalysis is presented at the end of this section to provide insight into the overall relationship
between PA and mortality in those with diabetes.
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Total PA
All seven studies examining total PA and mortality among those with T2D examined allcause mortality (50, 52-54, 56, 57, 60) and four examined CVD mortality (50, 52, 56, 57). Gregg
et al. (50) investigated the relationship between total PA and mortality in 2,896 adults with T2D
who participated in the 1990-1991 NHIS. Three categories were created for total PA (low: 0
hr/wk, moderate: 0-1.9 hr/wk, and high: ≥2 hr/wk). Following adjustment for age, gender, race,
body mass index, self-rated health, smoking, weight loss approaches, hospitalizations,
hypertension and use of antihypertensive medications, physician visits, limitations caused by
CVD and cancer, and level functional limitation, significantly lower risk for all-cause mortality
was revealed in those who were categorized as high total PA (HR 0.71, 95% CI 0.59-0.87). No
association was found for total PA and CVD mortality.
In another study by Hu and colleagues (52), using 3,708 Finnish adults with T2D, the
relationship between PA (LTPA and occupational) and mortality was examined. Physical activity
was defined as low (light levels of occupational, commuting (<1 min), and leisure-time PA),
moderate (reported only one of the all three types of moderate to high PA) or high (reported two
or three types of moderate to high PA). Following adjustment for age, gender, study year,
education, BMI, systolic blood pressure, total cholesterol level, and smoking, significantly lower
risks for all-cause mortality was found in those reporting PA in the moderate (HR 0.61, 95% CI
0.51-0.73) or high (HR 0.55, 95% CI 0.47-0.66) categories. Similar results were found for CVD
mortality.
Jonker et al. (53) examined the risk of all-cause mortality in 5,209 participants from the
Framingham Heart study with T2D. Physical activity was assessed via self-reported time spent
in light, moderate or vigorous activities over a week. Time spent (hrs/wk) were then multiplied
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by the metabolic cost of activity (i.e. 0.25 l/min for sleep) and then weighted according to
intensity (1.1: sedentary, 1.5: light PA, 2.4: moderate PA, and 5: vigorous PA). The weighted
hours were then converted into tertiles to examine a dose-response relationship. Significantly
lower risk for all-cause mortality was found for those in tertile 3 (HR 0.53, 95% CI 0.39-0.72)
compared to tertile 1.
In 712 adults with T2D, Loprinzi (54) examined the relationship between objectivelymeasured PA and the risk of all-cause mortality within the 2003-2006 NHANES. Activity was
categorized as minutes spent above 100 counts per minute (cpm). After adjustment for age,
gender, race-ethnicity, serum cotinine, poverty-to-income ratio (continuous); C-reactive protein
(CRP), cholesterol medication use, blood pressure medication use, diabetes medication,
glycosylated hemoglobin A1C and other illness, a significantly lower risk for mortality was
found (HR 0.68, 95% CI 0.56-0.83) for every 60 min of accrued activity above 100 cpm.
Sadarangani et al. (56) examined the dose-response relationship between PA and allcause mortality and CVD mortality in a sample with T2D. PA was categorized into three levels:
none (no reported activity), some (0.1–7.4 MET-hr/wk) and meeting the recommendations (≥7.5
MET-hr/wk). Those reporting some activity had significantly lower risk for both all-cause (HR
0.74, 95% CI 0.61-0.89) and CVD mortality (HR 0.68, 95% CI 0.51-0.92). Those reporting
meeting the recommendations had significantly lower risk for both all-cause (HR 0.65, 95% CI
0.53-0.79) and CVD mortality (HR 0.60, 95% CI 0.44-0.82) compared to those reporting none.
Using data from the European Prospective Investigation into Cancer and Nutrition study
(EPIC) study, Sluik et al. (57) investigated the relationship between LTPA and all-cause
mortality in participants with T2D. Participants reported the time spent in activity and quartiles
(inactive, moderately inactive, moderately active, and active) were created based off of the sum
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MET-hr/wk for total PA. Those who were categorized as moderately inactive (HR 0.68, 95% CI
0.54-0.76) and moderately active (HR 0.58, 95% CI 0.43-0.77) had significantly lower risk for
all-cause mortality. Moderately inactive (HR 0.46, 95% CI 0.28-0.74), moderately active (HR
0.31, 95% CI 0.15-0.60), and active participants (HR 0.48, 95% CI 0.25-0.94) all had lower risk
for CVD mortality compared to inactive participants.
Using data from 1,013 participants with T2D in the Greek EPIC study, Trichopoulou et
al. (60) examined the relationship between total PA and the risk of all-cause mortality. Activity
was categorized into quintiles (1: <30, 2: 30 to <32, 3: 32 to <34, 4: 34 to <37, 5: ≥37) of METhrs/d based on self-reported PA. A summary dose-response analysis was conducted per 1 unit
increase in quintile. A significant dose-response relationship was found for every 1-unit increase
in quintile and all-cause mortality (HR 0.76, 95% CI 0.63-0.92).
Leisure-time PA
Seven studies examined LTPA and all-cause mortality risk (49, 51, 55-57, 59, 61) and
four examined LTPA and CVD mortality (49, 51, 57, 59) in participants with T2D. Using data
from the NHANES I, Ford et al. (39) examined the risk for all-cause and CVD mortality among
602 participants with T2D. Leisure-time PA was categorized from a single question: “Do you get
much exercise in things you do for recreation?”. Three categories were used: much exercise,
moderate exercise, or little to no exercise. There were no significant reductions in risk for allcause mortality or CVD mortality across LTPA categories.
In a 2004 study conducted by Hu et al. (51) the relationship between LTPA and the risk
of all-cause and CVD mortality was examined among 3,316 Finnish adults with T2D. LTPA was
categorized into three levels: 1) low (almost completely inactive), 2) moderate (some physical
activity for ≥4 h/wk) and 3) high ((vigorous physical activity for ≥3 h/wk) Following adjustment
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for age, gender, study year, body mass index, systolic blood pressure, cholesterol, smoking, and
other types of PA, significantly lower risks for all-cause mortality were found for moderate (HR
0.86, 95% CI 0.75-0.98) and high (RR 0.72, 95% CI 0.55-0.95) LTPA. For CVD mortality, those
categorized as moderate (HR 0.84, 95% CI 0.71-0.99) or high (HR 0.69, 95% CI 0.49-0.99)
LTPA had significantly lower risk.
Using data from NHANES III, Nelson and colleagues (55) investigated the association
between LTPA and all-cause mortality in 1,507 adults with T2D. PA was assessed via selfreported time spent across several activities which was then converted to MET-min/wk based on
intensity specific levels. Leisure-time PA was dichotomized: those reporting none or those
reporting any LTPA. In participants reporting any LTPA participation, a significantly lower risk
for all-cause mortality was found (HR 0.63, 95% CI 0.49-0.80).
Sadarangani et al. (56) investigated the relationship between LTPA (sport and exercise
participation) and all-cause and CVD mortality in a sample with T2D. Participants reported
frequency, duration and type of activity; with at least 15 min per bout of activity. Intensity was
examined by asking if the participants were out of breath, or sweaty when performing the
activity. Activity was categorized in three levels based on the calculated MET-minutes for
reported activities: none, below median, or above median. Significant reductions in risk for allcause mortality were found for those in the median (HR 0.74, 95% CI 0.55-0.99) and above
median (HR 0.71, 0.51-0.99) groups compared to those with no reported activity. No significant
associations were found for LTPA and CVD mortality.
Using data from the EPIC study, Sluik et al. (57) investigated the relationship between
PA and all-cause mortality in participants with T2D. Participants reported time spent in activity
and quartiles (inactive, moderately inactive, moderately active, and active) were created based
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off of the sum MET-hr/wk for LTPA. Following adjustment for covariates, moderately inactive
(HR 0.77, 95% CI 0.60-0.99) and active (HR 0.62, 95% CI 0.46-0.85) participants had lower risk
for all-cause mortality. Only active participants had lower risk for CVD mortality (HR 0.30, 95%
CI 0.14-0.64).
Tanasescu et al. (59) examined the association between PA and all-cause mortality in a
sample of 3,058 men with T2D from the Health Professionals’ follow-up study. Quintiles of PA
were created based on MET-hr/wk calculated from self-reported participation in LTPA.
Significantly lower risk for all-cause mortality was found in those categorized into the third (HR
0.64, 95% CI 0.45-0.91), fourth (HR 0.64, 95% CI 0.45-0.90) and fifth (HR 0.65, 95% CI 0.450.93) quintiles. It is evident that a threshold effect was found with no significant decreases in
mortality risk existing past the third quintile. No significant relationship was found for CVD
mortality.
In an analysis using data from the Aerobics Center Longitudinal Study (ACLS), Wei et
al. (61) examined the relationship between LTPA and all-cause mortality in participants with
T2D. Activity was defined as reporting any participation in walking, jogging, or aerobic exercise
in their leisure-time in the 3 months before examination. Following adjustment for age,
examination year, smoking, alcohol, baseline CVD, family CVD, high cholesterol, diabetes
status, glucose, blood pressure, and overweight status, those who reported any activity had
significantly lower risk for all-cause mortality (HR 0.56, 95% CI 0.40-0.78) compared to
inactive participants.
Occupational PA, transportational PA, and domestic PA
In the single study examining occupational PA, Hu et al. (51) examined the relationship
between PA and the risk of all-cause and CVD mortality in 3,316 Finnish adults with T2D.
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Occupational PA was categorized as light (physically very easy, sitting office work), moderate
(standing and walking) or active (walking and heavy lifting). Following adjustment for age,
gender, study year, BMI, systolic blood pressure, cholesterol, smoking, and the two other types
of PA (transportational and LTPA), significantly lower risks for all-cause mortality (HR 0.67,
95% CI 0.57-0.78) and CVD mortality (HR 0.69, 95% CI 0.57-0.85) were found, only in the
active group compared to the light group.
The single study examining transportational PA and the risk for all-cause and CVD
mortality was also conducted by Hu et al. (51) using the same participants as the previously
mentioned study. Transportational PA was categorized into three levels: 1) motorized
transportation or no work (0 minutes of walking or cycling), 2) walking or bicycling 1 to 29
minutes, and 3) walking or bicycling for ≥30 minutes. In the full-adjusted models, no significant
reduction in mortality risk was found for any volume of transportational PA.
In an analysis of 3,038 participants with T2D from the Scottish Health Survey and Health
Survey for England, Sadarangani et al. (56) examined the dose-response relationship between
domestic PA and all-cause mortality and CVD mortality. Participants reported time spent in
household or housework activities for at least 30 minutes. PA was categorized into three genderspecific levels: none (no reported activity), below median and above median PA. For all-cause
mortality, those categorized as being below median MET-hr/wk had a significant reduction in
all-cause mortality risk (HR 0.77, 95% CI 0.61-0.97). No significant relationships were found for
domestic PA and risk of CVD mortality.
Walking
Gregg et al. (50) investigated the relationship between walking and mortality in 2,896
adults with T2D who participated in the 1990-1991 NHIS. Three categories were created for
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both walking (low: 0 hr/wk, moderate: 0-1.9 hr/wk, and high: ≥2 hr/wk). Following adjustment
for age, gender, race, BMI, self-rated health, smoking, weight loss approaches, hospitalizations,
hypertension and use of antihypertensive medications, physician visits, limitations caused by
CVD and cancer, and level functional limitation, significantly lower risk for all-cause mortality
was revealed in those who were categorized as high walking (HR 0.61, 95% CI 0.48-0.78).
High walking was also associated with reduced CVD mortality risk (HR 0.66, 95% CI 0.450.96).
In the aforementioned analysis by Sadarangani et al. (56), investigators also examined the
relationship between walking and both all-cause and CVD mortality. Walking was categorized
into three levels (none, below median, above median) based on calculated MET-hrs/wk from
reported time spent walking and pace (i.e. slow, average, brisk, or fast). Brisk and fast were
considered moderate intensity. Those categorized as above median for walking had a
significantly lower risk for all-cause mortality (HR 0.68, 95% CI 0.54-0.85). No relationship was
found across categories of walking and CVD mortality.
Using data from the EPIC study, Sluik et al. (57) investigated the relationship between
walking and all-cause mortality and CVD mortality in participants with T2D. Walking was
categorized into quartiles by hr/wk (inactive, moderately inactive, moderately active, and active).
Walking was only associated with lower risk for CVD mortality in moderately inactive (HR
0.40, 95% CI 0.22-0.74) and moderately active (HR 0.44, 95% CI 0.24-0.79) adults.
Smith et al. (58) examined the relationship between walking and CVD mortality in a
group of adults with T2D from the Rancho Bernardo Study. Participants self-reported the volume
of walking in miles/wk. Walking ≥1 mile/wk was associated with lower risk for all-cause
mortality (HR 0.54, 95% CI 0.33-0.88). No associations were found for CVD mortality.
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Using data from the Health Professionals’ follow-up study, Tanasescu et al. (59)
examined the association between PA and all-cause mortality in a sample of 3,058 men with
T2D. Walking quintiles were created based on MET-hr/wk calculated from self-reported
participation in PA. Only those in quintile 5 (≥16.1 MET-hrs/wk) of walking had a significant
reduction in risk for all-cause mortality (HR 0.60, 95% CI 0.41-0.88).
Summary of studies investigating physical activity and mortality in participants with diabetes
The relationship between PA and all-cause or CVD mortality has been examined across
several domains (Total, LTPA, occupational, transportational, domestic, and walking). It is
evident from the literature presented there is a severe paucity of studies specifically for
occupational PA (51), transportational PA (51) and domestic PA (56). Regarding total PA, LTPA
and walking, a 2012 meta-analysis by Sluik et al. (57) summarized the results of several of the
aforementioned studies (49-53, 55, 58, 60, 61). For analyses examining total PA, a significant
summary effect was found for both all-cause (HR 0.60, 95% CI 0.49-0.73) and CVD (HR 0.58,
95% CI 0.50-0.66) mortality when comparing the most active to least active groups. For LTPA,
significant summary effects were found for both all-cause (HR 0.64, 95% CI 0.57-0.72) and
CVD (HR 0.64, 95% CI 0.51-0.80) mortality comparing the most active to least active groups.
Walking (comparing the most active vs. least active) was associated with lower risk for all-cause
(HR 0.68, 95% CI 0.59-0.78) and CVD (HR 0.59, 95% CI 0.46-0.76) mortality.
From the studies presented it is evident that PA is associated with a similar decreased risk
for all-cause and CVD mortality, specifically in those with T2D. However, due to the vast
differences in PA measurement, it cannot be determined the minimum dose needed to see
significant risk reductions for mortality. Therefore, future research should focus on doseresponse analysis structured around the 2008 DHHS aerobic PAG to determine minimum dose
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required. Nonetheless, PA, especially total, LTPA and walking, are effective in reducing
mortality risk in those with T2D.
Physical activity and mortality in those with diabetes; effect modification by race/ethnicity
One study (62) has examined the relationship between PA and mortality in those with
T2D while subsequently examining the effect modification by race-ethnicity. One study (63)
examined cardiorespiratory fitness and mortality. A 2015 study by Glenn et al. (62) examined
the association between self-reported PA, sedentary time, and mortality among NHB and NHW
adults from low-income households. Physical activity was categorized into quartiles based on
calculated MET-hrs/d from self-reported time spent across several activities. Following
adjustment for age, gender, BMI, income, education, history of comorbidities (hypertension,
high cholesterol, myocardial infarction, and stroke), smoking, T2D characteristics (insulin use
and time since diabetes diagnosis), and sedentary time, both NHBs and NHWs had significantly
lower HRs for all-cause mortality across quartiles 2, 3, and 4 of PA compared to quartile 1
[NHW (2: HR 0.66, 95% CI 0.54-0.82, 3: HR 0.64, 95% CI 0.51-0.79, 4: HR 0.55, 95% CI 0.430.70); NHB (2: HR 0.83, 95% CI 0.73-0.95, 3: HR 0.68, 95% CI 0.59-0.79, 4: HR 0.69, 95% CI
0.60-0.80)]..
Kokkinos et al. (63) examined the relationship between cardiorespiratory fitness and allcause mortality in a sample of male NHB and NHW adults with T2D. Tertiles of fitness were
crated specific to the sample based on peak METs from a Bruce treadmill test. Following
adjustment for age, BMI, blood pressure medications, statins, hypertension, dyslipidemia,
smoking, and mortality in the first year of follow-up, significantly lower risk for mortality was
found in NHBs who were in fitness tertiles 2 (RR 0.65, 95% CI 0.53-0.79) and 3 (RR 0.56, 95%
CI 0.40-0.77). Similar results were found in NHWs in tertiles 2 (RR 0.57, 95% CI 0.544-0.73)
35

and 3 (RR 0.34, 95% CI 0.23-0.51).
The results of these studies indicate that there seems to be no effect modification of raceethnicity on the relationship between PA and all-cause mortality in those with type 2 diabetes.
Physical activity and diabetes-related mortality
While there are many studies that have shown an inverse relationship between PA and
mortality among those with T2D; only two studies (11, 12) have examined the relationship
between PA and diabetes-related mortality. In addition, only a single study has examined
cardiorespiratory fitness and diabetes-related mortality (61). For this section, diabetes-related
mortality is defined as mortality related to any type of diabetes.
Using participants in the Danish Diet, Cancer, and Health study, Andersen et al. (11)
examined the relationship between PA and diabetes-related mortality. Participants were 50-65
years of age and self-reported demographic information, dietary and health behaviors such as
smoking, alcohol consumption and PA. Physical activity was assessed via questionnaire that
asked about weekly hours spent participating in sports, cycling, gardening, walking, housework
(cleaning), and household chores (house repairs). Physical activity was then dichotomized
according to reported participation in sports, cycling, gardening or walking. Diabetes-related
mortality was defined using the ICD-10 codes E10-E14. Following adjustment for air pollution,
gender, calendar year, other PA, OPA, smoking status, smoking intensity, smoking duration,
alcohol intake, environmental tobacco smoke, education, fruit and vegetable intake, fat intake,
risk occupation, mean income in municipality, and marital status, those reporting any
participation in sports (HR 0.34, 95% CI 0.21-0.55), cycling (HR 0.61, 95% CI 0.42-0.89), or
gardening (HR 0.42, 95% CI 0.28-0.62) had significantly lower HRs for diabetes-related
mortality compared to those reporting no participation. In those reporting walking, statistical
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significance was not attained (HR 0.77. 95% CI 0.44-1.33).
Williams et al. (12) examined the relationship between MET-hrs/d of walking and
mortality, including mortality from diabetes. Study participants were from the National Walker’s
Health Study. Participants reported demographic characteristics, dietary behaviors, health
behaviors, medication use, and weekly walking participation (distance and average speed).
Mortality was classified using the ICD-10 mortality codes. Walking (MET-hrs/d) was
categorized into four categories: <1.07 (category 1), 1.07-1.8 (category 2), >1.8-3.5 (category 3),
and ≥3.6 (category 4). Following adjustment for age, race, gender, education, prior heart attack,
aspirin use, and intakes of red meat, fruit, and alcohol, those in category three (HR 0.36, 95% CI
0.18-0.73) and category four (HR 0.09, 95% CI 0.2-0.4) had significantly lower HRs for
diabetes-related mortality compared to category one. Following further adjustment for
medication use and baseline BMI, results remained significant for category four only (HR 0.17,
95% CI 0.04-0.73). In a separate analysis adjusting for reported BMI when started walking, a
significant HR was found for category four (HR 0.17, 95% CI 0.04-0.80); with those in category
three were trending towards significance (HR 0.41, 95% CI 0.16-1.03, p=0.06).
A separate survival analysis using the same sample from Williams et al. (12) examined if
the HR for the underlying cause of death was changed when including risk from other causes. In
other words, would risk for diabetes-related mortality change in someone whose underlying
cause of death was not from diabetes. Following adjustment for covariates, medication use, and
baseline BMI, those in categories three (HR 0.59, 95% CI 0.38-0.90) and four (HR 0.41, 95% CI
0.23-0.71) had significantly lower HRs for mortality from diabetes compared to category one.
When adjusting for BMI, results remained significant. These results indicate that despite diabetes
not being the primary cause of death, higher volumes of walking are significantly associated with
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a lower risk for diabetes-related mortality.
In an analysis of 1,188 men with T2D from the ACLS, Wei et al. (61) examined the
relationship between fitness and diabetes-related mortality. Following adjustment for age,
examination year, smoking, alcohol, baseline cardiovascular disease, family history of CVD,
high cholesterol, diabetes status, glucose level, high blood pressure, and overweight status, those
who were classified as unfit had a significantly greater risk for death from diabetes (RR 7.4, 95%
CI 1.4-39.6) compared to those who were fit.
It is evident from the presented studies that an inverse relationship exists between PA and
the risk of diabetes-related mortality. Andersen et al. (58) revealed significant protection from
diabetes-related mortality in those reporting sports, cycling, gardening or walking; indicating that
different types of PA can protect against diabetes-related mortality. Williams et al. (59) revealed
that ≥3.6 MET-hrs/d of walking was significantly associated with lower risk for diabetes-related
mortality independent of several important covariates including race. Moreover, walking was
significantly associated with reduced risk for diabetes as a secondary cause of death independent
of race. Cardiorespiratory fitness was also found to be significantly associated with increased
risk for diabetes-related morality in those who were unfit compared to fit.
Summary
Diabetes (the vast majority being T2D) is a complex, deleterious metabolic disease that is
reaching epidemic proportions in the U.S. Currently, the prevalence estimates range from 9.3%
(13, 14) to 14.5% (15). More importantly, the prevalence of diabetes is consistently higher
among minority groups when compared to NHWs, independent of the survey method and
diagnostic criteria used.
It is well established there is an inverse association between PA and risk of T2D. These
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results were further extended by Boyer et al. (10) (appendix 2); who examined the effect
modification of race-ethnicity on this relationship. When comparing the most to the least active,
significant and similar risk reductions were seen in all race-ethnic groups (NHW, Asians,
Hispanic, and American Indian) with the exception of NHB. Several mechanisms were
postulated by Boyer et al. (10) (appendix 2) to provide physiological rationale for the results
seen.
The relationship between PA and mortality in those with T2D is well established, with an
inverse association being found across most studies. When examining the effect modification of
race-ethnicity on this relationship, the two studies examined reveal a more pronounced reduction
in mortality risk in NHWs compared to NHBs. However, more research is needed. Specific to
diabetes-related mortality, only two studies have been conducted examining PA and risk.
Moreover, these studies did not examine this relationship specific to different race-ethnic groups.
Knowing that PA does not reduce the risk for T2D equally across race-ethnicity (specifically
NHB), it is necessary to further extend the body of literature to diabetes-related mortality.
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PART 3
METHODOLOGY

40

The purpose of this study was to examine the effect modification of race-ethnicity on the
association between PA and diabetes-related mortality in two nationally representative samples
of U.S. adults. The study will utilize data from both the National Health and Nutrition
Examination Survey (NHANES) III and the 1999-2006 continuous NHANES that are linked to
the National Death Index (NDI). The following section provides a detailed description of the
methodology to be used for this study including: a description of the participants, the
methodology behind NHANES data collection, a description of the NDI and linkage to
NHANES, a description of the variables of interest, and data analysis.
Participants
The participants included in this study participated in either the NHANES III or the 19992006 NHANES and are described below.
NHANES III
The study participants for all analyses in research question 1, using the NHANES III, will
meet the following inclusion criteria:


Adults 20-79 years of age. 79 years was chosen as the upper end cutpoint for age as
previous research has shown that the role of diabetes becomes ambiguous in its
contribution to mortality at higher ages (32).



Did not die within the first three years of follow-up. Within the NHANES III, the cut off
of three years has been previously used (12).



Completed testing at the mobile examination center (MEC).



Had complete data for all variables of interest.



If female, were not pregnant or lactating.
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1999-2006 NHANES
The study participants for all analyses for research questions 2A-2C using the 1999-2006
NHANES met the following inclusion criteria:


Adults 40-79 years of age. 79 years was chosen as the upper end cutpoint for age as
previous research has shown that the role of diabetes becomes ambiguous in its
contribution to mortality at higher ages (32).



Completed testing at the mobile examination center (MEC).



Had complete data for all variables of interest.



If female, were not pregnant or lactating.
The age-range for research questions 2A-2C has been previously used in a continuous

NHANES mortality analysis (64). Due to the vast majority of diabetes diagnoses occurring
between the ages of 40 and 64 years (65) and the prevalence of those below 40 being low (65),
we elected to use the age cutoff of 40-79 years of age.
NHANES data collection
The NHANES studies, conducted by the National Center for Health Statistics (NCHS) ,
began forty-one years ago in 1976 and were designed to provide population based estimates of
health, health behaviors and disease via a representative sample of the U.S. (66). Several cycles
of the NHANES have been conducted; beginning in 1976 with the first phase (NHANES I) (67).
NHANES II was conducted between 1976 and 1980 (67). NHANES III was conducted in two
phases; the first from 1988 to 1991 and the second form 1991 to 1994 (68). Beginning in 1999,
the NHANES moved to a continuous two-year cycle with a focus on emerging health issues
within the U.S. (69).
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The NHANES is cross-sectional in nature and uses a complex, multi-stage sampling
design to obtain its participants (70). Furthermore, all participants are non-institutionalized
residents within the 50 states or the District of Columbia and over the age of two months. The
stages of sampling are broken into four parts (70). The first is the selection of primary sampling
units (PSUs), which are usually single counties but are sometimes combined, adjacent counties
to ensure the PSU’s meet the minimum population size requirement (68). The second stage is
characterized by dividing the PSUs into segments the size of a city block. The third stage is
characterized by a random sampling of households within the divided segments. A component of
the NHANES is the oversampling of minority groups (i.e. African Americans, adolescents [1219 years], and adults ≥60 years of age) to ensure adequate representation within the sample (70).
Within stage 3 of the sampling methods, a higher probability exists for sampling in regions
where oversampled participants reside. Stage four is characterized by randomly selecting at least
one participant from each household selected.
Within the NHANES, several different assessments and measurements are conducted. All
NHANES participants are assessed via the household interview in which demographic
characteristics, socioeconomic status, self-reported health behaviors, and health issues are
collected (66). A subsample of participants undergo a detailed health examination and laboratory
tests at the MEC in which several physiological variables are measured such as blood pressure,
cardiorespiratory fitness and glycosylated hemoglobin (HbA1c) (66, 71).
National Death Index Data Linkage
The National Death Index (NDI) is a national database run by the NCHS that maintains
the records of all U.S. deaths starting in 1979 (72). From the data available at the NDI, it is
possible to link those records to participants within NCHS surveys, such as the NHANES, using
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the identifying information (such as name, social security number, gender, race, and marital
status) (72). Death records are then matched to NHANES data based upon seven specific criteria
(72):
“1. Social Security Number (SSN)”
“2. First and last name, exact month of birth, year of birth within 1 year”
“3. Last name, first initial and middle initial, exact month of birth, year of birth within 1
year”
“4. First and last name, exact month of birth, exact day of birth”
“5. Last name, first initial and middle initial, exact month of birth, exact day of birth”
“6. First name, father’s surname, exact month of birth, exact year of birth”
“7. For females only, first name, exact month and year of birth, and last name from the
survey record matching birth surname on the NDI record (for females who change their
name after marriage but don’t supply a birth surname)”
Death records matching with survey data are then scored on a 1-5 “class” scale to assess the
strength of matching (72). The class scale taken from the NDI documentation is as follows (72):
“Class 1: Agreed on at least 8 (of 9) or 4 (of 4) digits of SSN, first name, middle initial,
last name birth year (+/- 3 years), birth month, sex, and state of birth”
“Class 2: Agreed on at least 7 (of 9) or 4 (of 4) digits of SSN at least 5 more of the
following items: first name, middle initial, last name, birth year (+/- 3 years), birth
month, sex, and state of birth.”
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“Class 3: There were two types of Class 3 matches:”
“Type A: SSN is unknown, but last name matched and at least 7 of the following
items agreed: first name, middle initial, last name, birth year (+/- 3 years), birth
day, sex, race, marital status and state of birth.”
“Type B: Records in this category were initially put in Class 5 but switched to
Class 3 if after review, there was the possibility that SSN was either recorded
incorrectly or that the spouse’s SSN was recorded instead of the subject’s SSN.
In this category, SSN was known but 3 or more (of 9) and 1 or more (of 4) digits
did not agree, but at least 8 of the following items agreed: first name, middle
initial, last name, birth year, birth day, sex, race, marital status, and state of birth.
All total scores were adjusted to reflect the final class code for the potential
matches. For example, any record that was switched from Class 5 to Class 3 had
its score adjusted to reflect that SSN is missing, with the value of 0 assigned to
SSN.”
“Class 4: SSN was unknown on either the NCHS survey submission record or the NDI
record and fewer than 8 of the items listed in Class 3 matched.”
“Class 5: SSN was present but fewer than 7 (of 9) or 4 (of 4) digits on SSN agreed.”
Following class scoring, all class 1 records were included; and record classes 2-4 used a specific
cut-off point to clarify true matches (72). Those who did not meet class 1 or the specific criteria
for classes 2-4 were considered no matches and were thus de-identified. Specific to NHANES,
participants with matched NDI records were linked by their respondent sequence number
(SEQN), which is the individual identifier variable within the NHANES datasets found within
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the demographic file. The public-release version of the NDI mortality records (73) were used to
merge and link the NHANES individual records by SEQN in both the NHANES III and the
1999-2006 NHANES components of the current study.
Measures
The following section details the variables used.
Effect Modification: Race/Ethnicity
All analyses were stratified by race-ethnicity to answer all research questions. Raceethnicity, contained with the demographic data files, will be categorized and defined by the
variables DMARETHN (NHANES III) and RIDRETH1 (1999-2006 NHANES) which uses four
categories to classify race-ethnicity (non-Hispanic white, non-Hispanic Black, Mexican
American and Other). For analyses in NHANES III, non-Hispanic white, non-Hispanic Black,
and Mexican American were used. For the 1999-2006 NHANES, non-Hispanic white and nonHispanic Black were used.
Dependent Variable: Diabetes-related mortality
The dependent variable in this study was diabetes-related mortality obtained from the
NDI. The public-use mortality codes available are derived from the restricted-use mortality files
which provides detailed information about causes of death (73) (Appendix 1, table 2). From this
list, mortality from many different diseases is recoded into all-encompassing diseases such as
disease of the heart or malignant neoplasms (Appendix 1, table 2) (73). This allows for a more
general examination of mortality from a population-based standpoint and ensures that no
sensitive information is attained from the study participants. Furthermore, within the linkedmortality data, to ease statistical analysis across multiple years or data sets, all causes of death
46

codes before 1999 (International Statistical Classification of Diseases, Injuries, and Causes of
Death [ICD-9]) were recoded to match the ICD-10 causes of death.
For research questions 1-2C, diabetes-related mortality was determined from the publicuse mortality data files using the ICD-10 (E10-E14) codes (73). Table 1 in appendix 1 provides
the descriptions of each ICD-10 code used to classify diabetes mortality. In order to include
those who had diabetes as an underlying or non-primary cause, diabetes-related mortality was
defined as either death from diabetes mellitus or if diabetes was flagged on the death certificate
with multiple causes of death.
Primary independent variables: Self-Report and Accelerometer Physical Activity
Physical activity was the primary independent variable in the analyses. Several different
measures of PA were used across the research questions depending upon the specific year and
cycle of NHANES.
NHANES III (Self-Reported Physical Activity)
The following describes the methodology used to classify and categorize PA for research
question 1 specific to NHANES III. Within the NHANES III, intensity and frequency of 13
possible leisure-time activities were reported. Leisure-time PA (LTPA) was assessed via
questionnaire inquiring about participation in eight specific aerobic activities (walking,
running/jogging, cycling, swimming, aerobics, calisthenics, swimming, and lawn
work/gardening) (68). Furthermore, four open-ended PA questions were also asked to assess
activity beyond the nine specific activity questions. The intensity of each activity, denoted by a
specific metabolic equivalent (MET), was defined and classified according to the Compendium
of Physical Activities (74). One MET is defined as 3.5 ml/kg/min and equates to the energy cost
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of rest (75). Participants also self-reported the monthly frequency of each activity reported.
Duration was not assessed in the NHANES III PA component. Furthermore, activity associated
with lifting weights was excluded as the study purpose was specifically examining aerobic PA.
The primary independent variable in this study was a three category, physical activity
guideline index (PAGI); using the 2007 PA guidelines (76) as the criteria for meeting the
recommendations (≥ 5 d/wk of moderate-intensity PA or ≥3 d/wk of vigorous-intensity PA).
Initially, each reported activity was categorized into one of five intensity categories based upon
the age-specific MET cut-points in the 1996 Surgeon General's Report on Physical Activity and
Health (77)(appendix 4). Categories were adjusted based on the relative intensities for the
following age groups: 20-39, 40-59, and 60-79. The five categories were as follows: very light
(level 1), light (level 2), moderate (level 3), hard (level 4), and very hard (level 5). Intensity
levels 2 and 3 were classified as moderate-intensity activity; intensity levels 4 and 5 were
classified as vigorous-intensity activity. The weekly frequency for each activity (calculated by
dividing the monthly frequency by 4.3) was multiplied by its coinciding relative-intensity
activity level (1-5); creating a physical activity score (PAS) for each individually reported
activity. The individual PAS were then summed to create an age-adjusted overall total PAS.
The three categories for the PAGI are as follows: inactive, insufficiently active, and
active. Inactive was defined as a total PAS of 0 or those who’s PAS only included “very light”
activity. Across the 13 potential activities reported, only 10 participants reported only “very
light” activity. Thus, they were categorized as inactive. Insufficiently active was defined as a
total PAS ranging between >0 and <10. Active was defined as a PA score of ≥10. The cutoff of
10 was used as it is a proxy cutoff that equates to 5 bouts/wk of moderate-intensity activity (78,
79). For the purpose of the PAGI, bouts were assumed to be reflective of days/week (d/wk). For
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example: The NHANES III MET value associated with the walking question was 3.5 METs. In
an adult aged 38, this would categorize them into PA intensity level 2; which would be
considered a moderate-intensity activity (see appendix 4) for that age-group. If at least 5 d/wk of
walking are reported then this participant would be classified as active (i.e. PA intensity level 2 x
5 d/wk = PA score 10).
1999-2004 NHANES (Self-Reported Physical Activity)
The following details the methodology that will be used to classify and categorize PA for
research question 2A. Self-reported LTPA, transportational PA and domestic PA over the past
month were assessed with data being reported in two data files -- the Physical Activity
Questionnaire (PAQ) and the PA individual activities file (PAQIAF)(80). Data from these files
provide the following information specific to 43 different activities: type, frequency (times per
week), and duration (minutes per bout) for each activity. A MET score will be calculated and
assigned for each activity as well (81). From these variables MET-minutes per week will be
calculated for three domains: LTPA, transportational PA and domestic PA. A summary METminute score will then be calculated by adding the total MET-minutes from each domain. From
the total MET-minutes variable, two different classification methods will be used to examine the
dose-response association between PA and diabetes-specific mortality. The first is the creation of
age-adjusted, sample-specific PA MET-minutes quintiles. This method has been used in previous
NHANES analyses (82). The second method will directly examine the association between PA
and diabetes-specific mortality using the 2006 Department of Health and Human Services
(DHHS) aerobic PA guideline (33). Three categories will be created: 0 MET-minutes/wk
(Inactive), <500 MET-minutes/wk (Irregular PA), 500-999 MET-minutes/wk which equates to
meeting the 2008 DHHS aerobic PA guidelines of 150 minutes of MVPA/wk, and ≥1000 MET49

minutes/wk which equates to volumes exceeding the recommendations of ≥300 minutes/wk of
MVPA. This method has also been used in past studies (83, 84).
2003-2006 NHANES (Objective Physical Activity)
The following details the methodology, specific to accelerometer-measured PA, to be
used to classify and categorize PA for research questions 2B and 2C. Within the 2003-2006
NHANES, accelerometer data was collected using an ActiGraph model 7164 accelerometer.
Participants were instructed to wear the accelerometer on the right hip for seven consecutive
days and to remove the accelerometer when participating in water activities such as bathing or
swimming as well as sleeping (85). A valid day of wear time was defined as ≥10 hours of wear
time per day (86). In order to be utilized in the analysis, at least four days of valid wear time
were needed, with ≥60 minutes of zero accelerometer counts defined as non-wear time. Two
different common cutpoints (87) will be used to quantify minutes spent in MVPA per day; ≥2020
counts per minute (cpm) (86) and ≥760 cpm (88). Minutes to be included in the analyses
reflected all minutes spent above the MVPA thresholds.
To answer research question 3A, the dose-response relationship between PA and
diabetes-related morality will be examined for every 10 minutes of moderate-to-vigorous PA
(MVPA) accumulated per day. This incremental 10 minute increase in MVPA has been used in
previous analysis (89).
To examine the dose-response relationship between PA and diabetes-related mortality as
mentioned in research question 3B, we will use the Wolff-Hughes et al. (90) populationreferenced total activity count/day (TAC/d) percentiles. Briefly, the “activity counts” utilized in
this analysis are a reflection of what the accelerometer actually measures, and are created by
filtering, full-wave rectifying and integrating the raw acceleration across the 1-minute epochs.
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The TAC/d variable was specifically created by summing up the total activity counts and
dividing them by the number of valid wear days (42). These percentiles are demarcated at the 5 th,
10th, 25th, 50th, 75th, 90th, 95th and 97th percentiles. From these percentiles, quartiles (25 th, 50th and
75th) will be used to examine a more precise dose-response relationship and to ensure sufficient
power across quartiles.
Covariates
Several potential confounding measures will be used as covariates in this study. The following
list details the covariates used in the study:


Age: Age was examined continuously.



Gender: Categorized as male or female.



Education: Four categories of education will be used: < high school, high school
graduate, some college and college graduate.



Family history of diabetes: A family history of diabetes is linked to increased risk for
T2D and, thus, an increased risk for diabetes-related mortality (91). Participants selfreported family history of diabetes will be dichotomized as either yes or no. The 20052006 NHANES removed the family history questions specific to diabetes, therefore the
2003-2006 analyses did not include family history as a covariate.



Smoking: Smoking will be categorized as either current smoker, previous smoker, or
non-smoker based on self-report.



Alcohol consumption: Previous research has shown alcohol consumption to be inversely
associated with the risk of T2D (92) and, thus, could be linked to diabetes-related
mortality. For NHANES III, alcohol consumption was categorized as either non-drinker
or drinker by responding yes or no to the question “In the past 12 months did you
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MAPE2 have at least 12 drinks of any kind of alcoholic beverage”. For the 1999-2004
NHANES, a three-level categorical variable will be used to categorize alcohol
consumption based on the United States Department of Agriculture (USDA) and DHHS
gender specific cut-points (93): non-drinker (0 drinks/day), moderate (>0 and ≤1
[women], >0 and ≤2 [men] drinks/day), and above moderate (>1 [women], >2 [men]
drinks/day).


Glycemic Index: A three-category variable was created based on the current American
Diabetes Association glycosylated hemoglobin (HbA1c) recommendations (13) to
establish euglycemic (HbA1c <5.7%), those with pre-diabetes (HbA1c 5.7 - <6.5%), and
those with diabetes (HbA1c ≥6.5%).



Body mass index (BMI): BMI will be examined as a continuous variable



The Healthy Eating Index (HEI): The HEI is a quantitative reflection of overall dietary
quality and has been validated for use in the NHANES (94). The HEI is based upon 10
dietary components that are summed on a 0-100 scale; the higher the score being
indicative of a better dietary quality (95). HEI will be examined continuously.

Data analysis
All analyses were conducted using SAS 9.4 (96), which allows for the incorporation of
the sampling weights in the multi-staged, complex sampling design inherent to NHANES.
Sampling weights are used in analyses to account for the complex survey design, oversampling
of certain groups, non-response, and post-stratification (97). These weights are utilized to ensure
the correct representative sample is used in analyses.
For NHANES III, sampling weights are provided and are used based upon the sample
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participant characteristics and variables in the analysis (68). For the current study, due to use of
variables from the household interview and MEC examination, the final MEC weight
(WTPFEX6) will be used (68). For the continuous NHANES, 2-year sampling weights for the
interview, MEC and fasted laboratory files are provided by the NCHS. These weights can be
combined and calculated based on the cycles used (97). For the current study, a fasted 6-year
weight will be created for analyses using the 1999-2004 NHANES by combining the 4-year
sampling weights from the 1999-2002 NHANES and the 2-year fasted weights from the 20032004 NHANES. For analyses utilizing the 2003-2006 NHANES, a similar method was employed
by combining the fasted weights from the 2003-2004 NHANES and the 2005-2006 NHANES.
Statistical Analysis
SAS 9.4 (96) was used to manage all data inclusive of all complex variable recodes and
to validate recoding. Weighted prevalence estimates were generated using PROC
SURVEYFREQ. All research questions were analyzed using two SAS survival analysis features:
PROC LIFETEST and PROC SURVEYPHREG. PROC LIFETEST was used to estimate the
survivorship related to diabetes-related mortality via Kaplan-Meier (KM) curves. Specific KM
curves were generated across race-ethnic groups as well as the PA variables for the NHANES III
and the 1999-2004 NHANES. Furthermore, KM curves were created across the PA variables
specific to each race-ethnic group. PROC SURVEYPHREG was used to test the null hypothesis
that the individual Cox proportional hazard ratios are equal to 1 across PA measures within each
race-ethnic group. This procedure allows for the incorporation of sampling weights inherent with
the sampling design of NHANES. For all four research questions two models were created:
unadjusted and fully adjusted using the aforementioned covariates.
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PART 4
EFFECT MODIFICATION OF THE ASSOCIATION BETWEEN LEISURE-TIME
AEROBIC PHYSICAL ACTIVITY AND DIABETES-RELATED MORTALITY BY
RACE-ETHNICITY: NHANES III
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Abstract
Purpose: To examine potential effect modification by race-ethnicity of the relationship between
physical activity (PA) and diabetes-related mortality risk using a sample of U.S. adults from the
Third National Health and Nutrition Examination Survey (NHANES III). Methods: The sample
(n=10,717) included adults (≥20 years) who attended the Mobile Examination Center (MEC). An
age-standardized PA score (PAS) was calculated from the self-reported frequency and intensity
of 12 leisure-time aerobic activities. The PA scores were then grouped into three categories:
inactive (PAS = 0), insufficiently active (PAS >0 - <10), and active (PAS ≥10). A PAS of 10 was
chosen as a proxy cutoff for 5 bouts/wk of moderate-intensity activity, the 2007 American Heart
Association/American College of Sports Medicine aerobic PA guideline. Diabetes-related
mortality was defined as either death from diabetes mellitus as the primary cause or if diabetes
was flagged on the death certificate as a contributing cause. Race-ethnic groups included: nonHispanic white (NHW), non-Hispanic black (NHB), and Mexican American (MA). SAS 9.4
survey procedures were used for all statistical analyses. Results: There was no interaction
between PA and race-ethnicity (p=0.83). Compared to inactive NHW, there was a significantly
lower risk for diabetes-related mortality for insufficiently active (Hazard Ratio [HR] 0.51, 95%
Confidence Interval [CI] 0.29-0.89) and active (HR 0.57, 95% CI 0.33-1.00) NHW adults.
Statistical significance was not achieved for any level of activity for NHB and MA. A significant
p-for-trend was revealed only for MA. Conclusions: The results of this study suggest that
accumulation of any volume of PA is associated with a significantly lowered risk for diabetesrelated mortality only in NHW. A significant dose-response relationship was only observed
among MA. However, the interaction between race-ethnicity and PA did not attain statistical
significance. Thus the presence of effect modification could not be determined from the current
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study, but further investigation is warranted. Given longer follow-up time in the NHANES III
cohort, the ability to estimate more precise risk reductions will become plausible.
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Introduction
Diabetes is a deleterious metabolic condition characterized by chronic hyperglycemia.
Currently, diabetes is the seventh leading cause of mortality among adults in the United States
(U.S.)(approximately 2.8% of all deaths); with the vast majority of these deaths being related
specifically to type 2 diabetes (1, 2, 32). Despite being a top ten cause of death, diabetes is more
likely to be a contributing cause of death rather than the primary cause of death; accounting for
approximately 10.8% of deaths (2, 3, 32). Using data from the 1997-2009 National Health
Interview Survey (NHIS) and the 1999-2010 National Health and Nutrition Examination Survey
(NHANES), Stokes and Preston (32) found the population-attributable fraction (PAF) of death
from diabetes was approximately 11.5%; suggesting that diabetes is the third leading cause of
death in U.S. adults. Considering its strong link to cardiovascular disease (4, 5), cancers (6),
kidney disease (7), and stroke (8); it is evident that diabetes plays a substantial role in mortality
related to cardiovascular and metabolic causes.
The current mortality rates associated with diabetes differ across race-ethnic groups (1).
The age-adjusted mortality rate attributable to diabetes is higher among Hispanics (25.1 per
100,000) and non-Hispanic blacks (NHB) (38.2 per 100,000) compared to those who are nonHispanic white (NHW) (18.6 per 100,000) (1). Moreover, compared to NHW, NHB and
Hispanics are 2.3 and 1.5 times more likely to die from diabetes, respectively (1). In the
aforementioned analysis by Stokes and Preston (32), the percent of deaths from diabetes as the
primary cause, as well as a contributing cause, were significantly higher in NHB and Mexican
Americans (MA) compared to NHW. However, the PAFs were not statistically different across
groups despite NHW having a 2% lower PAF. Given the clear disparities between race-ethnic
groups, understanding how different preventive health behaviors, such as physical activity (PA),
relate to diabetes-related mortality risk is of critical importance.
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A recent meta-analysis by Boyer et al. (10) examined the effect modification of raceethnicity on the relationship between aerobic PA and incidence of type 2 diabetes. When
comparing the most active to the least active groups, a significant summary protective effect was
found for NHW, American Indians, Asians, and Hispanics. No significant reduction in risk was
found for NHB. Furthermore, when conducting a sensitivity analysis, the significant summary
effect of PA was eliminated in Hispanics. Knowing the clear link between diabetes incidence and
risk of diabetes-related mortality, it is hypothesized that the results of Boyer et al. (10) could
translate to diabetes-related mortality.
Currently, only two studies have investigated the relationship between PA and diabetesrelated mortality (11, 12). Using data from the Danish Diet, Cancer, and Health Cohort,
Andersen et al. (11) found that any participation in sports (Hazard ratio [HR] 0.34, 95% CI 0.210.55), cycling (HR 0.61, 95% CI 0.42-0.89), or gardening (HR 0.42, 95% CI 0.28-0.62) resulted
in significantly lower HRs for diabetes-related mortality compared to those reporting no
participation in these activities. In those reporting walking, statistical significance was not
attained (HR 0.77. 95% CI 0.44-1.33). Due to the relatively homogenous sample of white
individuals, race-ethnicity was not controlled for. In the second study, Williams et al. (12)
examined the relationship between daily MET-hours (MET-hrs/d) of self-reported walking and
diabetes-related mortality using data form the National Walkers’ Health Study. MET-hrs/d of
walking were categorized into four levels: <1.07 MET-hrs/d (category 1), 1.07-1.8 MET-hrs/d
(category 2), >1.8-3.5 MET-hrs/d (category 3), and ≥3.6 MET-hrs/d (category 4). Only those in
category 4 (HR 0.17, 95% CI 0.04-0.80) had a significant reduction in risk for diabetes-related
mortality. All analyses were adjusted for race-ethnicity; however effect modification was not
examined. While these two studies reveal an inverse relationship between PA and diabetes-
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related mortality, there currently exists no literature examining this relationship with attention to
the possible effect modification within race-ethnicity.
The NHANES and the available National Data Index (NDI) linked data, provide a
population based opportunity to examine the extent to which PA protects against diabetes-related
mortality across several race-ethnic groups. Therefore, the purpose of this study was to examine
the effect modification of race-ethnicity on the association between PA and diabetes-related
mortality using data from the NHANES III and the NDI. It is hypothesized that similar doses of
aerobic PA will not lead to similar risk reductions for diabetes-related mortality when comparing
NHW to NHB and MA.
Methods
Participants
The present study utilized data from the NHANES III (1988-1994) (98). The NHANES is
a cross-sectional survey conducted by the National Center for Health Statistics (NCHS) that
utilizes a complex, multistage sampling design to provide a representative sample of the noninstitutionalized U.S. population. Within the NHANES III, several different assessments and
measurements were conducted. All NHANES III participants underwent a household interview
in which demographic characteristics, socioeconomic status, self-reported health behaviors, and
health issues were self-reported (66). A subsample of participants underwent a detailed health
examination and laboratory test at a mobile examination center (MEC) in which several
physiological variables were measured such as glycosylated hemoglobin (HbA1c) (66, 71).
For the present study participants met the following inclusion criteria: 1) adults 20-79
years of age (79 years was chosen as the upper end cutoff for age as previous research has shown
that the role of diabetes becomes ambiguous in its contribution to mortality at higher ages (32));
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2) did not die within the first three years of follow-up to reduce the potential effects of residual
confounding from other chronic diseases; 3) completed testing at the MEC; 4) had complete data
for all variables of interest; and 5) if female, were not pregnant or lactating. The total sample for
the current study was 10,717 participants at baseline.
Physical activity
Within the NHANES III, intensity and frequency of 12 possible leisure-time activities
were reported. Leisure-time PA (LTPA) was assessed via questionnaire inquiring about
participation in eight specific aerobic activities (walking, running/jogging, cycling, swimming,
aerobics, calisthenics, swimming, and lawn work/gardening) (68). Furthermore, four open-ended
PA questions were also asked to assess activity beyond the eight specific activity questions. The
intensity of each activity, denoted by a specific metabolic equivalent (MET), was defined and
classified according to the Compendium of Physical Activities (74). One MET is defined as 3.5
ml/kg/min and equates to the energy cost of rest (75). Participants also self-reported the monthly
frequency of each activity reported. Duration was not assessed in the NHANES III PA
component. Furthermore, activity associated with lifting weights was excluded as the study
purpose was specifically examining aerobic PA.
The primary independent variable in this study was a three category, physical activity
guideline index (PAGI); using the 2007 PA guidelines (76) as the criteria for meeting the
recommendations (≥ 5 d/wk of moderate-intensity PA or ≥3 d/wk of vigorous-intensity PA).
Initially, each reported activity was categorized into one of five intensity categories based upon
the age-specific MET cut-points in the 1996 Surgeon General's Report on Physical Activity and
Health (77)(appendix 4). Categories were adjusted based on the relative intensities for the
following age groups: 20-39, 40-59, and 60-79. The five categories were as follows: very light
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(level 1), light (level 2), moderate (level 3), hard (level 4), and very hard (level 5). Intensity
levels 2 and 3 were classified as moderate-intensity activity; intensity levels 4 and 5 were
classified as vigorous-intensity activity. The weekly frequency for each activity (calculated by
dividing the monthly frequency by 4.3) was multiplied by its coinciding relative-intensity
activity level (1-5); creating a physical activity score (PAS) for each individually reported
activity. The individual PAS were then summed to create an age-adjusted overall total PAS.
The three categories for the PAGI are as follows: inactive, insufficiently active, and
active. Inactive was defined as a total PAS of 0 or those whose PAS only included “very light”
activity. Across the 12 potential activities reported, only 10 participants reported only “very
light” activity. Thus, they were categorized as inactive. Insufficiently active was defined as a
total PAS ranging between >0 and <10. Active was defined as a PA score of ≥10. The cutoff of
10 was used as it is a proxy cutoff that equates to 5 bouts/wk of moderate-intensity activity (78,
79). For the purpose of the PAGI, bouts were assumed to be reflective of days/week (d/wk). For
example: The NHANES III MET value associated with the walking question was 3.5 METs. In
an adult aged 38, this would categorize them into PA intensity level 2; which would be
considered a moderate-intensity activity (see appendix 4) for that age-group. If at least 5 d/wk of
walking are reported, this participant would be classified as active (i.e. PA intensity level 2 x 5
d/wk = PA score 10).
Diabetes-related mortality
The dependent variable of interest was diabetes-related mortality. The NCHS linked
death records from the National Death Index (NDI) to the NHANES participants’ sequence
numbers in NHANES via a process outlined elsewhere (72)(Chapter 3). Within those who were
deceased, cause of death was determined and classified using the International Statistical
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Classification of Diseases, Injuries, and Causes of Death (ICD)-10 codes. Diabetes-related
mortality was determined from the public-use mortality data files using the ICD-10 codes E10E14 (73). In order to include those who had diabetes as an underlying or non-primary cause,
diabetes-related mortality was defined as either death from diabetes mellitus or if diabetes was
flagged on the death certificate with multiple causes of death.
Covariates
Several potential confounding measures were used as covariates in this study. The
demographic covariates included: age (examined continuously), gender (categorized as male or
female), education (< high school, high school graduate, or some college/college graduate), and
family history of diabetes (yes or no). Health behavior covariates included: self-reported
smoking (current smoker, previous smoker, or non-smoker), alcohol consumption (categorized
as either drinker or non-drinker by responding yes or no to the question “In the past 12 months
did you have at least 12 drinks of any kind of alcoholic beverage”), and the Healthy Eating Index
(HEI). The HEI is a quantitative reflection of overall dietary quality and has been validated for
use in the NHANES (94). The HEI is based upon 10 dietary components that are summed on a 0100 scale; the higher the score being indicative of a better dietary quality (95). HEI was
examined continuously. Metabolic covariates included: glycemic index (a three-category
variable based on the current American Diabetes Association HbA1c recommendations (13) to
establish euglycemia (HbA1c <5.7%), those with pre-diabetes (HbA1c 5.7 - <6.5%), and those
with diabetes (HbA1c ≥6.5%)), and body mass index (BMI) (examined continuously).
Statistical analysis
All variable recodes and analyses were conducted using SAS 9.4 (96), which allows for
the incorporation of the sampling weights to account for the complex survey design,
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oversampling of certain groups, non-response, and post-stratification inherent to NHANES (97).
These weights are utilized to ensure the correct representative sample is used in analyses.
Weighted prevalence estimates were generated using PROC SURVEYFREQ. PROC
LIFETEST was used to estimate the survivorship related to diabetes-related mortality via
weighted Kaplan-Meier curves. Specific Kaplan-Meier curves were created across the PA
variables specific to each race-ethnic group. PROC SURVEYPHREG was used to test the null
hypothesis that the individual Cox proportional hazard ratios (HR) are equal to 1 across PA
measures within each race-ethnic group. This procedure allows for the incorporation of sampling
weights inherent with the sampling design of NHANES. Two specific analyses were conducted.
The first examined the relationship between PA and diabetes-related mortality using raceethnicity as a controlling covariate. Within this analysis, the interaction between race-ethnicity
and the PAGI was tested. The second examined the same relationship stratifying by raceethnicity. Two models were used across the two specific analyses: unadjusted and fully adjusted
using the aforementioned covariates.
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Results
Table 4.1 provides the demographic, health behavior and physical activity characteristics
of the total study sample and specific to race-ethnicity. Compared to NHW, NHB and MA were
younger, had a significantly higher prevalence of diabetes and family history of diabetes.
Regarding PA participation, NHB and MA had a significantly lower median PAS score and had
a higher prevalence of inactive participants.
Table 4.2 provides the diabetes-related mortality characteristics of the total study sample
and specific to race-ethnicity. Compared to NHW, NHB and MA had a significantly younger
baseline age when examined at the MEC as well as a significantly younger age in which
mortality occurred. Compared to NHW, NHB and MA had a higher age-adjusted mortality rate
per 10,000 person years.
Figures 4.1, 4.2, and 4.3 illustrate the weighted, unadjusted Kaplan-Meier survival
probability curves across the PAGI for each race-ethnic group. Across all race-ethnic groups the
poorest survival probability was in inactive participants.
Table 4.3 illustrates the results of the Cox proportional hazards model examining the
relationship between the PAGI and diabetes-related mortality in the total sample. In model 2
(adjusted for age and race-ethnicity), a significant reduction in the hazard for diabetes-related
mortality was found for those who were categorized as either insufficiently active (HR 0.46, 95%
CI 0.31-0.67) or active (HR 0.35, 95% CI 0.23-0.53). For model 2, the p-for-interaction between
race-ethnicity and the PAGI was p=0.44. Following further adjustment for other covariates
(model 3) results remained significant, but attenuated (insufficiently active [HR 0.54, 95% CI
0.34-0.86], active [HR 0.58, 95% CI 0.36-0.94)]. For the fully-adjusted model 3, the p-forinteraction between race-ethnicity and the PAGI was p=0.83.
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Table 4.4 displays the results of the Cox Proportional HR analyses of the PAGI with diabetesrelated mortality stratified by race-ethnicity. In the unadjusted analysis, NHWs categorized as
insufficiently active (HR 0.30, 95% CI 0.18-0.48) or active (HR 0.26, 95% CI 0.16-0.43) had
significantly lower risk for diabetes-related mortality. In the unadjusted analysis for NHBs,
significantly lower risk for diabetes-related mortality was found for those who were either
insufficiently active (HR 0.44, 95% CI 0.26-0.75) or active (HR 0.27, 95% CI 0.12-0.58). In the
unadjusted analysis in MA, only those categorized as active had a significantly lower risk for
diabetes-related mortality (HR 0.32, 95% CI 0.17-0.60). In the fully-adjusted analysis, only
insufficiently active (HR 0.51, 95% CI 0.29-0.89) and active (HR 0.57, 95% CI 0.33-0.99)
NHWs had a significant reduction in risk for diabetes-related mortality. In NHB and MA, no
significant risk reductions were found for the PAGI and diabetes-related mortality following
further adjustment for all covariates. Linear trend analysis found only MA having a significant
inverse trend across categories of the PAGI for diabetes-related mortality (p=0.04).
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Table 4.1. Demographic, heath, mortality, and physical activity characteristics of the participants:
NHANES III (N=10,717)
Valueb

Variables

RACE-ETHNICITY
Total
Demographics
Age - (SE)
Gender - % (SE)
Male
Female
Education - % (SE)
Less than high school
High school graduate
Some college/college graduate
Family History of Diabetes - % (SE)
Yes
No
Metabolic Markers
Body Mass Index (kg/m2) - (SE)
Glycemic Status - % (SE)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100) - (SE)
Smoking Status - % (SE)
Current smoker
Former
Non-smoker
Alcohol consumption - % (SE)
Drinker (≥12 dks/yr)
Non-drinker (<12 dks/yr)
Physical Activity
Physical Activity Score – median (IQR)
Physical Activity Guideline Index - % (SE)
Inactivea
Insufficiently Active (PAS ≥0-<10)
Active (PAS ≥10)

NHW (N=4563)

NHB (N=3057)

MA (N=3097)

Χ2

42.7

(0.4)

40.2

(0.5)

37.3

(0.5) *

33.6

(0.5) *,^

p<0.001

48.3
51.7

(0.6)
(0.6)

51.5
48.5

(0.7)
(0.7)

49.5
50.5

(1.2)
(1.2)

60.5
39.5

(1.3) *,^
(1.3) *,^

p<0.001

20.5
34.9
44.6

(0.9)
(0.8)
(1.2)

17.6
35.1
47.3

(1.0)
(0.9)
(1.4)

27.7
38.2
34.1

(1.2) *
(1.4)
(1.7) *

54.4
25.7
19.9

(1.9) *,^
(1.2) *,^
(1.5) *,^

p<0.001

22.9
77.1

(0.7)
(0.7)

21.7
78.3

(0.8)
(0.8)

29.1
70.9

(1.0) *
(1.0) *

31.0
69.0

(1.0) *
(1.0) *

p<0.001

26.5

(0.1)

25.3

(0.1)

26.6

(0.1) *

26.6

(0.1) *

p<0.001

4.4
13.2
82.4

(0.3)
(0.8)
(0.9)

3.8
11.3
84.9

(0.3)
(0.9)
(1.0)

8.1
27.7
64.2

(0.5) *
(1.0) *
(1.1) *

6.1
16.0
77.9

(0.4) *,^
(1.1) *,^
(1.2) *,^

p<0.001

63.2

(0.3)

63.5

(0.5)

58.8

(0.5) *

64.0

(0.5) ^

p<0.001

39.7
27.9
32.4

(0.9)
(0.7)
(1.2)

38.6
29.3
32.1

(1.1)
(0.8)
(1.2)

43.6
18.2
38.2

(1.2) *
(1.0) *
(1.2) *

50.9
23.0
26.1

(1.0) *,^
(0.8) *,^
(1.1) *,^

p<0.001

35.9
64.1

(1.3)
(1.3)

34.7
65.0

(1.5)
(1.5)

42.8
57.2

(1.2) *
(1.2) *

37.5
62.5

(0.9) ^
(0.9) ^

p<0.001

12.3

(3.5-28.9)

13.3

(3.7-29.6)

(0.3-21.1) *,^

p<0.001

11.9
44.4
43.7

(0.7)
(1.1)
(1.3)

10.2
44.3
45.5

(0.7)
(1.2)
(1.5)

(1.4) *,^
(1.6)
(1.3) *

p<0.001

9.0
18.7
45.5
35.8

(1.4-26.0) *
(1.0) *
(1.1)
(1.4) *

5.4
24.5
44.5
31.0

SE = Standard Error; PAS: Physical Activity Score; A1c: glycosylated hemoglobin; dks: drinks; yr: year; IQR: Interquartile Range. NHW: nonHispanic white; NHB: non-Hispanic black; MA: Mexican American.
a
Zero activity reported.
b
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as weighted percentage
(SE).
*
significantly different (p<0.05) from NHW; ^significantly different (p<0.05) from NHB.
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Table 4.2. Diabetes-related mortality rates by race-ethnic group: NHANES III
RACEETHNICITY

N

Death
events

Baseline* age
(SE)

Non-Hispanic White
Non-Hispanic Black
Mexican American

4563
3057
3097

127
88
116

62.1 (0.8)
58.0 (1.0)
54.6 (1.3)

age of death
(SE)
75.1 (1.2)
69.7 (1.0)
68.3 (1.3)

*When examined at the Mobile Examination Center
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Total
person-years
81,008.3
54,841.5
58,086.1

Crude mortality rate
(per 10,000 personyears)
15.7
16.0
19.9

Age-standardized mortality
rate
(per 10,000 person-years)
12.3
18.1
26.6

Table 4.3. Diabetes-related mortality risk and the Physical Activity Guideline Index: NHANES III
(N=10,717)
Variables

Physical Activity
Physical Activity Guideline Index
Inactive
Insufficiently Active (PAS ≥0-<10)
Active (PAS ≥10)
Demographics
Age (years)
Race-ethnicity
NHW
NHB
MA
Gender
Male
Female
Education
Less than high school
High school graduate
Some college/college graduate
Family History of Diabetes
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)
Smoking Status
Current smoker
Former
Non-smoker
Alcohol consumption
Drinker (≥12 dks/yr)
Non-drinker (<12 dks/yr)

Hazard Ratio (95% Confidence Interval)
Model 1

Model 2#

Model 3^

1.00
0.34 (0.25-0.48)*
0.29 (0.20-0.42)*

1.00
0.46 (0.31-0.67)*
0.35 (0.23-0.53)*

1.00
0.54 (0.34-0.86)*
0.58 (0.36-0.94)*

1.11 (1.09-1.12)*

1.10 (1.08-1.12)*

1.00
1.42 (0.97-2.07)
1.61 (1.13-2.32)*

1.00
0.76 (0.53-1.09)
1.00 (0.67-1.52)
1.00
0.80 (0.52-1.24)
1.00
1.05 (0.70-1.56)
0.74 (0.40-1.35)
1.00
0.77 (0.55-1.08)
1.05 (0.99-1.08)
1.00
0.17 (0.10-0.26)*
0.07 (0.04-0.12)*
1.00 (0.99-1.02)
1.00
0.42 (0.29-1.62)
0.43 (0.28-0.66)*
1.00
0.72 (0.49-1.08)

P-for-interaction
Race-ethnicity x PAGI

0.44

0.83

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. *p<0.05
#Adjusted for physical activity, age and race-ethnicity
^Adjusted for physical activity, age, race-ethnicity, gender, education, family history of diabetes, body mass index, glycemic
status, healthy eating index, smoking status, and alcohol consumption

68

Figure 4.1. Non-Hispanic White Kaplan-Meier Survival Curve: Physical Activity Guideline Index (PAGI) and diabetes-realted
mortality
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active
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Figure 4.2. Non-Hispanic Black Kaplan-Meier Survival Curve: PAGI and diabetes-realted mortality
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active
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Figure 4.3. Mexican American Kaplan-Meier Survival Curve: PAGI and diabetes-realted mortality
PAGI 1: Inactive; PAGI 2: Insufficiently Active; PAGI 3: Active
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Table 4.4. Diabetes-related mortality risk and the Physical Activity Guideline Index stratified by race-ethnicity: NHANES III

Physical Activity Guideline Index
Physical Activity Score

Inactive
0

Insufficiently Active
>0-<10

Active
≥10

Total
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

1946
102
33527.8
1.00
1.00

4829
151
88132.0
0.34 (0.25-0.48)*
0.54 (0.34-0.86)*

3942
78
72276.1
0.29 (0.20-0.42)*
0.58 (0.36-0.94)*

p<0.001
p=0.08

Non-Hispanic White
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

552
32
8837.8
1.00
1.00

1991
50
35847.4
0.30 (0.18-0.48)*
0.51 (0.29-0.89)*

2020
45
36323.1
0.26 (0.16-0.43)*
0.57 (0.33-1.00)^

p<0.001
p=0.14

Non-Hispanic Black
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

590
32
997.2
1.00
1.00

1432
40
25706.1
0.44 (0.26-0.75)*
0.62 (0.34-1.15)

1035
16
19218.3
0.27 (0.12-0.58)*
0.56 (0.27-1.19)

p=0.002
p=0.14

Mexican American
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

804
38
14712.8
1.00
1.00

1406
61
26638.5
0.76 (0.52-1.12)
0.84 (0.59-1.19)

887
17
16734.8
0.32 (0.17-0.60)*
0.50 (0.23-1.09)

p<0.001
p=0.04

a

p-for-trend

Adjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol
consumption. HR: Hazard Ratio. *p<0.05. ^p=0.048
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Discussion
The current study is the first to examine the potential effect modification of race-ethnicity on the
relationship between aerobic PA and diabetes-related mortality. In the non-stratified analysis, the
results indicate that accumulation of any volume of PA is sufficient to reduce risk for diabetesrelated mortality. Furthermore, no significant trend was evident. In the race-ethnicity specific
analysis, the results allude to possible effect modification by race-ethnicity in that only NHW
had a statistically significant reduction in risk for diabetes-related mortality whether
insufficiently active or active. Moreover, a significant dose-response was found only for MA
9illusrtaed by the significant p-for-trend). However, there was no statistically significant
interaction between race-ethnicity and PA in the age-adjusted or fully-adjusted analyses which
suggests no effect modification.
The results of the current study found no significant trends in the fully adjusted analyses
for either NHW or NHB suggesting that any volume of activity may be sufficient to reduce
diabetes-related mortality risk and accruing more activity does not lead to more favorable risk
reductions. The magnitude of the hazard ratio estimates were similar between NHW and NHB,
especially in those who were active. However, the results also indicate that in the fully adjusted
models, the risk reductions among insufficiently active and active NHB were not statistically
significant. It is important to note that the total number of deaths as well as the sample size was
lower among insufficiently active and active NHB compared to NHW. These factors could have
very well influenced the results as the lack of power could have driven the large confidence
intervals, thus the lack of statistical significance. Given that previous analyses (99-103)
examining effect modification by race-ethnicity on PA and all-cause mortality have consistently
shown no differences between NHB and NHW, it is possible that no effect modification exists
between NHW and NHB for PA and diabetes-related mortality. It is hypothesized that given
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additional time for follow-up in the NHANES III cohort, the magnitude of mortality events
among NHB will increase allowing for more precise estimates of risk and, potentially, attainment
of statistical significance for the PA and race-ethnicity interaction.
MA were the only race-ethnic group to present statistical evidence for a dose-response
relationship (evidenced by a statistically significant p-for-trend) associated with PA and
diabetes-related mortality. Furthermore, MA were the only group who had no statistically
significant reduction in the insufficiently active group in the unadjusted analysis; indicating a
potential difference in the minimum volume of PA needed to reduce risk for diabetes-related
mortality when compared to NHW and NHB. Despite attempting to adjust for confounders, it is
possible other variables play a role in mediating the effect of PA on diabetes-related mortality
including occupational PA (OPA), increased allostatic load (30, 104), and issues related to
diminished access to healthcare (103, 105). Further research is warranted specifically in those
identifying as MA to further quantify the dose-response relationship between LTPA and
diabetes-related mortality. More specifically, examination of potential physiological mechanisms
that may explain the current findings as well as the potential interaction between PA other
measures, such as allostatic load, is needed within the scope of race-ethnicity and diabetesrelated mortality.
There are several strengths to the current study. First, the large, population-based sample
allows for a generalization of the results to the population of the U.S. Second, the methodology
behind the NDI mortality linkage has been previously validated (72, 106). Third, this is the first
study to examine the possible effect modification of race-ethnicity on the relationship between
PA and diabetes-related mortality. Only two previous studies have investigated this relationship
(11, 12), both of which found an inverse relationship between PA and diabetes-related mortality
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risk. However, both studies failed to examine effect modification by race-ethnicity. This study
also adds to the two previous studies (10, 62) that have examined the effect modification of raceethnicity on aspects of the diabetes life experience. Briefly, a meta-analysis by Boyer et al. (10)
found effect modification by race-ethnicity on the relationship between PA and type 2 diabetes
risk. Specifically, when comparing the most active to least active, NHB and Hispanics had no
significant reduction in risk for type 2 diabetes. An analysis by Glenn et al. (62) found similar
risk reductions for all-cause mortality across quartiles of PA in NHW and NHB. Finally, this
study also addresses the recommendations outlined by the 2008 Physical Activity Guidelines
Committee report (33) which state that there is a need to examine the interaction between raceethnicity and PA on a number of health-related outcomes including mortality. It is evident that
more research is needed to fully understand how PA may be associated with differential
diabetes-related mortality across race-ethnic groups.
This study is not without limitations. The first is the inability to track potential changes in
PA measures over the course of follow-up. Moreover, there is always the possibility of residual
confounding, particularly from constructs such as allostatic load, markers of socioeconomic
status not included in this analysis, and diabetes medication use. A second limitation is that
duration of PA bouts was not measured as part of the NHANES III PA interview. Thus, a true
measure of total LTPA volume was unable to be quantified. Furthermore, due to the nature of
self-report data, the PA data is subject to both recall bias as well as the social desirability effect.
Next, previous studies have shown low sensitivity and specificity in how diabetes is classified as
a cause/contributing cause of death (32). Thus, the under-reporting of deaths attributable to
diabetes could be a factor in the overall large confidence intervals and HR estimates across
categories of the PAGI. A final limitation is that the public-use mortality data file limits the
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ability to examine mortality specific to diabetes “type”. While the vast majority of diabetes
deaths are related to type 2 diabetes (1), some deaths may have come from type 1 or others
(excluding gestational diabetes). Thus, a sensitivity analysis isolating death from type 2 diabetes
is warranted in future research.
In conclusion, the results of this study indicate that accumulation of any volume of PA is
associated with a significantly lowered risk for diabetes-related mortality. In the race-ethnicity
specific analyses, estimates for the reduction in risk among NHW and NHB were similar in
magnitude and additionally suggested that any volume of PA is associated with a significantly
lowered risk for diabetes-related mortality; although there was no attainment of statistical
significance in NHB. Moreover, there was evidence of a dose-response relationship only among
MA illustrated by the significant trend. Nevertheless, no statistical significance was achieved
across any level of the PAGI for MA. These results allude to potential effect modification by
race-ethnicity in that NHW were the only group that had a statistically significant reduction in
risk for diabetes-related mortality across categories of the PAGI. However, there was no
statistically significant interaction between race-ethnicity and PA. Thus, the results advocate that
until more data are available within the NHANES III cohort, there is an inability to truly
determine, statistically, the extent in which effect modification does or does not exist across raceethnicity.
Future studies should investigate these relationships using more robust measures of PA;
either more detailed questionnaires including duration or via objective monitors such as
accelerometers. The continuous NHANES has a more robust PA interview questionnaire (19992004) that includes duration of PA, as well as accelerometer-derived PA measures (2003-2006),
and could be used to further study the effect modification of race-ethnicity on the relationship
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between PA and diabetes-related mortality. As stated before, with the continued follow-up time
of the NHANES III cohort and as more data becomes available from the NDI, the ability to
estimate more accurate risk reductions will become plausible.
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Appendix 1: National Death Index causes of death tables
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The following tables provide a visual representation of the International Statistical Classification
of Diseases, Injuries, and Causes of Death codes used to (a) classify death from diabetes mellitus
(Table A1.1) and (b) provide a frame of reference for the recoding of all deaths to match the
ICD-10 code for cause of death (Table A1.2)
The following tables provide a visual representation of the International Statistical Classification
of Diseases, Injuries, and Causes of Death codes used to (a) classify death from diabetes mellitus
(Table 1) and (b) define the ICD-10 codes used to categorize diabetes mortality (Table 2)
Table A1.1. Mortality codes used to classify death from type 2 diabetes
UCOD_LEADING
113 Recode
Cause Title and ICD-10
RECODE
Codes
007
046
Diabetes mellitus (E10-E14)
*Adapted from Appendix 4. Tenth Revision 113 Selected Causes of Death (UCOD_113) (1)

Table A1.2. ICD-10 codes
ICD-10 Code
Cause description
E10
Insulin-dependent diabetes mellitus
E11
Non-insulin-dependent diabetes mellitus
E12
Malnutrition-related diabetes mellitus
E13
Other specified diabetes mellitus
E14
Unspecified diabetes mellitus
*Adapted from LIST OF ALL VALID ICD-10 CODES, 1999-2011
Table 2: Modified version of the “List of all valid ICD-10 codes, 1999-2011” illustrating the
cause descriptions associated with death from diabetes mellitus
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Abstract
Background: It is well known physical activity (PA) plays a role in the prevention of type 2
diabetes (T2D). However, the extent to which PA may impact T2D risk among different raceethnic groups is unknown. Therefore, the purpose of this study was to systematically examine the
effect modification of race-ethnicity on PA and T2D. Methods: PubMed and Embase databases
were systematically searched through June 2016. Study assessment for inclusion was conducted
in three phases: 1) title review (N= 13,022), 2) abstract review (N=2,200), and 3) full text review
(N=265). A total of 27 studies met the inclusion criteria and were used in the analysis. Relative
risks (RRs) and 95% confidence intervals (CIs) were extracted and analyzed using the
Comprehensive Meta-Analysis software. All analyses used a random-effects model. Results: A
significant protective summary RR, comparing the most active group to the least active PA
group, was found for non-Hispanic White (RR 0.71, 95% CI 0.60-0.85), Asians (RR 0.76, 95%
CI 0.67-0.85), Hispanics (RR 0.75, 95% CI 0.64-0.89), and American Indians (RR 0.73, 95% CI
0.60-0.88). The summary effect for non-Hispanic Blacks (RR 0.91, 95% CI 0.76-1.08) was nonsignificant. Conclusions: The results of this study indicate that PA (comparing most to least
active groups) provides significant protection from T2D with the exception of non-Hispanic
Blacks. The results also indicate a need for race-ethnicity specific reporting of RRs in
prospective cohort studies that incorporate multi-ethnic samples.
Highlights: There is a significant and similar risk reduction associated with physical activity
across race-ethnicity with the exception of non-Hispanic blacks
There are several physiological mechanisms that may explain this finding that are in need of
further exploration in the context of physical activity
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INTRODUCTION
The prevalence of type 2 diabetes among adults in the United States (U.S.) is estimated to
be anywhere from 9.3-14.5%, depending upon the dataset and diagnostic criteria (1, 2).
Furthermore, by the year 2050, the type 2 diabetes prevalence in the U.S. is projected to reach
upwards of 21-33% (3). However, substantial race-ethnic disparities exist in the prevalence of
type 2 diabetes. At 15.9%, American Indian/Alaskan Natives have the highest estimated
prevalence of type 2 diabetes (1). The next highest prevalence rates are found among NonHispanic Blacks (NHB, 13.2%), Hispanics (12.8%), Asians (9.0%) and those who are nonHispanic White (NHW, 7.6%) (1). Race-ethnic disparities in the prevalence of type 2 diabetes
are expected to persist4: the projected 50 year increase in prevalence of type 2 diabetes will be
highest among NHBs, followed by Hispanics and other ethnicities compared to NHW.
Physical activity (PA) is an important component of type 2 diabetes prevention
initiatives5 and has been shown to reduce the risk of type 2 diabetes (6). However, the extent of
type 2 diabetes protection associated with PA has yet to be fully examined in regards to effect
modification by race-ethnicity. A narrative review by Gill et al. (7) suggested varying thresholds
of PA protection against type 2 diabetes may across race-ethnic groups. Moreover, the authors
also suggested that the current U.S. Department of Health and Human Services (DHHS) uniform
guideline of 150 min moderate-intensity aerobic PA per wk 8 may not provide equal protection
against developing type 2 diabetes across race-ethnic groups.
The 2008 Physical Activity Guidelines Committee Report (9), indicates significant need
to further understand the effects of PA on diabetes risk among ethnically-diverse populations.
While meta-analyses have examined and established a clear inverse relationship between PA and
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type 2 diabetes risk (6, 10), to our knowledge, no meta-analysis has assessed effect modification
of this relationship by race-ethnicity. Therefore, the purpose of this systematic review and metaanalysis was to compile the evidence from prospective cohort studies on potential effect
modification of the aerobic PA and type 2 diabetes risk relationship by race-ethnic groups.
METHODS
Data sources and searches
Systematic searches of the literature were independently conducted in PubMed and
Embase by two authors (W.R.B. and E.C.F.). A modified version of the search criteria employed
by Aune et al. (6) was used: (physical activity OR exercise OR sports OR walking OR biking OR
running OR fitness OR exercise test OR inactivity OR sedentary activity) AND diabetes AND
(case–control OR retrospective OR cohort OR cohorts OR prospective OR longitudinal OR
follow-up OR cross-sectional OR trial) AND (ethnic OR ethnic group OR race OR racial group).
Furthermore studies included in another meta-analysis we screened as well (6). Standard
guidelines for conducting and reporting meta-analyses were followed (11).
Study Selection
Research articles were examined for the following eligibility criteria: human participants
who were without type 2 diabetes at the start of the studies and were adults (≥18 years) at the
time of follow-up; assessed aerobic-based PA; published or available in English; were
prospective cohort studies; assessed and reported the race-ethnicity specific relative risks (RR)
for type 2 diabetes; adjusted risk estimates for age; and allowed for the determination of a most
versus least physically active group. The article screening process is presented in Figure A1.1. A
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total of 27 individual articles met the full eligibility criteria (12-38). Race-ethnic groups
identified and used in the analyses were NHW, NHB, Asian, Hispanic, and American Indian.

Relevant studies identified by using
multiple key words
(n=13,022)
Studies removed
(n=10,822)

Relevant studies after duplicate
removal and title screening
(n=2200)

Studies removed
(n=1,935)

Relevant articles after abstract reading
(n=265)

Studies removed
(n=238)

Relevant studies following full article
reading
(n=27)

Figure A1.1. PRISMA Flow Chart
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Data Extraction and Quality Assessment
Relative risks and 95% confidence intervals (CIs) for diabetes were extracted and entered
into Comprehensive Meta-Analysis (CMA) software version 3.0 (Biostat, Englewood, NJ, USA,
2014). Random-effects models were used for all analyses, given that true effects are likely to
vary across studies (rather than a fixed-model, which assumes the same value or true effect for
all studies) (39). In all studies, the RR estimates extracted were those comparing the highest to
the lowest level of PA. A second analysis was conducted among studies (17, 21, 28, 37, 38) that
used the current DHHS moderate-intensity aerobic PA guideline of at least 150 min/wk as their
demarcation point for PA (8) (i.e., comparing those who met the recommendations to those who
did not). Race-ethnic groups utilized in the secondary analysis included all identified previously
except American Indians.
Quality assessment was performed using the Quality Assessment Tool for Observational
Cohort and Cross-Sectional Studies (40) which uses a 14 question scale (higher score
corresponding to higher quality) to assess quality. All studies were independently rated by two
researchers (W.B. and E.F.); all studies were rated as ‘good’ (average Quality Assessment score=
10.9, range 10-11). Since the studies were all of good quality, analyses examining the potential
impact of differential study quality on the main RR effects were not conducted.
Data Synthesis and Analysis
Data analysis was conducted using CMA software version 3.0. Heterogeneity was
quantified using I2; a descriptive index that estimates the ratio of true variation (heterogeneity) to
total variation across the observed effect sizes (39). An overall main effect of PA on type 2
diabetes was calculated for each race-ethnic group. A second analysis was conducted to assess
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the overall effect of meeting the 2008 DHHS moderate-intensity aerobic PA recommendation on
type 2 diabetes risk (8). Significance for the main effects was set at 0.05. Potential publication
bias was examined using a funnel plot.
RESULTS
A total of 1,150,574 participants were identified across all studies meeting the inclusion
criteria. Table A2.1 illustrates the characteristics of the individual studies (N=27). Duration of
follow-up ranged from two (30) to twenty-eight years (35). Studies were conducted in the U.S.
(n=9) and internationally (n=17), with one study conducted in both the U.S. and Canada (30).
The method for identifying cases of type 2 diabetes varied by study and included ascertainment
by medical records; report of insulin or medication use; 2 hr oral glucose tolerance tests; fasting
plasma glucose, or self-report of a physician diagnosis. Potential publication bias was not
detected in the funnel plot (supplemental figure 1 [supp. 1.]).
Figures 2-6 show the results comparing the most active to the least active groups among
the race-ethnic groups examined (Figure 2: NHW, Figure 3: Asian, Figure 4: Hispanic, Figure 5:
American Indian, Figure 6: NHB). Significant, and similar, summary RRs for PA and type 2
diabetes were found for NHWs (RR 0.71, 95% CI 0.60-0.85), Asians (RR 0.76, 95% CI 0.670.85), Hispanics (RR 0.74, 95% CI 0.64-0.84), and American Indians (RR 0.73, 95% CI 0.600.88). The summary effect for NHBs (RR 0.91, 95% CI 0.76-1.08) did not attain statistical
significance.
In analyses examining the 2008 DHHS moderate-intensity aerobic PA recommendation
and diabetes risk by race-ethnicity (data not shown), a suggestion of a significant trend was
observed for NHWs (RR 0.75. 95% CI 0.55-1.01, p=0.06) and Asians (RR 0.80, 95% CI 0.641.01, p=0.06), but the estimates did not attain statistical significance. The summary effects for
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meeting the 2008 DHHS moderate-intensity aerobic PA recommendation and diabetes risk
among NHBs (RR 1.26, 95% CI 0.84-1.90) and Hispanics (RR 0.95, 95% CI 0.66-1.65) did not
attain statistical significance.
Sensitivity analyses were conducted to examine the effect of removing a single study on
the overall summary effects by race-ethnic group (data not shown). No significant changes were
found to the race-ethnic specific summary RRs with the exception of Hispanics. When removing
Hsia et al. (18) from the Hispanic analysis, statistical significance was lost (RR 0.79, 95% CI
0.60-1.03, p=0.09). Furthermore, when removing Ma et al. (25) from the analysis, similar results
were found (RR 0.89, 95% CI 0.65-1.22, p=0.46).
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Table A2.1. Study characteristics
Author,
year

Race-Ethnicity

Country

Gender

Age
(years)

N

Burchfield,
1995

Asian

U.S.

M

45 - 68

6,815

Burke, 2007
Fan, 2015

NHW
Asian

Australia
China

M/F
M/F

15 - 88
35 - 74

Fretts, 2009

American
Indians

U.S.

M/F

Fretts, 2014

American
Indians
Asian

U.S.

Honda,
2015

Physical
activity
measure
hrs x estimated
O2 consumption

Followup
(years)
6

514
6,348

d/wk
MET-hrs

14
7.9

45 - 74

1,651

MET-hrs/wk

10

M/F

18 - 74

1,639

Steps/d

8

Japan

M/F

30 – 64

26,628

MET-hrs

5.2

MET-hrs/wk

4-8

min

9.4

Categorized by
min into
inactive,
moderate or
strenuous

5

Hsia, 2005

NHW, Asian,
Non-Hispanic
Black, Hispanic,
American Indian

U.S.

F

No range
presented

Hu, 2004

NHW

Finland

M/F

45 - 64

Total: 86,708
NHW: 74,240
NHB: 6,465
Asian: 2,445
Hispanic:
3,231
American
Indian: 327
4,369

James, 1998

Non-Hispanic
Black

U.S.

M/F

30 – 55

916
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Adjustments
age, BMI, subscapular/triceps skinfold ratio, systolic
blood pressure, triglycerides, glucose, hematocrit,
parental history of diabetes
sex, age, BMI, location
age, sex, geographic region (north or south),
educational level (0–6, 7–9, or ≥10 yr), cigarette
smoking (never, ever, or current), alcohol
consumption (yes or no), BMI, waist circumference
age, study site, sex, education (less than high school,
high school, post-high school),
cigarette smoking (never, ever, current), alcohol use
(never, ever, current), FH of diabetes
age, sex, site,
education (years), FH of diabetes
age, sex, shift work, sleep duration, alcohol
consumption, smoking,
hypertension, a family history of diabetes,
occupational activity, and walking for commuting to
and from work
alcohol (past/never vs current drinker), education,
smoking, hypertension, hypercholesterolemia, dietary
fiber (g),
percent energy from carbohydrate

age, sex, study year, systolic blood pressure, smoking
status, education, BMI
age, sex, education, BMI, WHR

Table A2.1 continued
Author, year

Race-Ethnicity

Country

Gender

Age
(years)

N

Physical
activity
measure
MET-min/wk

Followup
(years)
11.1

Joseph, 2016

NHW, Asian,
Non-Hispanic
Black, Hispanic

U.S.

M/F

45 - 84

Koloverou, 2014

NHW

Greece

M/F

32 - 59

Total: 5,348
NHW: 2,277
Non-Hispanic
Black: 1,293
Asian: 676
Hispanic:
1,102
1,485

Kriska, 2003
Lee, 2012

American Indian
Asian

U.S.
Korea

M/F
M

15 - 59
≥18

Ma, 2012

NHW, Asian,
Non-Hispanic
Black, Hispanic

U.S.

F

50 - 79

Nakanishi, 2004

Asian

Japan

M

Okada, 2000

Asian

Japan

Panagiotakos, 2008
Shi, 2013

NHW
Asian

Tonstad, 2013
(subsample of NonHispanic Blacks)
Tsai, 2015

Total min

10

age

1,728
675,496

MET-hrs/wk
min/wk

6
7.5

MET-hrs/wk

10.4

35 - 59

Total: 158,833
NHW:
133,541
Non-Hispanic
Black: 14,618
Asian: 4,190
Hispanic:
6,484
2,924

age, BMI
age, smoking status, alcohol intake,
hypertension, parental diabetes, baseline
glucose, BMI
age, FH of diabetes, hormone therapy use,
study arm, each lifestyle risk factor

Daily energy
expenditure
(kcals)

7

M

35 - 60

6,013

d/wk

59,966
personyears

Greece
China

M/F
M

>18
40 - 74

1,806
51,464

MET-min/wk
METS

5
5.4

Non-Hispanic
Black

U.S. and
Canada

M/F

≥30

7,160

d/wk

2

age
age, energy intake, smoking, alcohol
consumption, education level, occupation,
income FH of
diabetes
age

Asian

Taiwan

M/F

≥53

2,995

d/wk

14

age
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Adjustments
age, education, sex, study site, race/ethnicity,
occupational status, alcohol use, estimated
glomerular filtration rate, other
cardiovascular
health components

age, FH of diabetes, alcohol consumption,
cigarette smoking, BMI, weekly energy
expenditure on physical exercise, systolic
blood pressure, HDL cholesterol,
triglycerides
age, BMI, alcohol consumption, smoking
habits, blood pressure, parental history of
Type 2 diabetes

Table A2.1 continued
Author,
year

RaceEthnicity

Country

Gender

Age
(years)

N

Follow-up
(years)

Adjustments

70,658

Physical
activity
measure
METS

Villegas,
2006
Villegas,
2009
Waki,
2005

Asian

China

F

40 - 70

4.6

40 - 70

62,227

METs/d

4.6

M/F

40 - 59

28,896

10

Finland

M/F

≥18

20,487

times/wk
engaged in
activity
MET-hrs/d

age, kcal/d, education level, income level, occupation,
smoking, alcohol, hypertension, chronic diseases
age, WHR, BMI, kcal/d, alcohol consumption, smoking,
education level, income level, occupation, hypertension
age

Asian

China

F

Asian

Japan

Waller,
2010
Wang.
2010
Xu, 2012

NHW

28

age, BMI

American
Indians
Asian

U.S.

M/F

45 - 74

1,677

MET-hrs/wk

7.8

age, sex

China

M/F

≥35

3,031

min/wk

3

China

M/F

≥35

4,550

min/wk

3

age, sex, residence area, educational attainment, BMI
category,
cigarette smoking, alcohol drinking, TV viewing,
vegetables intake, meat intake, diagnosed hypertension
age, gender, educational attainment, FH/PA,
body weight status, cigarette smoking, alcohol drinking,
TV viewing, vegetables intake, meat intake, diagnosed
hypertension

Xu, 2015

Asian

U.S. = United States, M = Male, F = Female, MET = Metabolic Equivalent, hr = Hour, BMI = Body Mass Index, WHR = Waist-to-hip ratio, kcal
= Kilocalorie, FH = Family History, TV = Television, HDL = High-density lipoprotein cholesterol
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Figure A2.2. Relative risks for diabetes by aerobic physical activity (most vs. least): NHW adults.
N = 238,719. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight
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Figure A2.3. Relative risks for diabetes by aerobic physical activity (most vs. least): Asian adults.
N = 928,319. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight
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Figure A2.4. Relative risks for diabetes by aerobic physical activity (most vs. least): Hispanic adults.
N = 10,817. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight
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Figure A2.5. Relative risks for diabetes by aerobic physical activity (most vs. least): American Indian adults.
N = 7,022. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight
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Figure A2.6. Relative risks for diabetes by aerobic physical activity (most vs. least): Non-Hispanic Black adults
N = 30,452. RR: Relative Risk. LCL: Low 95% Confidence Limit. UCL: Upper 95% Confidence Limit. WGHT: Weight
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Funnel Plot of Standard Error by Log risk ratio
0.0

Standard Error

0.1

0.2

0.3

0.4

0.5
-2.0

-1.5

-1.0

-0.5

0.0

0.5

1.0

1.5
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Figure A2.7. Funnel plot assessing publication bias within prospective cohort studies examining PA and type 2 diabetes risk.
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DISCUSSION
This systematic review and meta-analysis provides insight into race-ethnic differences in
the effect of aerobic PA on type 2 diabetes risk. With the exception of NHBs, a similar
magnitude of protection was found comparing the most active to the least active groups, ranging
from 24% (among Asians) to 29% (among NHWs). The summary estimate for NHBs, though
protective, did not attain statistical significance. The results of this analysis add to the existing
literature on PA and type 2 diabetes (6, 10) by demonstrating effect modification by raceethnicity.
Previous work (7, 41-43) has also found that there may be race-ethnicity specific
differences in the volume of aerobic PA necessary to elicit protection against type 2 diabetes.
Celis-Morales et al. (41) found that Asian men needed 266 min/wk of moderate aerobic PA in
order to achieve similar cardiometabolic profiles (inclusive of fasting glucose and fasting insulin)
as NHW men participating in 150 min/wk of moderate aerobic PA. Steinbrecher et al. (42), in a
study contrasting race-ethnic specific differences of type 2 diabetes risk with PA, found that
moderate intensity PA was associated with lower risk for type 2 diabetes only among NHW
males and females. In the same study, Native Hawaiians and Japanese Americans were found to
receive no protection from moderate intensity PA. However, vigorous intensity sport activity was
associated with lower risk for type 2 diabetes across all race-ethnic groups independent of
gender. These results indicate that higher volumes, as well as a higher intensity, may be needed
to provide similar protection from type 2 diabetes across various race-ethnic groups.
Among the studies included the current analysis, five studies directly reported the racespecific RRs based upon meeting versus not meeting the current DHHS moderate-intensity
aerobic PA recommendation and type 2 diabetes risk. The summary results of these studies
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suggest a trend towards significant protection against type 2 diabetes for Asians and NHWs, but
not NHBs or Hispanics. While these results need to be interpreted with caution, this illustrates a
lack of studies specifically examining how meeting the current moderate-intensity aerobic PA
guideline relates to type 2 diabetes risk. Previous work in the Diabetes Prevention Program (5)
(designed to examine how lifestyle change inclusive of PA, dietary change and weight loss
impacts type 2 diabetes risk) indicated that lifestyle intervention, inclusive of 150 min/wk of
moderate aerobic PA, significantly reduced the incidence of type 2 diabetes in NHWs, NHBs,
Asians, Hispanics and American Indians. It is possible that meeting the recommendations may
not have a significant impact on diabetes risk reduction among NHBs without the addition of
weight loss and dietary intervention; however more research is needed.
The discussion above, in addition to the results of the current meta-analysis, prompted the
current authors to examine/review possible underlying physiological mechanisms that explain
the race-ethnic differences in the protective role of PA. Further, the current results warranted
specific focus on these mechanisms in NHBs.
Mechanisms proposed
There are several physiological mechanisms proposed that could explain the lack of
significance found for NHBs in the current analysis. These include: 1) genetic predisposition, 2)
compromised hepatic suppression of endogenous glucose production (EGP) in response to
insulin, 3) lower insulin sensitivity (Si) in the peripheral tissues (specifically skeletal muscle)
despite similar volumes of aerobic PA, 4) a down regulation of insulin receptors driven by
hyperinsulinemia and decreased hepatic insulin clearance, 5) increases in intramuscular adipose
tissue (IMAT) and intra-myocellular lipid content (IMCL) deposits, and 6) skeletal muscle fiber
type differences.
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It is well known that decreases in Si are related to an increased risk for type 2 diabetes
(44, 45). Lakoski and colleagues (46), when comparing NHBs to NHWs, found similar changes
in the homeostatic model assessment of insulin resistance (HOMA-IR) for every 10 minute
increase in MVPA, moderate PA, or vigorous PA. Among NHB and NHW women, Irwin and
colleagues (47) reported similar decreases in fasting insulin levels for every 90 MET-min/d
change. Another study conducted by Hasson et al. (48) found no differences in the acute
improvements in whole-body Si comparing NHBs to NHWs following a single 75 minute bout of
exercise at 75% VO2 max. The results of these studies indicate that NHBs and NHW have
similar physiological responses in the change in S i from PA. However, similar levels of Si among
NHWs and NHBs may not be indicative of similar risk profiles for type 2 diabetes as other
factors may contribute.
1. Genetic predisposition
Despite the similar changes in Si in response to PA, NHBs tend to have lower initial Si
compared to NHWs (49-51); which may contribute to the lack of significance found in the
current study. Further explanation of this potential increased susceptibility to diabetes is
associated with the relationship between whole-body S i and insulin response in NHBs compared
to NHW and Asians. In a recent systematic review, Kodama et al. (50) calculated and illustrated
the relationship between whole-body S i and the acute-insulin response to glucose (AIRg).
Specifically in NHBs with normal glucose tolerance (NGT), the authors concluded that due to
the relationship found between Si and AIRg, even the slightest decrease in Si results in large
nonlinear increases in AIRg which plays a role in the progression towards type 2 diabetes. In
contrast, these changes in Si among NHWs and Asians result in a vastly lower magnitude of
changes in AIRg. In other words, among NHBs, the slightest decrease in S i results in a large
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increase in the volume of insulin needed to maintain normal blood glucose. Furthermore, NHBs
with similar Si values had significantly higher AIRg compared to NHWs. This relationship was
further confirmed in a study by Albu et al. (52) which found higher AIRg in NHBs during an
intravenous-glucose-tolerance test independent of S i, visceral adipose tissue, intramuscular
adipose tissue (IMAT), subcutaneous adipose tissue, and skeletal muscle mass. Thus Kodama et
al. (50) and Albu et al. (52) conclude there is underlying genetic phenotype in NHBs that may
predispose them to increased risk to type 2 diabetes reflected by this relationship.
2. Hepatic influence
Previous research examining the potential mechanism behind why NHBs are at a higher
risk for type 2 diabetes has focused on the contributions of hepatic glycemic function. Insulin
acts primarily on the peripheral tissues but also has inhibitory effects on hepatic endogenous
glucose production (EGP) (53, 54). EGP has been shown to be the primary determinant of
glucose tolerance (55) as well as a contributor to the development of type 2 diabetes (56). The
aforementioned mechanisms may contribute to the lack of significant findings for NHBs in the
current meta-analysis. While still controversial, a review by Gaillard et al. (57) suggested that
impaired EGP may be a contributing factor to the increased susceptibility of NHBs to type 2
diabetes compared to NHWs. Moreover, in studies that showed similar EGP between NHBs and
NHWs, AIRg tended to be higher in NHBs which is indicative of the increased compensation of
the pancreatic β-cells to secrete more insulin. Thus, while EGP is linked to increased risk for
type 2 diabetes, this proposed mechanism may not be a driving factor as results are equivocal.
3. Peripheral Si
A review by Gaillard et al. (57) showed that while hepatic S i differences between NHBs
and NHWs remains uncertain, peripheral Si tends to be lower among NHBs. With the established
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association between type 2 diabetes risk and peripheral S i; another mechanism to describe the
findings of the current study is a diminished response of the skeletal muscle to changes in
peripheral Si. Delany et al. (43) revealed that participation in similar volumes of objectively
measured PA (via upper extremity activity monitors), peripheral S i (calculated by dividing the
rate of glucose disposal by the plasma insulin concentration) was 26% lower in NHBs compared
to NHWs in the absence of obesity. Furthermore, hepatic S i as well as EGP was similar between
groups. Haffner et al. (58) found lower peripheral S i (quantified by insulin-mediated glucosedisposal) independent of aerobic PA. The results of these studies indicate that aerobic PA may
not affect peripheral Si in the same manner that it affects hepatic Si, especially in NHBs, which
could explain the lack of significance found in the current analysis. However, more research is
warranted to confirm.
4. Hepatic Insulin Clearance
The consistent findings (50, 57) that show NHBs have higher AIRg compared to NHWs
even with similar values of Si could also explain the differences seen in peripheral S i. Higher
AIRg is related to decreases in hepatic insulin clearance (50, 59). Gaillard et al. (57) suggested
that the compensatory hyperinsulinemic response to a diminished hepatic insulin clearance may
contribute to the down-regulation of the skeletal muscle insulin receptors. This would directly
lead to decreases in peripheral Si. It can also be postulated that this mechanism would manifest
independent of aerobic PA as aerobic PA does not seem to impact AIRg in the same way as is
does hepatic Si. However, as stated by Gaillard et al. (57) this needs further exploration.
5. Skeletal muscle adiposity
One mechanism that may influence the decreased peripheral S i in NHBs is IMAT and
intra-myocellular lipid content (IMCL). IMAT, defined as the adipose tissue found within the
117

muscle fascia, has been linked to a decrease in S i through inhibition of the insulin signaling
pathway (60) leading to compromised insulin-stimulated glucose uptake and decreased S i. A
recent study by Goedecke et al. (61) showed that, in NHB women, increased IMCL defined as
the accumulation of lipid particles within the muscle cell, and muscle fat % (IMAT) in the soleus
were significantly correlated with lower S i. NHW women had no relationship between IMCL
and Si. It is important to note that dietary habits and PA volume were similar between groups.
Albu et al. (52) showed that despite similar overall associations, NHB women had significantly
lower Si across volumes of IMAT compared to NHWs. Furthermore, the study participants had
similar PA volumes. The results of these studies indicate that independent of PA, the increase in
skeletal muscle lipid content may play a role in the decreased peripheral S i observed in NHBs.
However, Ingram et al. (62) found conflicting evidence in NHB participants who had no
significant correlation between IMCL and decreased peripheral Si; but NHWs did. Study
participants were sedentary and no differences were found in regards to PA between groups.
While this mechanism may explain differences in peripheral S i and perhaps the lack of
significance in the current study, more research is needed to isolate the true effects of skeletal
muscle lipid accumulation on Si and type 2 diabetes risk.
6. Skeletal muscle fiber type
Another mechanism that could contribute to lower S i and compromised glucose control
(63), is a higher percentage of type II skeletal muscle fibers that can be found among NHBs
compared to NHWs. Previous research contrasting race-ethnic groups has suggested a potential
predisposition to an increased risk for type 2 diabetes with higher percentages of type II fibers
(63, 64). More specfically, among lean, obese or particpants with type 2 diabetes, type I fibers
have been shown to have a higher expression of GLUT4, a greater insulin-stimulated glucose
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disposal rate, higher glucose oxidation rates and higher nonoxidative glucose metabolism
compared to type II fibers (65). Interestingly, the expression of proteins specifc to the effects of
insulin were similar across fiber types i.e. phosphoregulation. However, the study suggests that
there needs to be more research to examine how phosphoregulation itself relates to glucose
uptake and similar phosphoregulation might not mediate S i differences between fiber types.
These results were futher confirmed by Daugaard et al. (66) who showed that only type I fibers
had a significant increase in the expression of GLUT4 compared to both IIa and IIx fibers
following two weeks of one-leg knee extensor training at 65% of maximum workload. The
authors also conclude that increasing the intensity of the activity could have led to different
findings i.e. changes in GLUT4 expression among Type II fibers. Thus, PA at higher intensities
may be necessary to elicit the same benefits as those with higher percentages of type I fibers
(64). However, more research is needed to confirm this hypothesis especially among NHBs.
Nevertheless, among NHBs there is evidence to suggest that the biochemical differences
between type I and type II fibers coupled with a higher percentage of type II fibers may help
partially explain the findings of the current study.
Limitations
This study is not without limitations. First, all meta-analyses are subject to potential
publication bias (39). We attempted to examine potential bias using a funnel plot procedure,
which revealed no issues in regards to potential publication bias. Nonetheless, this issue is
inherent to the systematic review process. Another limitation is that PA was self-reported in the
studies used with the exception of one which used pedometers. Previous literature has shown
limitations to using self-reported PA measures which may overestimate time spent in MVPA as
well as failure to capture other intensities or sporadic activity (67, 68). Also, the lack of studies
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specifically examining the relationship between PA and type 2 diabetes using the current DHHS
aerobic PA recommendation does not provide enough evidence to clearly draw conclusions. The
final limitation relates to inherent issues regarding the definitions of race-ethnicity (69). More
specifically, only four of the definitions we used are considered to be race (NHB, NHW, Asian,
and American Indian) and one is considered to be ethnicity (Hispanic) (70). Furthermore, there
were semi-heterogeneous definitions of “race” and “ethnicity” used across the studies in this
analysis. The authors of the current study elected to group study participants into five common
race-ethnic groups found in the literature to provide the best insight into the race-ethnic specific
relationship between aerobic PA and type 2 diabetes risk.
Future Directions
In the current meta-analysis, there was an evident paucity of prospective cohort studies
reporting race-ethnic specific RRs, specifically in NHBs (N=5), Hispanics (N=3), and American
Indians (N=5). Sensitivity analyses revealed a complete loss of statistical significance when Hsia
et al. (18) or Ma et al. (25) were removed from the model; thus the interpretability of the
summary RR for Hispanics is drastically limited by the available literature. Therefore, priorities
for future research in this area should include prospective cohort studies examining PA and type
2 diabetes among multi-ethnic cohorts to examine and report risk across race-ethnic groups
(rather than using race-ethnicity as a confounding variable). Furthermore, due to the mechanisms
discussed previously, it is also evident that specific intensities should be examined as intensity
may play a role in reducing risk for type 2 diabetes in NHBs.
Conclusion
In conclusion, with the exception of NHBs, PA plays a significant role in reducing the
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risk for type 2 diabetes across race-ethnic groups. Furthermore, the current study illustrates the
need to continue investigating effect modification of relationship by race-ethnicity, as well as the
need to examine the effect modification between the current aerobic PA guideline and type 2
diabetes risk by race-ethnicity. There are several complex, physiological mechanisms that may
explain the findings of the current study, which suggest there may be different race-specific
thresholds in regards to the minimum aerobic PA needed to significantly reduce the risk for type
2 diabetes. Future studies may lead to a re-examination of the current aerobic PA guideline for
potential changes specific to race-ethnicity.
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Appendix 3
Yearly trends in diabetes-related mortality across NHW and NHB
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The following table is adapted from the Centers for Disease Control and Prevention webpage:
Age-Adjusted Death Rates for Hyperglycemic Crises as Underlying Cause per 100,000 Diabetic
Population, by Race and Sex, United States, 1980–2009.
Table A3.1. Age-Adjusted Death Rates for Hyperglycemic Crises as Underlying Cause per
100,000 Diabetic Population, by Race and Sex, United States, 1980–2009
White
Males

Black
Females

Males

Females

Year

Rate

SE

Rate

SE

Rate

SE

Rate

SE

1980

50.4

3.3

36.2

1.7

97.4

14.2

64.9

7.1

1981

46.5

3.3

35.8

1.7

111.1

18.0

66.3

7.7

1982

44.7

3.2

34.7

2.4

108.7

20.6

67.9

10.4

1983

41.1

3.2

41.2

3.1

175.7

54.8

55.1

8.4

1984

44.6

3.4

33.1

2.0

133.2

33.1

53.7

8.0

1985

44.2

4.8

32.2

2.4

102.6

25.9

61.2

10.4

1986

39.9

4.1

34.8

2.6

97.9

20.9

61.2

14.9

1987

44.2

4.2

31.1

2.3

73.5

12.8

42.5

6.6

1988

46.6

3.7

35.3

2.1

116.4

18.8

52.3

6.3

1989

50.1

3.9

34.5

2.0

128.6

23.2

48.7

5.0

1990

42.2

3.6

28.9

1.6

137.3

40.8

53.4

5.7

1991

40.7

3.3

29.0

1.7

142.3

40.2

52.1

7.0

1992

39.6

3.0

23.0

1.3

103.3

24.1

43.2

6.4

1993

36.2

2.7

25.4

1.6

96.8

17.1

36.9

4.4

1994

41.1

3.4

25.0

1.6

81.4

13.7

45.1

6.0

1995

46.5

4.7

24.0

1.5

96.4

21.1

45.8

6.2

1996

46.1

4.2

21.2

1.2

78.5

14.2

40.5

5.1

1997

35.5

2.6

21.7

1.2

79.8

12.2

37.9

4.0
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Table A3.1 continued
White

Black

Males

Females

Year

Rate

SE

1998

32.1

2.0

1999

33.5

2000

Rate

Males
SE

Rate

20.0

0.9

85.0

2.1

18.7

0.8

30.4

1.8

17.0

2001

25.8

1.5

2002

32.9

2003

Females
Rate

SE

11.2

32.9

2.8

70.7

9.7

31.6

2.5

0.7

67.1

7.8

27.1

1.9

18.0

0.7

63.1

6.3

26.3

1.9

1.9

16.4

0.6

61.7

6.3

25.9

1.9

33.7

2.1

16.6

0.7

54.4

5.5

28.5

2.4

2004

27.5

1.6

14.1

0.7

55.4

5.9

27.9

2.0

2005

25.7

1.4

13.7

0.6

45.8

4.2

19.5

1.6

2006

22.8

1.5

13.4

0.7

53.8

5.6

20.3

1.6

2007

24.0

1.7

13.2

0.7

44.6

5.1

22.9

2.0

2008

21.2

1.4

14.1

0.7

47.5

6.4

19.6

1.6

2009

19.5

1.5

11.7

0.6

42.6

7.0

16.0

1.5

SE = Standard Error
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Appendix 4
Age-specific MET cut-points in the 1996 Surgeon General's report on physical activity
and health
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Table A4.1. 1996 Surgeon General's Report on Physical Activity and Health

Intensity (METs) in healthy adults
Young
(20-39)

Middle aged
(40-64)

Old
(65-79)

Very old
(80+)

Very light

<3.0

<2.5

<2.0

<1.25

Light

3.0-4.7

2.5-4.4

2.0-3.5

1.26-2.2

Moderate

4.8-7.1

4.5-5.9

3.6-4.7

2.3-2.95

Hard

7.2-10.1

6.0-8.4

4.8-6.7

3.0-4.25

Very Hard

≥10.2

≥8.5

≥6.8

≥4.25
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Appendix 5
Supplementary tables for Part 4:
Effect modification of the association between leisure-time aerobic physical activity and
diabetes-related mortality by race-ethnicity: a population-based prospective study using
NHANES III
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Table A5.1. Demographic, Heath and Physical Activity characteristics of participants stratified by
diabetes-related mortality status: NHANES III (N=10,717)
Valuec

Variables
Alive or non-diabetesrelated mortality
(n=10,386)
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college/college graduate
Family History of Diabetes (%)
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Drinker (≥12 dks/yr)
Non-drinker (<12 dks/yr)
Physical Activity
Physical Activity Score (median)
Physical Activity Guideline Index (%)
Inactiveb
Insufficiently Active (PAS ≥0-<10)
Active (PAS ≥10)
Physical Activity Index (%)
Inactivea
Quartile 1
Quartile 2
Quartile 3
Quartile 4

Diabetes-related mortality
(n=331)

Χ2

42.4

(0.4)

61.2

(0.7) *

p<0.001

48.3
51.7

(0.6)
(0.6)

50.4
49.6

(4.7)
(4.7)

p<0.001

20.2
34.8
45.0

(0.9)
(0.8)
(1.3)

40.4
38.4
21.2

(4.2) *
(4.9)
(4.6) *

p<0.001

22.5
77.5

(0.7)
(0.7)

43.8
56.2

(4.3) *
(4.3) *

p<0.001

26.5

(0.1)

30.6

(0.6) *

p<0.001

3.5
13.0
83.5

(0.3)
(0.8)
(1.0)

48.9
23.6
27.5

(3.5) *
(3.8)
(4.0) *

p<0.001

63.1

(0.3)

65.1

(1.0)

p=0.09

39.9
27.6
32.5

(0.9)
(0.7)
(1.0)

30.9
39.0
30.1

(3.7)
(3.9) *
(3.7)

p<0.01

35.3
64.7

(1.3)
(1.3)

64.6
35.4

(4.4) *
(4.4) *

p<0.001

12.6

(3.6-29.2)

(0.5-3.4)*

p<0.001

11.5
44.5
44.0

(0.7)
(1.1)
(1.4)

27.5
39.3
33.2

(3.9) *
(4.4)
(4.2)

p<0.001

11.5
21.6
22.6
22.1
22.2

(0.7)
(1.0)
(0.6)
(0.8)
(1.0)

26.4
25.9
14.3
23.3
10.1

(3.8) *
(3.8)
(2.3) *
(4.3)
(2.3) *

p<0.001

5.4

SE = Standard Error; PAS: Physical Activity Score; A1c: glycosylated hemoglobin; dks: drinks; yr: year
a
Zero activity reported.
b
Zero activity or only very light activity reported.
c
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as weighted percentage
(SE).
*significantly different (p<0.05) from “Alive or non-diabetes-related mortality”
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Table A5.2. Diabetes-related mortality risk and the Physical Activity Guideline Index stratified by raceethnicity: NHANES III (N=10,717)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

MA

Fully-adjusted

Fully-adjusted

Fully-adjusted

Physical Activity
Physical Activity Guideline Index
Inactive

1.00

1.00

1.00

Insufficiently Active (PAS ≥0-10)

0.51 (0.29-0.89)*

0.62 (0.34-1.15)

0.84 (0.59-1.19)

Active (PAS ≥10)

0.57 (0.33-0.99)*

0.56 (0.27-1.19)

0.50 (0.23-1.09)

1.10 (1.18-1.13)*

1.08 (1.06-1.11)*

1.09 (1.06-1.11)*

Age
Gender
Male

1.00

1.00

1.00

Female

0.86 (0.52-1.41)

0.63 (0.33-1.21)

0.65 (0.38-1.10)

Education
Less than high school

1.00

1.00

1.00

High school graduate

1.03 (0.65-1.66)

1.14 (0.66-1.97)

0.70 (0.36-1.39)

Some college/college graduate

0.73 (0.35-1.52)

0.80 (0.41-1.55)

1.36 (0.66-2.79)

Yes

1.00

1.00

1.00

No

0.73 (0.49-1.13)

0.91 (0.60-1.41)

0.95 (0.57-1.57)

1.05 (1.02-1.09)

1.03 (0.99-1.08)

1.04 (0.99-1.10)

Diabetes (A1c ≥ 6.5%)

1.00

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.16 (0.09-0.28)*

0.14 (0.07-0.31)*

0.19 (0.10-0.35)*

Euglycemic (A1c < 5.7%)

0.06 (0.03-0.11)*

0.14 (0.06-0.30)*

0.10 (0.07-0.17)*

1.00 (0.98-1.02)

1.00 (0.99-1.03)

1.01 (0.99-1.02)

Family History of Diabetes

Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status

Health Behaviors
Healthy Eating Index (0-100)
Smoking Status
Current smoker

1.00

1.00

1.00

Former

0.40 (0.25-0.64)*

0.55 (0.25-1.18)

0.50 (0.27-0.93)*

Non-smoker

0.45 (0.27-0.74)*

0.35 (0.16-0.77)*

0.23 (0.13-0.42)*

1.00

1.00

1.00

0.62 (0.36-1.08)

1.05 (0.58-1.91)

Alcohol consumption
Drinker (≥12 dks/yr)
Non-drinker (<12 dks/yr)

0.74 (0.45-1.20)

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. *p<0.05
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Appendix 6
Research question 1, part 2:
Is there a dose-response relationship between self-reported quartiles of PA and diabetesrelated mortality across race-ethnic groups?
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Using the data from the NHANES III, a dose-response analysis was conducted using
quartiles of PA. Using the methodology outlined in chapter 3, the physical activity scores (PAS)
were then recoded into quartiles using the following methods:
Creation of five-level PA Index (PAI). The PAI was created to examine the doseresponse relationship with diabetes-related mortality in NHANES III. Participants with a PAS of
zero served as the referent group. The other four categories within the PAI were categorized
using PAS quartiles. More specifically, the PAS quartiles were generated by excluding those
with a “zero” PAS to find the PAS cut-points at the 25 th, 50th and 75th percentiles. The cut-points
for the PAI are as follows: Category 1 (PAS: 0), Category 2 (PAS: >0-5.46), Category 3 (PAS:
5.47-14.41), Category 4 (PAS: 14.42-31.32), and Category 5 (PAS: ≥31.33).
Table A6.4 displays the results of the analysis examining relationship between PA
quartiles and the risk of diabetes-related mortality using race-ethnicity as a covariate. In the
unadjusted analysis, significantly lower risk for diabetes-related mortality was found for all
quartiles. Following adjustment for age and race-ethnicity, significance remained for quartiles 2
(HR 0.30, 95% CI 0.18-0.50), 3 (HR 0.54, 95% CI 0.33-0.91), and 4 (HR 0.23, 95% CI 0.130.40. Following further adjustment for all covariates, results remained significant for quartiles 2
(HR 0.41, 95% CI 0.24-0.68) and 4 (HR 0.38, 95% CI 0.22-0.64).
Tables A6.5 and A6.6 display the results of the analysis examining the effect
modification of race-ethnicity on the relationship between PA quartiles and the risk of diabetesrelated mortality. In the unadjusted analyses significantly lower risk for diabetes-related
mortality was found across all quartiles in NHW and NHB. Significance was only found in the
fourth quartile in MA. Following adjustment for covariates, NHW in quartiles 2 (HR 0.38, 95%
CI 0.20-0.71) and 4 (HR0.35, 95% CI 0.20-0.34) had significantly lower risk for diabetes-related
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mortality. Only NHB in the first quartile (HR 0.44, 95% CI 0.24-0.81) retained significance
following further adjustment for covariates. In MA, significance remained in the fourth quartile
(HR 0.36, 95% CI 0.16-0.81). A significant trend was found only for NHW.
The results of this analysis must be interpreted with caution for two reasons. First, the
results of the Kaplan-Meier survival curves (not shown) indicated that the use of quartiles
violated the proportional hazards assumption of the models. Second, due to the few deaths
spaced across the quartiles of activity, the confidence intervals associated with each HR are
large. It can be postulated that as more data becomes available from the NDI, the use of a more
detailed dose-response (such as the quartiles) examination will become possible. Because of
these two reasons, drawing conclusions from this analysis is not recommended.
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Physical Activity Quintile Characteristics
Table A6.1. Physical Activity characteristics of the participants: NHANES III (N=10,717)
Valueb

Variables
Physical Activity Quartiles
Physical Activity Index (%)
Inactivea
Quartile 1
Quartile 2
Quartile 3
Quartile 4

11.8
21.7
22.4
22.1
22.0

(0.7)
(1.0)
(0.6)
(0.8)
(1.0)

SE = Standard Error.
a
Zero activity reported.
b
Weighted percentage (SE).

Table A6.2 Physical Activity characteristics of participants stratified by diabetes-related mortality status:
NHANES III (N=10,717)
Valueb

Variables
Alive or non-diabetesrelated mortality
(n=10,386)
Physical Activity Index (%)
Inactivea
Quartile 1
Quartile 2
Quartile 3
Quartile 4

11.5
21.6
22.6
22.1
22.2

(0.7)
(1.0)
(0.6)
(0.8)
(1.0)

SE = Standard Error.
a
Zero activity reported.
b
Weighted percentage (SE).
*
significantly different (p<0.05) from “Alive or non-diabetes-related mortal
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Diabetes-related mortality
(n=331)
26.4
25.9
14.3
23.3
10.1

(3.8) *
(3.8)
(2.3) *
(4.3)
(2.3) *

Χ2

p<0.001

Table A6.3. Physical Activity characteristics of participants stratified by race-ethnicity: NHANES III
(N=10,717)
Valueb

Variables
NHW
Physical Activity Index (%)
Inactivea
Quartile 1
Quartile 2
Quartile 3
Quartile 4

10.2
21.1
23.1
22.0
22.6

NHB
(0.7)
(1.1)
(0.7)
(0.9)
(1.1)

18.6
18.6
20.3
21.4
21.1

SE = Standard Error.
a
Zero activity reported.
b
Weighted percentage (SE).
*
significantly different (p<0.05) from NHW; ^significantly different from NHB.
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Χ2

MA
(1.0) *
(0.8)
(0.7)
(0.9) *
(1.2)

24.4
17.2
19.5
18.8
20.1

(1.4) *,^
(1.0)
(1.1) *,^
(1.0) *
(1.1) *

p<0.001

Table A6.4. Diabetes-related mortality risk and the Physical Activity Index: NHANES III (N=10,717)
Variables

Physical Activity
Physical Activity Index
Inactive
Q1
Q2
Q3
Q4
Demographics
Age (years)
Race-ethnicity
non-Hispanic white
non-Hispanic black
Mexican American
Gender
Male
Female
Education
Less than high school
High school graduate
Some college/college graduate
Family History
Family History of Diabetes
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status

Hazard Ratio (95% Confidence Interval)
Unadjusted

Age and raceethnicity adjusted

Fully-adjusted

1.00
0.49 (0.31-0.76)*
0.22 (0.13-0.36)*
0.46 (0.27-0.77)*
0.18 (0.11-0.30)*

1.00
0.66 (0.43-1.02)
0.30 (0.18-0.50)*
0.54 (0.33-0.91)*
0.23 (0.13-0.40)*

1.00
0.65 (0.41-1.05)
0.41 (0.24-0.68)*
0.88 (0.52-1.50)
0.38 (0.22-0.64)*

1.11 (1.09-1.12)*

1.10 (1.08-1.12)*

1.00
1.47 (0.99-2.16)
1.72 (1.21-2.47)*

1.00
0.74 (0.51-1.06)
1.04 (0.69-1.55)
1.00
0.78 (0.50-1.21)
1.00
1.33 (0.74-2.41)
1.46 (0.77-2.77)

1.00
0.76 (0.54-1.06)
1.05 (1.02-1.08)*

Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)
Smoking Status
Current smoker
Former
Non-smoker
Alcohol consumption
Drinker (≥12 dks/yr)
Non-drinker (<12 dks/yr)

1.00
0.17 (0.11-0.26)*
0.07 (0.04-0.12)*
1.00 (0.99-1.02)
1.00
0.42 (0.30-0.60)*
0.42 (0.28-0.64)*
1.00
0.73 (0.50-1.07)

Q: Quartile. *p<0.05
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Table A6.5. Diabetes-related mortality risk and the Physical Activity Index stratified by race-ethnicity:
NHANES III (N=10,717)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

MA

Fully-adjusted

Fully-adjusted

Fully-adjusted

Inactive

1.00

1.00

1.00

Q1

0.67 (0.38-1.15)

0.44 (0.24-0.81)*

0.74 (0.48-1.15)

Q2

0.38 (0.20-0.71)*

0.63 (0.25-1.62)

0.64 (0.32-1.28)

Q3

0.90 (0.46-1.76)

0.75 (0.36-1.57)

1.38 (0.78-2.41)

Q4

0.35 (0.20-0.34)*

0.62 (0.24-1.57)

0.36 (0.16-0.81)*

1.11 (1.08-1.13)*

1.09 (1.06-1.11)*

1.09 (1.07-1.11)*

Male

1.00

1.00

1.00

Female

0.82 (0.50-1.37)

0.63 (0.33-1.20)

0.62 (0.35-1.09)

Less than high school

1.00

1.00

1.00

High school graduate

1.10 (0.72-1.69)

1.12 (0.67-1.87)

0.71 (0.37-1.38)

Some college/college graduate

0.75 (0.37-1.53)

0.77 (0.39-1.51)

1.19 (0.58-2.43)

Yes

1.00

1.00

1.00

No

0.73 (0.48-1.11)

0.90 (0.58-1.37)

0.92 (0.56-1.53)

1.06 (1.02-1.09)*

1.03 (0.99-1.07)

1.05 (0.99-1.11)

Diabetes (A1c ≥ 6.5%)

1.00

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.16 (0.10-0.28)*

0.14 (0.07-0.30)*

0.18 (0.09-0.34)*

Euglycemic (A1c < 5.7%)

0.06 (0.03-0.11)*

0.14 (0.06-0.30)*

0.10 (0.06-0.16)*

1.00 (0.98-1.02)

1.00 (0.99-1.03)

1.01 (0.99-1.02)

Physical Activity
Physical Activity Index

Age
Gender

Education

Family History
Family History of Diabetes

Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status

Health Behaviors
Healthy Eating Index (0-100)
Smoking Status
Current smoker

1.00

1.00

1.00

Former

0.40 (0.26-0.60)*

0.53 (0.39-1.15)

0.47 (0.25-0.88)*

Non-smoker

0.44 (0.27-0.70)*

0.35 (0.16-0.78)*

0.22 (0.13-0.40)*

Drinker (≥12 dks/yr)

1.00

1.00

1.00

Non-drinker (<12 dks/yr)

0.75 (0.48-1.19)

0.60 (0.35-1.04)

1.03 (0.57-1.84)

Alcohol consumption

Q: Quartile. *p<0.05
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Table A6.6. The relationship between the physical activity index and diabetes-related mortality: NHANES III
Inactive

Q1

Total
Physical Activity Score
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

0
1938
101
8809.83
1.00
1.00

>0-<5.88
2131
67
17462.25
0.49 (0.31-0.76)
0.65 (0.41-1.05)

Non-Hispanic White
Physical Activity Score
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

0
550
31
8809.83
1.00
1.00

Non-Hispanic Black
Physical Activity Score
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa
Mexican American
Physical Activity Score
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

Physical Activity Index
Q2

Q3

Q4

p-for-trend

≥5.88-<14.93
2239
57
18397.42
0.22 (0.13-0.36)
0.41 (0.24-0.68)

≥14.93-<31.63
2266
71
18868.50
0.46 (0.27-0.77)
0.88 (0.52-1.50)

≥31.63
2143
35
17470.33
0.18 (0.11-0.30)
0.38 (0.22-0.64)

p<0.001
p=0.03

>0-<5.95
971
31
17462.25
0.47 (0.28-0.80)
0.67 (0.38-1.15)

≥5.95-<15.29
1016
20
18397.42
0.19 (0.10-0.34)
0.38 (0.20-0.71)

≥15.29-<31.86
1061
29
18868.50
0.42 (0.22-0.80)
0.90 (0.46-1.76)

≥31.86
965
16
17470.33
0.17 (0.09-0.30)
0.35 (0.20-0.34)

p<0.001
p=0.05

0
586
32
9902.33
1.00
1.00

>0-<4.13
610
15
10854.75
0.37 (0.21-0.67)
0.44 (0.24-0.81)

≥4.13-<13.80
616
12
11318.92
0.36 (0.15-0.86)
0.63 (0.25-1.62)

≥13.80-<29.67
644
21
11588.42
0.49 (0.24-0.99)
0.75 (0.36-1.57)

≥29.67
601
8
11237.08
0.22 (0.08-0.60)
0.62 (0.24-1.57)

p=0.01
p=0.52

0
802
38
14672.58
1.00
1.00

>0-<3.54
550
21
10609.17
0.71 (0.35-1.42)
0.74 (0.48-1.15)

≥3.54-<11.04
607
25
11440.50
0.54 (0.29-1.00)
0.64 (0.32-1.28)

≥11.04-<27.69
561
21
10526.92
0.86 (0.50-1.50)
1.38 (0.78-2.41)

≥27.69
577
11
10836.92
0.24 (0.11-0.51)
0.36 (0.16-0.81)

p<0.001
p=0.15

a

Adjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol
consumption. HR: Hazard Ratio. Q: Quartile
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Appendix 7
Demographic charateristics of the 1999-2004 NHANES
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Table A7.1. Baseline demographic, Heath and Physical Activity characteristics of the participants: 19992004 NHANES (N=3,327)
Valueb

Variables
Physical Activity
Met-min/wk (median)
Physical Activity Guideline 3 (%)
Inactivea
Insufficiently Active
Active
Physical Activity Guideline 4 (%)
Inactivea
Insufficiently Active
Active
High Active
Physical Activity Quintiles (%)
Inactivea
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Family History
Family History of Diabetes (%)
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

688.2

(161.2-1700.0)

16.1
24.7
59.2

(1.19)
(0.84)
(1.40)

16.1
24.7
18.9
40.3

(1.19)
(0.84)
(0.77)
(1.44)

16.1
16.4
17.1
16.9
16.4
17.3

(1.19)
(0.78)
(0.81)
(0.85)
(0.82)
(0.85)

55.6

(0.24)

49.4
50.6

(0.90)
(0.90)

17.3
26.7
28.3
27.7

(1.15)
(1.18)
(1.07)
(1.46)

25.0
75.0

(1.27)
(1.27)

28.6

(0.18)

6.7
16.4
76.9

(0.46)
(1.06)
(1.21)

53.2

(0.54)

20.6
35.0
44.4

(0.96)
(0.98)
(1.17)

32.2
58.8
9.0

(2.01)
(1.77)
(0.77)

SE = Standard Error.
a
Zero activity reported.
b
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day)
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High
Active: ≥1000 MET-min/wk.
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Table A7.2. Demographic, Heath and Physical Activity characteristics of participants stratified by
diabetes-related mortality status: 1999-2004 NHANES (N=3,327)
Valueb

Variables

Alive or non-diabetes-related
mortality (n=3,265)
Physical Activity
Met-min/wk (median)
Physical Activity Guideline 3 (%)
Inactivea
Insufficiently Active
Active
Physical Activity Guideline 4 (%)
Inactivea
Insufficiently Active
Active
High Active
Physical Activity Quintiles (%)
Inactivea
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Family History
Family History of Diabetes (%)
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

Diabetes-related mortality
(n=62)

(168.8-1708.5)

41.9

(0-378.4)*

15.8
24.6
59.7

(1.15)
(0.82)
(1.37)

43.2
32.6
24.2

(4.37) *
(5.42)
(2.11) *

15.7
24.6
19.1
40.6

(1.15)
(0.82)
(0.78)
(1.41)

43.2
32.6
8.9
15.3

(4.37) *
(5.42)
(2.76) *
(2.31) *

15.8
16.0
17.2
17.0
16.5
17.5

(1.15)
(0.77)
(0.80)
(0.85)
(0.82)
(0.84)

43.2
21.9
11.4
10.8
6.2
6.4

(4.37) *
(5.31)
(3.03)
(2.98)
(1.41) *
(2.28) *

55.5

(0.23)

63.8

(1.53) *

50.6
49.4

(0.93)
(0.93)

53.8
46.2

(5.24)
(5.24)

16.0
26.7
28.3
28.0

(1.14)
(1.19)
(1.08)
(1.47)

42.1
27.0
27.1
3.8

(6.59) *
(4.29)
(5.09)
(1.30) *

24.6
75.4

(1.23)
(1.23)

42.3
57.3

(4.10) *
(4.10) *

28.5

(0.18)

31.0

(1.42)

6.0
16.4
77.6

(0.35)
(1.07)
(1.19)

14.5
22.8
62.7

(3.19) *
(4.53)
(3.83) *

53.2

(0.54)

55.7

(1.41)

20.5
35.1
44.4

(0.95)
(0.98)
(1.16)

34.6
24.1
41.2

(4.75) *
(4.01) *
(4.52)

31.8
59.1
9.1

(1.95)
(1.71)
(0.78)

65.7
30.7
3.6

(6.31) *
(6.33) *
(1.15) *

695.9

SE = Standard Error
a
Zero activity reported. bMedian values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed
as percentage (SE).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day)
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High
Active: ≥1000 MET-min/wk.
*
significantly different (p<0.05) from “Alive or non-diabetes-related mort
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Table A7.3. Demographic, Heath and Physical Activity characteristics of participants stratified by raceethnicity: 1999-2004 NHANES (N=3,327)
Valueb

Variables
NHW
Physical Activity
Met-min/wk (median)
Physical Activity Guideline 3 (%)
Inactivea
Insufficiently Active
Active
Physical Activity Guideline 4 (%)
Inactivea
Insufficiently Active
Active
High Active
Physical Activity Quintiles (%)
Inactivea
Quintile 1
Quintile 2
Quintile 3
Quintile 4
Quintile 5
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Family History
Family History of Diabetes (%)
Yes
No
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)
Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

745.5

NHB

(216.3-1770.3)

278.6

(0-1134.9)*

13.9
24.9
61.2

(1.30)
(0.92)
(1.50)

33.2
22.9
43.9

(2.05) *
(1.16)
(2.06) *

13.9
24.9
19.4
41.8

(1.30)
(0.93)
(0.81)
(1.56)

33.2
22.9
16.1
27.8

(2.05) *
(1.16)
(1.38)
(1.62) *

13.9
16.4
17.7
17.4
16.8
17.8

(1.30)
(0.84)
(0.91)
(0.94)
(0.89)
(0.93)

33.2
13.4
12.8
13.5
13.3
13.8

(2.05) *
(1.05)
(1.07) *
(1.30)
(1.03)
(1.18)

55.9

(1.53)

53.4

(1.53) *

51.1
48.9

(0.99)
(0.99)

47.6
52.4

(1.75)
(1.75)

17.6
27.2
28.6
29.6

(1.25)
(1.35)
(1.20)
(1.67)

37.2
23.6
25.9
13.3

(2.26) *
(1.77)
(1.58)
(1.46) *

23.1
76.9

(1.39)
(1.39)

39.2
60.8

(1.74) *
(1.74) *

28.3

(1.42)

30.2

(1.42)

5.8
15.1
79.1

(0.55)
(1.17)
(1.37)

14.2
26.8
59.0

(1.12) *
(2.28) *
(1.41) *

53.7

(1.41)

49.5

(1.41)

19.4
36.8
43.8

(1.07)
(1.03)
(1.30)

30.5
21.4
48.1

(1.61) *
(1.21) *
(1.67)

30.8
60.0
9.2

(2.29)
(2.02)
(0.86)

43.2
49.1
7.7

(1.77) *
(2.02) *
(1.17)

SE = Standard Error
a
Zero activity reported.
b
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day)
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: ≥500 MET-min/wk.
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-499 MET-min/wk; Active: 500-999 MET-min/wk; High
Active: ≥1000 MET-min/wk.
*
significantly different (p<0.05) from NHW.
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Appendix 8
Among the 1999-2004 NHANES, is there a dose-response relationship between selfreported PA (3-level) and diabetes-related mortality across race-ethnic groups?
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Using the data from the 1999-2004 NHANES, a dose-response analysis was conducted
using the 3-level PA (PAG3) variable outlined in chapter 3. Briefly, PA was coded into three
categories based on the 2008 PA guidelines: 0 MET-minutes/wk (Inactive), <500 METminutes/wk (Insufficiently Active), ≥500 MET-minutes/wk which equates to meeting the 2008
DHHS aerobic PA guidelines of 150 minutes of MVPA/wk. Due to the overwhelming lack of
diabetes-related mortality deaths in MA, the 1999-2004 analyses were conducted only in NHW
and NHB. The results of the analyses are displayed in tables A8.1, A8.2 and A8.3.
The results in Table A8.1 reveal significantly lower risk for diabetes-related mortality in
those who were insufficiently active (HR 0.47, 95% CI 0.26-0.84) or active (HR 0.14, 95% CI
0.08-0.27). Following adjustment for age and race-ethnicity, results remained significant for only
active participants (HR 0.20, 95% CI 0.10-0.39). Following further adjustment for covariates,
both insufficiently active (HR 0.54, 95% CI 0.34-0.86) and active (HR 0.58, 95% CI 0.36-0.94)
participants had significantly lower risk for diabetes-related mortality.
Tables A8.2 and A8.3 illustrate the results of the analysis examining the relationship
between the PAG3 and diabetes-related mortality stratified by race-ethnicity. In the unadjusted
analysis for NHW, participants categorized as either insufficiently active (HR 0.46, 95% CI
0.22-0.99) or active (HR 0.14, 95% CI 0.07-0.30) had significantly lower risk for diabetesrelated mortality compared to inactive participants. In NHB, only active participants had
significantly lower risk (HR 0.19, 95% CI 0.06-0.59). Following further adjustment for
covariates, results remained significant only for active NHW (HR 0.28, 95% CI 0.14-0.57).
While not statistically significant, active NHB had a pronounced risk reduction that approached
significance (HR 0.34, 95% CI 0.11-1.02). A significant p-for-trend was found for NHW
(p=0.001) and NHB (p=0.04).
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The results of the current analysis indicate that meeting the 2008 aerobic PA guidelines
provides significant protection from diabetes-related mortality among those who are NHW.
Among NHB, a clinically meaningful risk reduction was found among those who were active.
However results did not attain statistical significance. Similar to the results found in the analysis
using the NHANES III data, at a similar dose of activity (active PA), the risk reduction was
similar between NHW and NHB. The overall low number of deaths related to diabetes and
smaller sample size, especially in NHB, is likely contributing to the lack of significance and
large confidence intervals found in the analysis.
When compared to the PA questionnaire in NHANES III, the 1999-2004 NHANES has
the addition of duration as well as PA across different domains (i.e. transportation and domestic),
thus providing researchers a more comprehensive examination of PA. Furthermore, the 19992006 NHANES also contains a questionnaire on muscular strengthening activity (MSA). Given
the established effect of MSA on risk factors for diabetes-related mortality such as insulin
sensitivity and glucose intolerance, the 1999-2006 NHANES provides the ability to examine
how MSA relates to diabetes-related mortality. As more data are added to the NDI and
subsequently the NHANES, it is likely the confidence intervals will decrease providing a better
illustration of how PA relates to diabetes-related mortality.
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Table A8.1. Relationship between the Physical Activity Guideline (3-level) and diabetes-related
mortality: 1999-2004 NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Age and race-ethnicity
adjusted

Unadjusted

Fully-adjusted

Physical Activity
Physical Activity Guideline 3
Inactive

1.00

1.00

1.00

Insufficiently Active

0.47 (0.26-0.84)*

0.63 (0.34-1.14)

0.54 (0.34-0.86)*

Active

0.14 (0.08-0.27)*

0.20 (0.10-0.39)*

0.58 (0.36-0.94)*

1.07 (1.04-1.10)*

1.06 (1.01-1.11)*

NHW

1.00

1.00

NHB

1.79 (0.94-3.41)

0.80 (0.40-1.61)

Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.59 (0.33-1.05)

Education
Less than high school

1.00

High school graduate

0.90 (0.70-1.56)

Some college

1.03 (0.43-2.50)

College graduate

0.27 (0.05-1.57)

Family History
Family History of Diabetes
Yes

1.00

No
Body Mass Index (kg/m2)

0.59 (0.34-1.04)
0.99 (0.93-1.06)

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.20 (0.10-0.44)*

Euglycemic (A1c < 5.7%)

0.04 (0.01-0.13)*

Health Behaviors
Healthy Eating Index (0-100)

1.01 (0.99-1.02)

Smoking Status
Current smoker

1.00

Former

0.28 (0.11-0.71)*

Non-smoker

0.44 (0.21-0.92)*

Alcohol consumption
Non-drinker

1.00

Moderate

0.56 (0.26-1.19)

Above moderate

0.78 (0.25-2.45)

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American.
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: ≥500 MET-min/wk.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).*p<0.05
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Table A8.2. Relationship between the Physical Activity Guideline (3-level) and diabetes-related mortality
stratified by race-ethnicity: 1999-2004 NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

Unadjusted

Fully-adjusted

Unadjusted

Fully-adjusted

1.00

1.00

1.00

1.00

Insufficiently Active

0.46 (0.22-0.99)*

0.79 (0.39-1.60)

0.61 (0.25-1.49)

0.93 (0.30-2.18)

Active

0.14 (0.07-0.30)*

0.28 (0.14-0.57)*

0.19 (0.06-0.59)*

0.34 (0.11-1.02)

Physical Activity
Physical Activity Guideline 3
Inactive

Demographics
Age

1.05 (0.99-1.12)*

1.08 (1.03-1.12)*

Gender
Male

1.00

1.00

Female

0.55 (0.26-1.17)

0.98 (0.34-2.73)

Less than high school

1.00

1.00

High school graduate

1.18 (0.46-3.02)

0.51 (0.19-1.41)

Some college

1.52 (0.51-4.41)

0.12 (0.01-1.16)

College graduate

0.31 (0.04-2.60)

0.42 (0.05-3.38)

Education

Family History
Family History of Diabetes
Yes

1.00

1.00

No

0.55 (0.26-1.15)

0.61 (0.24-1.55)

1.00 (0.93-1.08)

0.92 (0.84-1.02)

Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.19 (0.07-0.49)*

0.23 (0.08-0.62)*

Euglycemic (A1c < 5.7%)

0.03 (0.01-0.15)*

0.12 (0.04-0.38)*

1.01 (0.99-1.03)

1.00 (0.98-1.03)

1.00

1.00

Health Behaviors
Healthy Eating Index
Smoking Status
Current smoker
Former

0.31 (0.11-0.87)*

0.14 (0.04-0.53)*

Non-smoker

0.43 (0.16-1.15)

0.37 (0.15-0.91)*

1.00

1.00

Moderate

0.51 (0.20-1.31)

0.70 (0.33-1.50)

Above moderate

0.50 (0.05-4.93)

1.10 (0.25-4.92)

Alcohol consumption
Non-drinker

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American.
Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: ≥500 MET-min/wk.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).*p<0.05
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Table A8.3. Hazards ratios from analyses examining the relationship between physical activity (3-level) and diabetes-related
mortality: 1999-2004 NHANES
Physical Activity Guideline 3
MET-min/wk

Inactive
0

Insufficiently Active
>0-<500

Active
≥500

Total
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

699
29
5996.58
1.00
1.00

796
17
7151.50
0.47 (0.26-0.84)
0.54 (0.34-0.86)

1832
16
16828.67
0.14 (0.08-0.27)
0.58 (0.36-0.94)

p<0.001
p<0.001

Non-Hispanic White
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

369
13
3066.50
1.00
1.00

580
11
5226.92
0.46 (0.22-0.99)
0.79 (0.39-1.60)

1433
11
13269.50
0.14 (0.07-0.30)
0.28 (0.14-0.57)

p<0.001
p=0.001

Non-Hispanic Black
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

330
16
2930.08
1.00
1.00

215
6
1913.67
0.61 (0.25-1.49)
0.93 (0.30-2.18)

399
5
3559.17
0.19 (0.06-0.59)
0.34 (0.11-1.02)

p=0.002
p=0.04

a

p-for-trend

Adjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol
consumption. HR: Hazard Ratio. Physical Activity Guideline 3: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active:
≥500 MET-min/wk.
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Figure A8.1. Kaplan-Meier Survival Curve: Physical Activity Guideline 3 and Non-Hispanic
White
PAG3 1: Inactive; PAG3 2: Insufficiently Active; PAG3 3: Active
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Figure A8.2. Kaplan-Meier Survival Curve: Physical Activity Guideline 3 and Non-Hispanic
Black
PAG3 1: Inactive; PAG3 2: Insufficiently Active; PAG3 3: Active
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Appendix 9
Among the 1999-2004 NHANES, is there a dose-response relationship between selfreported PA (4-level) and diabetes-related mortality across race-ethnic groups?

159

Using the data from the 1999-2004 NHNAES, a dose-response analysis was conducted
using the 4-level PA (PAG4) variable outlined in chapter 3. Briefly, PA was coded into four
categories based on the 2008 PA guidelines: 0 MET-minutes/wk (Inactive), <500 METminutes/wk (Insufficiently Active), 500-<1000 MET-minutes/wk (Active) which equates to
meeting the 2008 DHHS aerobic PA guidelines of 150 minutes of MVPA/wk and ≥1000 METminutes/wk (High active) which equates to volumes exceeding the recommendations of ≥300
minutes/wk of MVPA. The results of the analyses are displayed in tables A9.1, A9.2 and A9.3.
The results in Table A9.1 reveal significantly lower risk for diabetes-related mortality in
those who were insufficiently active (HR 0.47, 95% CI 0.26-0.84), active (HR 0.17, 95% CI
0.08-0.36) or high active (HR 0.13, 95% CI 0.05-0.33). Following adjustment for age and raceethnicity, results remained significant for insufficiently active (HR 0.24, 95% CI 0.11-0.52) and
active participants (HR 0.18, 95% CI 0.07-0.48). Following further adjustment for covariates,
both insufficiently active (HR 0.40, 95% CI 0.18-0.93) and active (HR 0.30, 95% CI 0.13-0.72)
participants had significantly lower risk for diabetes-related mortality.
Tables A9.2 and A9.3 illustrate the results of the analysis examining the relationship
between the PAG4 and diabetes-related mortality stratified by race-ethnicity. In the unadjusted
analysis for NHW, participants categorized as either insufficiently active (HR 0.46, 95% CI
0.22-0.98), active (HR 0.14, 95% CI 0.05-0.41) or high active (HR 0.14, 95% CI 0.05-0.40) had
significantly lower risk for diabetes-related mortality compared to inactive participants. In NHB,
only high active participants had significantly lower risk (HR 0.05, 95% CI 0.01-0.38).
Following further adjustment for covariates, results remained significant for high active NHW
(HR 0.31, 95% CI 0.12-0.79) and NHB (HR 0.09, 95% CI 0.02-0.44). A significant p-for-trend
was found for NHW (p=0.005) and NHB (p=0.01).
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The results of the current analysis indicate that exceeding the 2008 aerobic PA guidelines
(≥1000 MET-min/wk) provides significant protection from diabetes-related mortality among
those who are NHW. Furthermore, the results indicate that meeting the 2008 aerobic guidelines
of 500 MET-min/wk is not sufficient to provide protection. However, similar to the results
examining the PAG3, there is a sufficient lack of power due to the small sample size and low
amount of deaths related to diabetes. However, despite the lack of statistical power, there was
still a significant trend for both NHW and NHB across increasing dose of PA. As more data
become available from the NDI, the ability to examine thresholds based around the current PA
guidelines will become obtainable.
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Table A9.1. Relationship between Physical Activity Guideline (4-level) and diabetes-related mortality:
1999-2004 NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Age and race-ethnicity
adjusted

Unadjusted

Fully-adjusted

Physical Activity
Physical Activity Guideline 4
Inactive

1.00

1.00

1.00

Insufficiently Active

0.47 (0.26-0.84)*

0.63 (0.34-1.14)

0.76 (0.44-1.33)

Active

0.17 (0.08-0.36)*

0.24 (0.11-0.52)*

0.40 (0.18-0.93)*

High Active

0.13 (0.05-0.33)*

0.18 (0.07-0.48)*

0.30 (0.13-0.72)*

1.07 (1.04-1.10)*

1.06 (1.01-1.11)*

NHW

1.00

1.00

NHB

1.78 (0.94-3.40)

0.80 (0.40-1.61)

Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.59 (0.33-1.05)

Education
Less than high school

1.00

High school graduate

0.90 (0.70-1.56)

Some college

1.03 (0.43-2.50)

College graduate

0.27 (0.05-1.57)

Family History
Family History of Diabetes
Yes

1.00

No

(0.57 (0.34-1.05)

Metabolic Markers
Body Mass Index (kg/m2)

0.99 (0.93-1.06)

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.20 (0.10-0.44)*

Euglycemic (A1c < 5.7%)

0.04 (0.01-0.13)*

Health Behaviors
Healthy Eating Index

1.01 (0.99-1.02)

Smoking Status
Current smoker

1.00

Former

0.28 (0.11-0.71)*

Non-smoker

0.44 (0.21-0.92)*

Alcohol consumption
Non-drinker

1.00

Moderate

0.56 (0.26-1.19)

Above moderate

0.78 (0.25-2.45)

NHW: non-Hispanic white; NHB: non-Hispanic black;
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 500-999 MET-min/wk; High
Active: ≥1000 MET-min/wk.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).*p<0.05
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Table A9.2. Relationship between Physical Activity Guideline (4-level) and diabetes-related mortality
stratified by race-ethnicity: 1999-2004 NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW
Unadjusted

Fully-adjusted

NHB
Unadjusted

Fully-adjusted

Physical Activity
Physical Activity Guideline 4
Inactive

1.00

1.00

1.00

1.00

Insufficiently Active

0.46 (0.22-0.98)*

0.74 (0.37-1.50)

0.61 (0.25-1.49)

0.82 (0.31-2.18)

Active

0.14 (0.05-0.41)*

0.34 (0.10-1.10)

0.46 (0.14-1.46)

0.86 (0.22-3.39)

High Active

0.14 (0.05-0.40)*

0.31 (0.12-0.79)*

0.05 (0.01-0.38)*

0.09 (0.02-0.44)*

Demographics
Age

1.05 (0.99-1.12)*

1.08 (1.03-1.12)*

Gender
Male

1.00

1.00

Female

0.58 (0.26-1.18)

0.96 (0.34-2.73)

Education
Less than high school

1.00

1.00

High school graduate

1.18 (0.46-3.01)

0.48 (0.17-1.36)

Some college

1.50 (0.52-4.36)

0.11 (0.01-1.24)

College graduate

0.31 (0.03-2.91)

0.36 (0.06-3.37)

Family History
Family History of Diabetes
Yes

1.00

1.00

No

0.55 (0.76-1.15)

0.61 (0.24-1.56)

1.00 (0.93-1.08)

0.92 (0.84-1.02)

Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.19 (0.07-0.49)*

0.24 (0.08-0.68)*

Euglycemic (A1c < 5.7%)

0.03 (0.01-0.15)*

0.13 (0.04-0.41)*

1.01 (0.99-1.03)

1.01 (0.98-1.04)

Current smoker

1.00

1.00

Former

0.31 (0.11-0.87)*

0.14 (0.03-0.54)*

Non-smoker

0.43 (0.16-1.15)

0.37 (0.15-0.91)*

Health Behaviors
Healthy Eating Index
Smoking Status

Alcohol consumption
Non-drinker

1.00

1.00

Moderate

0.51 (0.20-1.31)

0.71 (0.32-1.62)

Above moderate

0.50 (0.05-5.14)

1.01 (0.23-4.44)

NHW: non-Hispanic white; NHB: non-Hispanic black.
Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active: 500-999 MET-min/wk; High
Active: ≥1000 MET-min/wk.
non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1 [women], >2 [men]
drinks/day).*p<0.05

163

Table A9.3. Hazards ratios from analyses examining the relationship between physical activity (4-level) and diabetes-related
mortality: 1999-2004 NHANES
Physical Activity Guideline 4
MET-min/wk

Inactive
0

Insufficiently Active
>0-<500

Active
500-<999

High Active
≥1000

Total
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

699
29
3066.50
1.00
1.00

796
17
7151.50
0.47 (0.26-0.84)
0.76 (0.44-1.33)

585
8
5303.08
0.17 (0.08-0.36)
0.40 (0.18-0.93)

1247
8
11525.58
0.13 (0.05-0.33)
0.30 (0.13-0.72)

p<0.001
p=0.002

Non-Hispanic White
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

369
13
3066.50
1.00
1.00

580
11
5226.92
0.46 (0.22-0.98)
0.74 (0.37-1.50)

442
4
4043.42
0.14 (0.05-0.41)
0.34 (0.10-1.10)

990
7
9217.58
0.14 (0.05-0.40)
0.31 (0.12-0.79)

p<0.001
p=0.005

Non-Hispanic Black
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

330
16
2930.08
1.00
1.00

215
6
1913.67
0.61 (0.25-1.49)
0.82 (0.31-2.18)

141
4
1239.58
0.46 (0.14-1.46)
0.86 (0.22-3.39)

257
1
2308.00
0.05 (0.01-0.38)
0.09 (0.02-0.44)

p<0.001
p=0.01

a

p-for-trend

Adjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol
consumption. HR: Hazard Ratio. Physical Activity Guideline 4: Inactive: 0 MET-min/wk; Insufficiently Active: >0-<500 MET-min/wk; Active:
500-999 MET-min/wk; High Active: ≥1000 MET-min/wk.
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Figure 9.1. Kaplan-Meier Survival Curve: Physical Activity Guideline 4 and Non-Hispanic
White
PAG4 1: Inactive; PAG4 2: Insufficiently Active; PAG4 3: Active; PAG4 4: High Active
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Figure 9.2. Kaplan-Meier Survival Curve: Physical Activity Guideline 4 and Non-Hispanic
Black
PAG4 1: Inactive; PAG4 2: Insufficiently Active; PAG4 3: Active; PAG4 4: High Active
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Appendix 10
Among the 1999-2004 NHANES, is there a dose-response relationship between selfreported quintiles of PA and diabetes-related mortality across race-ethnic groups?
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Table A10.1 displays the results of the analysis examining relationship between PA
quintiles and the risk of diabetes-related mortality using race-ethnicity as a covariate. In the
unadjusted analysis, significantly lower risk for diabetes-related mortality was found for all
quintiles with the exception of quintile 1. Following adjustment for age and race-ethnicity,
significance remained the same. Following further adjustment for all covariates, results remained
significant for quintile 4 (HR 0.24, 95% CI 0.06-0.95).
Tables A6.5 and A6.6 display the results of the analysis examining the effect
modification of race-ethnicity on the relationship between PA quartiles and the risk of diabetesrelated mortality. In the unadjusted analyses, significantly lower risk for diabetes-related
mortality was found across all quintiles in NHW except for quintile 1. Significance was only
found in the fourth quintile in NHB. There were no deaths in quintile 5 therefore no hazard ratio
could be calculated. Following adjustment for covariates, NHW in quartile 5 (HR 0.24, 95% CI
0.06-0.97) had significantly lower risk for diabetes-related mortality. No significant HR were
found for NHB following adjustment for all covariates.
Similar to the analyses with the NHANES III quartiles in Appendix 6, the results of this
analysis must be interpreted with caution. First, the results of the Kaplan-Meier survival curves
(not shown) indicated that the use of quintiles violated the proportional hazards assumption of
the models. Second, due to the few deaths spaced across the quartiles of activity, the confidence
intervals associated with each HR are large. In quintile 5 for NHB, there were no deaths
therefore no HR could be calculated. Thus, understanding the dose response relationship is
severely diminished. It can be postulated that as more data becomes available from the NDI, the
use of a more detailed dose-response (such as the quintiles) examination will become possible.
Because of these reasons, drawing conclusions from this analysis is not recommended.
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Table A10.1. Relationship between physical activity quintiles and diabetes-related mortality: 1999-2004
NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Age and race-ethnicity
adjusted

Unadjusted

Fully-adjusted

Physical Activity
Physical Activity Quintiles
Inactive

1.00

1.00

1.00

Q1

0.49 (0.24-1.02)

0.65 (0.31-1.35)

0.69 (0.33-1.43)

Q2

0.23 (0.10-0.53)*

0.33 (0.14-0.77)*

0.67 (0.31-1.45)

Q3

0.22 (0.10-0.49)*

0.33 (0.15-0.72)*

0.49 (0.22-1.10)

Q4

0.14 (0.04-0.43)*

0.19 (0.06-0.60)*

0.38 (0.12-1.27)

Q5

0.13 (0.04-0.45)*

0.17 (0.05-0.64)*

0.24 (0.06-0.95)*

1.07 (1.04-1.10)*

1.06 (1.01-1.11)*

NHW

1.00

1.00

NHB

1.84 (0.97-3.51)

0.80 (0.39-1.63)

Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.59 (0.32-1.07)

Education
Less than high school

1.00

High school graduate

0.88 (0.41-1.92)

Some college

1.03 (0.43-2.46)

College graduate

0.25 (0.04-1.40)

Family History
Family History of Diabetes
Yes

1.00

No

0.59 (0.33-1.06)

Metabolic Markers
Body Mass Index (kg/m2)

0.99 (0.93-1.06)

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.20 (0.09-0.44)*

Euglycemic (A1c < 5.7%)

0.04 (0.01-0.13)*

Health Behaviors
Healthy Eating Index

1.01 (0.99-1.02)

Smoking Status
Current smoker

1.00

Former

0.27 (0.10-0.69)*

Non-smoker

0.43 (0.20-0.91)*

Alcohol consumption
Non-drinker

1.00

Moderate

0.55 (0.25-1.18)

Above moderate

0.79 (0.26-2.41)

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. Q: Quintile.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).*p<0.05
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Table A10.2. Relationship between physical activity quintiles and diabetes-related mortality stratified by
race-ethnicity: 1999-2004 NHANES (N=3,324)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW
Unadjusted

Fully-adjusted

NHB
Unadjusted

Fully-adjusted

Physical Activity
Physical Activity Quintiles
Inactive

1.00

1.00

1.00

1.00

Q1

0.46 (0.18-1.20)

0.62 (0.25-1.57)

0.86 (0.32-2.31)

1.56 (0.55-4.43)

Q2

0.22 (0.09-0.59)*

0.71 (0.27-1.82)

0.37 (0.09-1.59)

0.23 (0.02-3.13)

Q3

0.21 (0.08-0.54)*

0.47 (0.18-1.22)

0.37 (0.10-1.33)

0.84 (0.19-3.74)

Q4

0.14 (0.04-0.51)*

0.42 (0.10-1.67)

0.11 (0.02-0.78)*

0.23 (0.05-1.12)

Q5

0.15 (0.04-0.56)*

0.24 (0.06-0.97)*

N/A

N/A

Demographics
Age

1.05 (0.99-1.12)*

1.08 (1.04-1.12)*

Gender
Male

1.00

1.00

Female

0.55 (0.26-1.17)

1.04 (0.33-3.22)

Education
Less than high school

1.00

1.00

High school graduate

1.16 (0.45-3.01)

0.41 (0.12-1.42)

Some college

1.49 (0.52-4.29)

0.10 (0.01-1.20)

College graduate

0.26 (0.03-2.36)

0.39 (0.04-3.67)

Family History
Family History of Diabetes
Yes

1.00

1.00

No

0.54 (0.26-1.17)

0.61 (0.24-1.55)

1.00 (0.93-1.08)

0.92 (0.83-1.02)

Metabolic Markers
Body Mass Index (kg/m2)
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.18 (0.07-0.48)*

0.21 (0.07-0.67)*

Euglycemic (A1c < 5.7%)

0.03 (0.01-0.14)*

0.12 (0.04-0.33)*

1.01 (0.99-1.03)

1.01 (0.98-1.02)

Current smoker

1.00

1.00

Former

0.29 (0.10-0.81)*

0.12 (0.03-0.47)*

Non-smoker

0.40 (0.15-1.11)

0.35 (0.14-0.88)*

Health Behaviors
Healthy Eating Index
Smoking Status

Alcohol consumption
Non-drinker

1.00

1.00

Moderate

0.50 (0.19-1.31)

0.71 (0.31-1.63)

Above moderate

0.51 (0.05-5.00)

0.91 (0.17-4.92)

NHW: non-Hispanic white; NHB: non-Hispanic black; MA: Mexican American. Q: Quintile
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).*p<0.05
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Table A10.3. Hazards ratios from analyses examining the relationship between physical activity (Quintiles) and diabetes-related
mortality: 1999-2004 NHANES
Physical Activity Quintiles
Inactive

Q1

Q2

Q3

Q4

Q5

p-for-trend

Total
MET-min/wk
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

0
699
29
5996.58
1.00
1.00

>0-<312.34
515
11
4546.58
0.49 (0.24-1.02)
0.69 (0.33-1.43)

≥312.34-<673.79
528
7
4839.08
0.23 (0.10-0.53)
0.67 (0.31-1.45)

≥673.79-<1245.09
512
8
4748.00
0.22 (0.10-0.49)
0.49 (0.22-1.10)

≥1245.09-<2382.52
514
4
4686.25
0.14 (0.04-0.43)
0.38 (0.12-1.27)

≥2382.52
559
3
5160.25
0.13 (0.04-0.45)
0.24 (0.06-0.95)

p<0.001
p=0.002

Non-Hispanic White
MET-min/wk
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

0
369
13
3066.50
1.00
1.00

>0-<307.42
388
6
3433.25
0.46 (0.18-1.20)
0.62 (0.25-1.57)

≥307.42-<682.35
409
5
3766.83
0.22 (0.09-0.59)
0.71 (0.27-1.82)

≥682.35-<1258.91
394
5
3696.17
0.21 (0.08-0.54)
0.47 (0.18-1.22)

≥1258.91-<2339.65
392
3
3596.50
0.14 (0.04-0.51)
0.42 (0.10-1.67)

≥2339.65
431
3
4014.58
0.15 (0.04-0.56)
0.24 (0.06-0.97)

p<0.001
p=0.008

Non-Hispanic Black
MET-min/wk
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa

0
330
16
2930.08
1.00
1.00

>0-<233.11
127
5
1113.33
0.86 (0.32-2.31)
1.56 (0.55-4.43)

≥233.11-<560.52
119
2
1072.25
0.37 (0.09-1.59)
0.23 (0.02-3.13)

≥560.52-<1022.72
118
3
1051.83
0.37 (0.10-1.33)
0.84 (0.19-3.74)

≥1022.72-<2077.38
122
1
1089.75
0.11 (0.02-0.78)
0.23 (0.05-1.12)

≥2077.38
128
0
1145.67
-

p=0.002
p=0.009

a

Adjusted for: age, gender, education, family history of diabetes, body mass index, glycemic status, healthy eating index, smoking status, alcohol
consumption. HR: Hazard Ratio. Q: Quintile
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Appendix 11
Demographic characteristics of the 2003-2006 NHANES
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Table A11.1. Baseline demographic, Heath and Physical Activity characteristics of the participants: 20032006 NHANES (N=2,595)
Valuea

Variables
Physical Activity
MVPA 760 (median)
MVPA 2020 (median)
Total Activity Counts/d (%)
Quartile 1
Quartile 2
Quartile 3
Quartile 4
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)

Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

95.2
13.8

(61.4–136.8)
(5.2-28.9)

27.0
26.1
23.7
23.2

(1.0)
(1.4)
(1.1)
(1.3)

55.6

(0.2)

48.1
51.9

(1.0)
(1.0)

11.9
27.4
32.3
28.4

(1.5)
(0.9)
(1.2)
(1.8)

28.6

(0.2)

7.7
19.5
72.8

(0.8)
(0.9)
(1.2)

53.2

(0.5)

20.0
33.7
46.3

(1.2)
(1.2)
(1.2)

31.5
59.7
8.8

(2.0)
(1.7)
(0.7)

SE = Standard Error. MVPA 760 = moderate-to-vigorous minutes physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous
minutes physical activity (≥2020 counts/min).
a
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day)
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Table A11.2. Demographic, Heath and Physical Activity characteristics of participants stratified by
diabetes-related mortality status: 2003-2006 NHANES (N=2,595)
Valuec

Variables

Alive or non-diabetes-related
mortality (n=2,572)
Physical Activity
MVPA 760 (median)
MVPA 2020 (median)
Total Activity Counts/d (%)
Quartile 1
Quartile 2
Quartile 3
Quartile 4
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)

Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

Diabetes-related
mortality
(n=23)

95.7
13.8

(61.8-136.9)
(5.3-28.9)

31.0
1.7

(22.3-35.3)*
(1.2-3.6) *

26.6
26.2
23.9
23.3

(1.0)
(1.4)
(1.1)
(1.3)

83.5
2.7
1.7
12.1

(2.7) *
(0.2) *
(1.8) *
(1.0) *

55.8

(0.4)

65.8

(0.7) *

48.0
52.0

(1.0)
(1.0)

62.9
37.1

(7.8)
(7.8)

11.7
27.5
32.3
28.6

(1.4)
(0.9)
(1.2)
(1.8)

53.1
22.0
22.5
2.4

(5.2) *
(1.7)
(5.6)
(0.2) *

29.0

(0.2)

28.7

(0.8)

7.4
19.4
73.2

(0.7)
(0.9)
(1.2)

66.5
31.7
1.8

(7.5) *
(7.6)
(0.1) *

49.1

(0.5)

43.5

(2.1)

20.0
33.7
46.3

(1.2)
(1.2)
(1.2)

30.7
27.7
41.6

(4.6)
(6.1)
(5.1)

31.2
59.9
8.9

(2.0)
(1.7)
(0.7)

76.8
21.3
1.9

(7.2) *
(7.2) *
(0.2) *

SE = Standard Error. MVPA 760 = moderate-to-vigorous physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous physical
activity (≥2020 counts/min).
a
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
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Table A11.3. Demographic, Heath and Physical Activity characteristics of participants stratified by raceethnicity: 2003-2006 NHANES (N=2,595)
Valuec

Variables
NHW (n=1892)

NHB (n=703)

Physical Activity

MVPA 760 (median)
MVPA 2020 (median)
Total Activity Counts/d (%)
Quartile 1
Quartile 2
Quartile 3
Quartile 4
Demographics
Age (mean)
Gender (%)
Male
Female
Education (%)
Less than high school
High school graduate
Some college
College graduate
Metabolic Markers
Body Mass Index (kg/m2)(mean)
Glycemic Status (%)
Diabetes (A1c ≥ 6.5%)
Pre-diabetes (A1c 5.7-6.5%)
Euglycemic (A1c < 5.7%)

Health Behaviors
Healthy Eating Index (0-100)(mean)
Smoking Status (%)
Current smoker
Former
Non-smoker
Alcohol consumption (%)
Non-Drinker
Moderate
Above Moderate

95.6
14.3

(62.0-136.9)
(5.4-29.4)

92.7
11.1

(53.4-134.8)
(4.2-25.1)

26.4
26.1
23.8
23.7

(1.1)
(1.6)
(1.2)
(1.4)

31.5
26.4
23.7
18.4

(1.7)
(1.5)
(1.8)
(1.3)

56.0

(0.4)

54.2

(0.4) *

48.6
51.4

(1.0)
(1.0)

43.5
56.6

(1.8)
(1.8)

10.4
27.8
32.3
29.5

(1.6)
(1.0)
(1.3)
(1.9)

25.2
24.5
31.7
18.6

(1.7) *
(1.7)
(1.2)
(1.7) *

28.8

(0.2)

30.8

(0.3) *

6.7
18.1
75.2

(0.8)
(1.0)
(1.3)

16.2
31.7
52.1

(1.8) *
(1.8) *
(2.4) *

49.4

(0.5)

46.6

(0.8) *

19.5
34.7
45.8

(1.3)
(1.3)
(1.4)

25.0
24.7
50.3

(2.3)
(1.3) *
(2.4)

29.8
60.9
9.3

(2.2)
(1.9)
(0.8)

45.7
48.9
5.4

(1.7) *
(1.9) *
(0.9) *

SE = Standard Error. MVPA 760 = moderate-to-vigorous physical activity (≥760 counts/min). MVPA 2020 = moderate-to-vigorous physical
activity (≥2020 counts/min).
a
Median values expressed as median (Interquartile Range). Mean expressed as mean (SE). All other variables expressed as percentage (SE).
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day)
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Appendix 12

3B. Is there a dose-response relationship between quartiles of accelerometer-derived total
activity counts/day (TAC/d) and diabetes-related mortality across race-ethnic groups?
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The results of the analysis addressing research question 3B are displayed in tables 12.1,
12.2, and 12.3. In the unadjusted as well as the age and race-ethnicity adjusted analyses,
significantly lower risk for diabetes-related mortality was found across all quartiles. Following
further adjustment for covariates, significance remained only in quartile 3. In the race-ethnicity
stratified analyses, a significantly lower risk for diabetes-related mortality was found only for
quartile 4 in NHW. No relationships were found for NHB. Following further adjustment for
covariates, results remained the same. Due to the significant lack of deaths, there was no ability
to calculate hazard ratios in quartiles 2 and 3 for NHW and quartile 4 for NHB. This removes the
ability to interpret the results in any way.
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Table A12.1. Relationship between physical activity and diabetes-related mortality: 2003-2006 NHANES
(N=2,595)
Variables

Hazard Ratio (95% Confidence Interval)
Age and race-ethnicity
adjusted

Unadjusted

Fully-adjusted

Physical Activity
Total Activity Counts/day
Quartile 1

1.00

1.00

1.00

Quartile 2

0.03 (0.01-0.17)*

0.03 (0.01-0.18)*

0.04 (0.01-0.19)

Quartile 3

0.02 (0.00-0.23)*

0.02 (0.00-0.25)*

0.04 (0.01-0.35)*

Quartile 4

0.17 (0.03-0.86)*

0.18 (0.04-0.88)*

0.30 (0.05-1.62)

1.09 (1.04-1.15)*

1.06 (1.01-1.12)*

NHW

1.00

1.00

NHB

1.82 (0.51-6.56)

0.80 (0.40-1.61)

Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.48 (0.17-1.41)

Education
Less than high school

1.00

High school graduate

0.24 (0.70-1.56)

Some college

0.51 (0.08-3.42)

College graduate

0.07 (0.01-1.02)

Metabolic Markers
Body Mass Index

0.91 (0.85-0.98)*

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.21 (0.07-0.66)*

Euglycemic (A1c < 5.7%)

0.01 (0.00-0.04)*

Health Behaviors
Healthy Eating Index

0.97 (0.92-1.02)

Smoking Status
Current smoker

1.00

Former

0.65 (0.16-2.68)

Non-smoker

1.58 (0.57-4.47)

Alcohol consumption
Non-drinker

1.00

Moderate

0.45 (0.10-2.02)

Above moderate

0.70 (0.06-8.53)

NHW: non-Hispanic white; NHB: non-Hispanic black.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05
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Table A12.2. Relationship between physical activity and diabetes-related mortality stratified by raceethnicity: 2003-2006 NHANES (N=2,595)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

Unadjusted

Fully-adjusted

Unadjusted

Fully-adjusted

Quartile 1

1.00

1.00

1.00

1.00

Quartile 2

No deaths

No deaths

0.25 (0.06-1.04)

0.18 (0.01-2.73)

Quartile 3

No deaths

No deaths

0.18 (0.02-1.78)

0.29 (0.03-2.59)

Quartile 4

0.20 (0.04-1.06)*

0.31 (0.12-0.79)*

No deaths

No deaths

Physical Activity
Total Activity Counts/day

Demographics
Age

1.06 (0.99-1.13)

1.12 (1.03-1.21)*

Gender
Male

1.00

1.00

Female

0.33 (0.10-1.11)

3.80 (1.27-11.43)*

Education
Less than high school

1.00

1.00

High school graduate

0.12 (0.01-1.00)*

1.34 (0.13-13.47)

Some college

0.53 (0.04-6.78)

0.34 (0.02-4.88)

College graduate

No deaths

3.36 (0.06-193.48)

0.93 (0.83-1.03)

0.87 (0.80-0.94)*

Metabolic Markers
Body Mass Index
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.19 (0.07-0.49)*

0.24 (0.06-1.00)*

Euglycemic (A1c < 5.7%)

No deaths

0.03 (0.00-0.84)*

0.96 (0.90-1.03)

1.01 (0.98-1.05)

Current smoker

1.00

1.00

Former

0.85 (0.09-7.91)

0.96 (0.29-3.18)

Non-smoker

3.43 (1.00-11.83)

0.03 (0.00-0.75)*

Health Behaviors
Healthy Eating Index
Smoking Status

Alcohol consumption
Non-drinker

1.00

1.00

Moderate

0.40 (0.05-3.08)

0.71 (0.32-1.62)

Above moderate

No deaths

1.01 (0.23-4.44)

NHW: non-Hispanic white; NHB: non-Hispanic black.
Alcohol consumption: non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05
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Table A12.3. The relationship between total activity counts/day quartiles and diabetes-related mortality: NHANES III
Total Activity Counts/day quartiles
Q1

Q2

Q3

Q4

p-for-trend

757
18
4776.00
1.00
1.00

668
2
4492.08
0.03 (0.01-0.17)
0.04 (0.01-0.20)

609
1
4063.50
0.02 (0.00-0.23)
0.04 (0.01-0.35)

561
2
3713.33
0.17 (0.03-0.86)
0.30 (0.05-1.63)

p=0.03
p=0.07

532
12
3356.50
1.00
1.00

476
0
3215.17
0.00 (0.00-0.00)
0.00 (0.00-0.00)

444
0
2962.58
0.00 (0.00-0.00)
0.00 (0.00-0.00)

440
2
2897.42
0.20 (0.03-1.06)
0.37 (0.07-2.84)

p=0.08
p=0.12

225
6
1419.50
1.00
1.00

192
2
1276.92
0.25 (0.06-1.04)
0.18 (0.01-2.73)

165
1
1100.92
0.18 (0.02-1.78)
0.29 (0.03-2.59)

121
0
815.92
0.00 (0.00-0.00)
0.00 (0.00-0.00)

p=0.02
p=0.13

Total
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa
Non-Hispanic White
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa
Non-Hispanic Black
N
No. of deaths
Person-years
Unadjusted HR
Adjusted HRa
a

Adjusted for: age, gender, education, body mass index, glycemic status, healthy eating index, smoking status, alcohol consumption. HR: Hazard
Ratio. Q: Quartile
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Appendix 13

3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA
(2020) and diabetes-related mortality across race-ethnic groups?
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Using the NHANES accelerometer cutpoint of 2020 cpm (1) the dose-response relationship
between accelerometer-derived minutes of MVPA2020 and diabetes-related mortality was examined.
MVPA was examined continuously in 10-minute increments. Tables A13.1, A13.2 and A13.3 display the
results of these analyses. Across all analyses, no significant reductions in risk were found for every 10
minute accrued of MVPA2020. Due to the lack of deaths related to diabetes as well as the low number of
mean minutes of MVPA, the confidence intervals were large. Thus, no relationships were found.

1.
National Health and Nutrition Examination Survey (NHANES) 2003-2004 documentation,
codebook, and frequencies, MEC exam component: physical activity monitor examination data. Atlanta,
GA: Centers for Disease Control and Prevention; 2007.
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Table A13.1. Relationship between accelerometer-derived MVPA (2020) and diabetes-related mortality:
2003-2006 NHANES (N=2,557)
Variables

Hazard Ratio (95% Confidence Interval)
Unadjusted

Age and race-ethnicity
adjusted

Fully-adjusted

0.33 (0.08-1.30)

0.48 (0.12-1.97)

0.65 (0.24-1.78)

1.06 (0.98-1.15)

1.04 (0.97-1.11)

NHW

1.00

1.00

NHB

1.76 (0.49-6.33)

0.68 (0.17-2.65)

Physical Activity
MVPA 2020 (Every 10 minutes)
Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.52 (0.20-1.33)

Education
Less than high school

1.00

High school graduate

0.31 (0.07-1.01)

Some college

0.45 (0.08-2.59)

College graduate

0.09 (0.01-1.10)

Metabolic Markers
Body Mass Index

0.93 (0.86-1.00)*

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.23 (0.08-0.71)*

Euglycemic (A1c < 5.7%)

0.01 (0.00-0.05)*

Health Behaviors
Healthy Eating Index

0.97 (0.93-1.02)

Smoking Status
Current smoker

1.00

Former

0.57 (0.19-1.67)

Non-smoker

1.07 (0.40-2.85)

Alcohol consumption
Non-drinker

1.00

Moderate

0.38 (0.10-1.52)

Above moderate

0.64 (0.05-7.71)

NHW: non-Hispanic white; NHB: non-Hispanic black.
MVPA 2020: Moderate-to-vigorous physical activity (≥2020 counts/min).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05
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Table A13.2. Relationship between accelerometer-derived MVPA (2020) and diabetes-related mortality
stratified by race-ethnicity: 2003-2006 NHANES (N=2,595)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

Unadjusted

Fully-adjusted

Unadjusted

Fully-adjusted

0.37 (0.09-1.49)

0.77 (0.30-1.99)

0.09 (0.00-1.95)

0.43 (0.11-1.65)

Physical Activity
MVPA 2020 (Every 10 minutes)
Demographics
Age(years)

1.04 (0.97-1.11)

1.10 (1.02-1.19)*

Gender
Male

1.00

1.00

Female

0.38 (0.14-1.06)

2.79 (0.66-11.82)

Education
Less than high school

1.00

1.00

High school graduate

0.20 (0.04-0.87)*

1.69 (0.34-8.47)

Some college

0.35 (0.05-2.70)

0.51 (0.06-4.51)

College graduate

No deaths

5.51 (0.14-220.81)

0.92 (0.83-1.02)

0.87 (0.83-0.92)*

Metabolic Markers
Body Mass Index
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.24 (0.06-0.97)*

0.24 (0.09-0.64)*

Euglycemic (A1c < 5.7%)

No deaths

0.03 (0.00-1.65)

0.96 (0.91-1.02)

1.01 (0.97-1.05)

Current smoker

1.00

1.00

Former

0.75 (0.13-4.22)

0.72 (0.17-2.98)

Non-smoker

2.08 (0.63-6.90)

0.03 (0.00-1.65)

Health Behaviors
Healthy Eating Index
Smoking Status

Alcohol consumption
Non-drinker

1.00

1.00

Moderate

0.35 (0.07-1.65)

0.57 (0.07-4.50)

Above moderate

No deaths

2.78 (0.51-15.27)

NHW: non-Hispanic white; NHB: non-Hispanic black.
MVPA 2020: Moderate-to-vigorous physical activity (≥2020 counts/min).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05

184

Appendix 14

3A. Is there a dose-response relationship between accelerometer-derived minutes of MVPA
(760) and diabetes-related mortality across race-ethnic groups?
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Using the Matthews et al. (1) cutpoint of 760 counts per minute (cpm) the dose-response
relationship between accelerometer-derived minutes of MVPA760 and diabetes-related mortality was
examined. MVPA was examined continuously in 10-minute increments. Tables A14.1, A14.2 and A14.3
display the results of these analyses. As displayed in table A14.1, in the analysis adjusting for age and
race-ethnicity, a significant reduction in risk was found for every 10-minutes of MVPA760 accrued.
Following adjustment for covariates, results were attenuated and significance was lost.
In unadjusted analyses stratifying by race-ethnicity, both NHW (HR 0.70, 95% CI 0.55-0.90) and
NHB (HR 0.67, 95% CI 0.46-0.96) had significant reductions in risk. Following adjustment for
covariates, significance was lost for NHW (HR 0.78, 95% CI 0.57-1.07) and NHB (HR 0.77, 95% CI
0.50-1.17).
The results of the analysis are promising in that the reduction in risk associated with every 10minyes accrued of MVPA760 was 22% in NHW and 27% in NHB. However, the results were not
statistically significant. As discussed in the previous appendices using the continuous NHANES, as more
data are available within the NDI, the ability to examine more robust measures of PA (i.e. accelerometerderived MVPA) and their relationship with diabetes-related mortality will become plausible.

1.
Matthews CE. Calibration of accelerometer output for adults. Med Sci Sports Exerc. 2005;37(11
Suppl):S512-22.
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Table A14.1. Relationship between accelerometer-derived MVPA (760) and diabetes-related mortality:
2003-2006 NHANES (N=2,595)
Variables

Hazard Ratio (95% Confidence Interval)
Unadjusted

Age and race-ethnicity
adjusted

Fully-adjusted

0.70 (0.56-0.87)*

0.74 (0.55-0.99)*

0.78 (0.60-1.02)

1.04 (0.96-1.12)

1.02 (0.96-1.09)

NHW

1.00

1.00

NHB

1.62 (0.46-5.81)

0.63 (0.16-2.51)

Physical Activity
MVPA 760 (Every 10 minutes)
Demographics
Age (years)
Race-ethnicity

Gender
Male

1.00

Female

0.38 (0.14-1.04)

Education
Less than high school

1.00

High school graduate

0.26 (0.07-1.01)

Some college

0.52 (0.11-2.53)

College graduate

0.08 (0.01-0.99)*

Metabolic Markers
Body Mass Index

0.91 (0.85-0.98)*

Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.23 (0.08-0.70)*

Euglycemic (A1c < 5.7%)

0.01 (0.00-0.05)*

Health Behaviors
Healthy Eating Index

0.97 (0.93-1.01)

Smoking Status
Current smoker

1.00

Former

0.53 (0.18-1.60)

Non-smoker

1.31 (0.59-2.92)

Alcohol consumption
Non-drinker

1.00

Moderate

0.46 (0.13-1.61)

Above moderate

0.77 (0.06-9.88)

NHW: non-Hispanic white; NHB: non-Hispanic black.
MVPA 760: Moderate-to-vigorous physical activity (≥760 counts/min).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05
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Table A14.2. Relationship between accelerometer-derived MVPA (760) and diabetes-related mortality
stratified by race-ethnicity: 2003-2006 NHANES (N=2,595)
Variables

Hazard Ratio (95% Confidence Interval)
Race-Ethnicity
NHW

NHB

Unadjusted

Fully-adjusted

Unadjusted

Fully-adjusted

0.70 (0.55-0.90)*

0.78 (0.57-1.07)

0.67 (0.46-0.96)*

0.77 (0.51-1.17)

Physical Activity
MVPA 760 (Every 10 minutes)
Demographics
Age

1.02 (0.96-1.09)

1.07 (0.98-1.16)

Gender
Male

1.00

1.00

Female

0.27 (0.09-0.82)*

2.57 (0.75-8.73)

Education
Less than high school

1.00

1.00

High school graduate

0.13 (0.02-1.07)

1.52 (0.29-7.93)

Some college

0.46 (0.08-2.86)

0.45 (0.07-2.96)

College graduate

No deaths

4.45 (0.13-152.65)

0.91 (0.83-1.00)*

0.87 (0.82-0.92)*

Metabolic Markers
Body Mass Index
Glycemic Status
Diabetes (A1c ≥ 6.5%)

1.00

1.00

Pre-diabetes (A1c 5.7-6.5%)

0.21 (0.05-0.86)*

0.25 (0.08-0.80)*

Euglycemic (A1c < 5.7%)

No deaths

0.03 (0.00-1.10)

0.96 (0.90-1.02)

1.01 (0.97-1.05)

Current smoker

1.00

1.00

Former

0.71 (0.14-3.67)

0.84 (0.25-2.83)

Non-smoker

2.78 (1.01-7.63)

0.03 (0.00-0.50)*

Health Behaviors
Healthy Eating Index
Smoking Status

Alcohol consumption
Non-drinker

1.00

1.00

Moderate

0.46 (0.11-1.96)

0.72 (0.11-4.85)

Above moderate

No deaths

2.43 (0.45-13.34)

NHW: non-Hispanic white; NHB: non-Hispanic black.
MVPA 760: Moderate-to-vigorous physical activity (≥760 counts/min).
Alcohol consumption: Non-drinker (0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above moderate (>1
[women], >2 [men] drinks/day).
*p<0.05

188

Appendix 15
Mortality Tables: NHANES III, 1999-2004 NHANES, 2003-2006 NHANES
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NHANES III mortality rates: all-cause, non-diabetes related, and diabetes-related

Table A15.1. Mortality rate for diabetes-related mortality by race-ethnic group: NHANES III

RACE

N

Death
events

Non-Hispanic White
Non-Hispanic Black
Mexican American

4563
3057
3097

127
88
116

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

62.1 (0.8)
58.0 (1.0)
54.6 (1.3)

75.1 (1.2)
69.7 (1.0)
68.3 (1.3)

81,008.34
54,841.50
58,086.08

Crude mortality
rate
(per 10,000 personyears)
15.7
16.0
19.9

Age-standardized
mortality rate
(per 10,000 person-years)
12.3
18.1
26.6

Table A15.2. Mortality rate for non-diabetes related mortality* by race-ethnic group: NHANES III
Crude mortality
Age-standardized
rate
mortality rate
RACE
N
(per 10,000 person(per 10,000 person-years)
years)
Non-Hispanic White 4563
1216
60.6 (0.7)
73.2 (0.6)
81,008.34
150.1
117.1
Non-Hispanic Black 3057
634
54.0 (0.7)
65.8 (0.8)
54,841.50
115.4
136.5
Mexican American 3097
433
51.2 (0.8)
64.1 (0.8)
58,086.08
74.5
96.3
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual
causes
Death
events

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Table A15.3. Mortality rate for all-cause mortality by race-ethnic group: NHANES III

RACE

N

Death
events

Non-Hispanic White
Non-Hispanic Black
Mexican American

4563
3057
3097

1343
722
549

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

60.8 (0.6)
54.5 (0.6)
51.8 (0.8)

73.4 (0.6)
66.3 (0.6)
64.8 (0.8)

81,008.34
54,841.50
58,086.08
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Crude mortality
rate
(per 10,000 personyears)
165.7
131.5
94.5

Age-standardized
mortality rate
(per 10,000 person-years)
129.5
154.7
122.8

1999-2004 NHANES mortality rates: all-cause, non-diabetes related, and diabetes-related

Table A15.4. Mortality rate for diabetes-related mortality by race-ethnic group: 1999-2004 NHANES

RACE

N

# of
deaths

Non-Hispanic White
Non-Hispanic Black

2383
944

35
27

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Crude mortality rate
(per 10,000 personyears)

64.5 (1.8)
61.5 (1.6)

70.7 (1.8)
67.6 (1.7)

21,573.84
8402.92

16.2
32.1

Age-adjusted mortality
rate
(per 10,000 personyears)
15.4
44.5

Table A15.5. Mortality rate for non-diabetes related mortality by race-ethnic group: 1999-2004 NHANES
Age-adjusted mortality
rate
RACE
N
(per 10,000 personyears)
Non-Hispanic White
65.7 (0.6)
71.7 (0.6)
21,573.84
165.9
156.1
2383
358
Non-Hispanic Black
59.5 (1.2)
64.6 (1.3)
8402.92
195.2
232.9
944
164
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual
causes
# of
deaths

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Crude mortality rate
(per 10,000 personyears)

Table A15.6. Mortality rate for all-cause mortality by race-ethnic group: 1999-2004 NHANES

RACE

N

# of
deaths

Non-Hispanic White
Non-Hispanic Black

2383
944

393
191

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Crude mortality rate
(per 10,000 personyears)

65.6 (0.7)
59.7 (0.9)

71.6 (0.7)
65.0 (1.0)

21,573.84
8402.92

182.2
227.3
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Age-adjusted mortality
rate
(per 10,000 personyears)
171.5
277.5

2003-2006 NHANES mortality rates: all-cause, non-diabetes related, and diabetes-related

Table A15.7. Mortality rate for diabetes-related mortality by race-ethnic group: 2003-2006 NHANES

RACE

N

# of
deaths

Non-Hispanic White
Non-Hispanic Black

1892
703

14
9

Baseline age
mean

Death age
mean

Total personyears

Crude mortality rate
(per 10,000 personyears)

65.5
67.6

70.7
71.3

12,431.67
4,613.25

11.3
19.5

Age-adjusted mortality
rate
(per 10,000 personyears)
10.7
33.4

Table A15.8. Mortality rate for non-diabetes related mortality by race-ethnic group: 2003-2006 NHANES
Age-adjusted mortality
rate
RACE
N
(per 10,000 personyears)
Non-Hispanic White 1892
150
65.1 (0.6)
69.2 (0.6)
12,431.67
120.7
115.4
Non-Hispanic Black
703
64
61.6 (1.3)
65.6 (1.5)
4,613.25
138.7
160.4
*Mortality from heart disease, cancer, respiratory diseases, accidents, cerebrovascular disease, Alzheimer’s, influenza and pneumonia, kidney disease, or residual
causes
# of
deaths

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Crude mortality rate
(per 10,000 personyears)

Table A15.9. Mortality rate for all-cause mortality by race-ethnic group: 2003-2006 NHANES

RACE

N

# of
deaths

Non-Hispanic White
Non-Hispanic Black

1892
703

164
73

Baseline age mean
(SE)

Death age mean
(SE)

Total personyears

Crude mortality rate
(per 10,000 personyears)

65.2 (0.7)
62.3 (1.1)

69.2 (0.7)
66.3 (1.3)

12,431.67
4,613.25

131.9
158.2
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Age-adjusted mortality
rate
(per 10,000 personyears)
126.1
193.8
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